ML20080N146
| ML20080N146 | |
| Person / Time | |
|---|---|
| Site: | Limerick  |
| Issue date: | 12/31/1994 |
| From: | Boyce R PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC |
| To: | |
| Shared Package | |
| ML20080N087 | List: |
| References | |
| PROC-941231, NUDOCS 9503060162 | |
| Download: ML20080N146 (185) | |
Text
{{#Wiki_filter:-- - _ _ --- -- - . - - ki
+
i v !l PECO !! ENERGY
+
Limerick i; Generating Station . f: f
?
i f II (; k h i I
~ ?!A A8aeE 8!88ais2 f R PDR il 1
--~ ~- - - - - - -
,7^.
. m .
- f;p n 4
f
' t i v PORC YES SQR- YES ,
NQA- NO-50.59 YES. , RESP.MGR. YES-L LIMERICK GENERATING STATION UNITS 1 AND 2 OFFSITE DOSE CALCULATION MANUAL ; l Revision 15 t t 6 PECO ENERGY COMPANY DOCKET NOS. 50-352-AND 50-353 - o t Approval: !* * " Plant Manager we J T - ~ m .- ,- - . , - , , - - e - w w
ODCM R3v. 15
-12/94
-Table of Contents Page Part I - RADIOLOGICAL EFFLUENT CONTROLS 1.0_ DEFINITIONS- 1 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS 6 2.1 METEOROLOGICAL MONITORING' INSTRUMENTATION 6 2.2 MAPS-DEFINING UNRESTRICTED AREAS AND SITE-BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6 2.3 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION '6-2.3.1 Concentration 9 2.3.2 Dose 9 2.3.3 Liquid Radwaste Treatment System 10 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 2.4.1 Dose Rate 10 2.4.2 Dose - Noble Gases 11 2.4.3 Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form 12 2.4.4 Ventilation Exhaust Treatment System 12 2.4.5 Venting and Purging 13 R2.4.6 Total Dose 13 2.5 MONITORING PROGRAM 13-2.5.1 Land Use Census 14 2.5.2 Interlaboratory Comparison Program 14 2.6 APPLICABILITY 14 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 16 3.1 METEOROLOGICAL MONITORING INSTRUMENTATION 17 i
g . - - -- - ~
.ODCM R;v. 15'
~
v: 12/941 j i
-Page- ]
j 3.2 RADIOACTIVE. LIQUID. EFFLUENT MONITORING.INSTURMENTATION. 21-3.2.1,. Radioactive Effluent. Monitoring
' Instrumentation ~ Controls 21
3.2.2 Concentration
L24 ; 3.2.3x 4 Dose '28
- 3 . 2 .' 4 .-Liquid Radwastel Treatment System 29-3.3 GASEOUS EFFLUENTS.
~
3.3.1- Radioactive Gaseous Effluent Motoring Instrumentation 30
'35 3.3.2 SITE. BOUNDARY Dose Rate .
3.3.3 Dose - Noble Gases- 39-
- 3.3.4 Dose - Iodine-131, Iodine-133, Tritium,;and-Radionuclides in Particulate Form 40 3.3.5 Ventilation Exhaust Treatment System J411 ;
3.3.6 Venting or. Purging 42
. 3.3.7 Total Dose 43; ;
3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1 Monitoring Program 44? 3.4.2 Land Use Census 157 -l 3.4.3 Interlaboratory Comparison Program 58 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL' OPERATING REPORT 59: .; I 3.6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 )
.l 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62' i l
j 11 4
y 4 x. ODCM Rev.-15 12/94.
-LIMERICK GENERATING STATION' OFFSITE DOSE CALCULATION MANUAL' TABLE CONTENTS
-Page
. Part II - CALCULATION METHODOLOGIES 1.0 ' LIQUID EFFLUENTS 63 1.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 63 1.2 LIQUID EFFLUENT-MONITOR SETPOINT DETERMINATION 64 1.2.1 Radwaste Discharge Monitor 64 1.2.2 Service Water Radiation Monitor -67 RER Service Water M o nitor 68 1.2.3 1.3 LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50 69 1.3.1 Member of the Public Dose - Liquid Effluents 69-1.4 LIQUID EFFLUENT DOSE PROJECTION 74
]
2.0 GASEOUS EFFLUENTS 75-2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 75 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION 75. i
.l 2.2.1 North Vent Noble Gas Effluent Monitors 77 2.2.2 South Vent Noble Gas Effluent Monitors 79 2.2.3 Noble Gas Effluent Fractional Contribution- 81 2.2.4 Noble Gas Effluent Default Setpoints 82 2.2.5 WRAM Noble Gas Effluent Monitor 86 2.3 GASEOUS EFFLUENT DOSE EVALUATIONS 91 2.3.1 Site Boundary Dose Rate - Noble Gases 92-2.3.2 Site Boundary Dose Rate - Radioiodine and :
Particulates 94 2.3.3 Noble Gas Air Dose 95 2.3.4 Radioiodine and Particulate Dose Calculations 10 CFR 50 96 111
i s w .ODCM Rev.I 15 .i 12/94 ) Page .. 2'.3.5 Annual Dose Evaluation' 99
~
;. 3 _ 2.4. GASEOUS EFFLUENT DOSE PROJECTION 102' 3 '. O . SPECIAL DOSE ~ ANALYSIS '103
.'3.1 : TOTAL DOSES TO MEMBERS OF THE PUBLIC 103 3.2- DOSES DUE TO ACTIVITIES:INSIDE THE SITE BOUNDARY :104 4.0--RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 106 4.1 SAMPLING PROGRAM 106
'4.2 INTERLABORATORY COMPARISON PROGRAM 106' APPENDICES Appendix A - Technical Specification /ODCM 159 Appendix B - Radiological Environmental Monitoring 162.
Program - Sample-Type, Location and-
- Analysis l
l 5 8 i I l t iv b
d
~
LODCM-RLv. 15 4 <n < 12/94-LIST'OF TABLES 37,;;. If1;1 . Surveillance Frequency Notation-I:3.1-1 MeteorologicalLMonitoring Instrumentation-
.I 3.1-2 Meteorological. Monitoring Instrumentation Surveillance; Requirements.
I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive. Liquid Effluent Monitoring Instrumentation-Surveillance'-Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent-Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and' Analysis Program , I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations.In , Environmental Samples I 3.4-3 Detection. Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors'iDaipj) For Liquid Effluents , II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases L II 2.2 Ingestion Individual. Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation , II 2.4 Nearest Gaseous Effluent Dose Receptor DistancesL(Meters) ; A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program 9 Y E- . _ , . . _ _ . _ . .
+ +
ODCM Rev. 15 12/94
, LIST OF FIGURES I 2.2-la Map Defining Exclusion Areas for Radioactive
-Gaseous and Liquid Effluents I 2.2-lb Map Defining Low Population Areas for-Radioactive Gaseous and Liquid Effluents I 3.1-1 Meteorological Tower Location II 1.3.1-1 LGS Dilution vs River Flow (Outfall)
II 1.3.1-2 LGS Dilution vs River Flow'(Citizen's Utility) II.:1.3.1-3 LGS Dilution vs River Flow (Phoenixville) II 1.3.1-4 LGS Dilution vs River Flow (Philadelphia Suburban) II 1.3.1-5 LGS Dilution vs River Flow (Crew Course) II 1-1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North Stack II 2-2 Gaseous Effluent Flow Diagram - South Stack II 2-3 Gaseous Effluent Flow Diagram - Hot Maintenance Shop B-1 Environmental Sampling Location on Site or Near the Limerick Generating Station B-2 Aquatic and Terrestrial' Environmental Sampling Location at Intermediate Distances from1the Limerick Generating-Station Airborne and TLD Environmental Sampling Locations at-B-3 . Intermediate Distances from the Limerick Generating. Station B-4 Environmental Sampling Locations at Remote Distances from the Limerick Generating Station vi
- g; @
< -- i 1
l 1 PURPOSE The' purpose of the Offsite Dose Calculation Manual is to establish methodologies and procedures for calculating doses to. individuals :in areas at and beyond.the SITE BOUNDARY due to radioactive effluents. from Limerick Generating Station. F f 4 e J F
I, , E i i i.
' PART I RADIOLOGICAL EI" FLUENT CONTROLS i
'l l
i 1 i h. I I f l (
8s . p, ~, j
$ -l .
ODCM Rsv. 15. a.1; .
- l - Pcg/94 12 ={
e 1.0 DEFINITIONS ]
.The following terms are taken from LGS Unit 1, Unit.2 Tech Specs.
; l ~.1 ACTION ACTION shall be that part'of:a specification which prescribes; remedial measures required under designated conditions.- ,
1.2 CHANNEL CALIBRATION , A CHANNEL CALIBRATION shall be the adjustment, as necessary, of { the channel output such that'it responds with the necessary , range and' accuracy to known values.of the parameter.which the-- channel monitors. -The CHANNEL CALIBRATION shall encompass.the entire channel including the sensor and alarm and/or trip . functions,.and shall include the CHANNEL-FUNCTION' TEST. . The CHANNEL CALIBRATION may be performed by any. series of . sequential, overlapping or total channel steps such that'the entire channel is calibrated. d 1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitativelassessment of channel ' behavior during operation by observation. This determination. shall include, where possible, comparison.of the. channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same. 1
+
parameter. e 1.4 CHANNEL FUNCTIONAL TEST .i A CHANNEL FUNCTIONAL TEST shall be: 4
. - . i
- a. Analog channels' =the injection of a simulated signal i into the channel as close to the sensor as practicable.
to verify OPERABILITY including alarm and/or trip: '
. functions and channel failure trips. ;
7
- b. Bistable channels - the injection of: a simulated signall into the sensor to verify OPERABILITY including alarm- il and/or trip functions.
The CHANNEL FUNCTIONAL TEST may be performed-by any series'of' ! sequential, overlapping or total-channel steps such that the
- entire channel is tested. ;
f 4 i'
\
+
j i
^_
; - - . . - - ~ ~ . . - ..
^ ? 4 ). ,
a p . , 4 ODCM Rev.'15'
-l1 H PIge 2, Ll 12/94
~
21.5 CONTINUOUS SAMPLING M Per ASTM Standard (1987) Section'II (Water and Environmental
-Technology), Volume 11.03, Article D1356;.is defined . 2 as" sampling without interruptions throughout an. operation or-r .
for a predetermined' time." -A CONTINUOUS SAMPLE is the opposite i.of a GRAB . SAMPLE.: The time, period.' involved to secure;(shut- "
- down) ventilation or.re-establish sampling of the release pathway shall meet the' intent of'CONTINUOUSLSAMPLING.
consistent with. industry standards, the time allowance shall. ' ~ ; not exceed 8 hours.
~
1.6 . DOSE EQUIVAT RNT I-131
' DOSE EQUIVALENT I-131 shall be that concentration of I-131',
microcuries.per gram, which alone:would produce the same thyroid. dose as the quantity'and isotopic mixture of I-131,,I-132, I-133, I-134 and I-135-.actually present. The thyroid dose lT conversion factors used for this calculation shall'be those- i listed in Table III of TID-14844, " Calculation.of. Distance'- . Factors'for-Power and Test Reactor Sites." i
. .- l 1.7 FREQUENCY NOTATION The FREQUENCY NOTATION specified for'the performance'of Surveillance Regttirements shall correspond to the intervals ~ ,
defined in Table II.1. -{
-i 1.8 MRMnRR(S) OF THE PUBLIC ,
MEMBER (S) OF THE PUBLIC shall include all' persons who are not. occupationally associated with the plant. This. category does - 4 not include employees of the utility,.its, contractors, or
. vendors. Also excluded from this' category are persons'who
- enter the alte to service equipment or to make-deliveries'.
This category.does include persons who use portions'of thefaite ' for recreational,. occupational or other. purposes not associated: with the plant. . 1.9 OFFSITE DOSE CALCULATION MANUE i The OFFSITE DOSE CALCULATION MANUAL;(ODCM)'shall contain the? - methodology and parameters used in the calculation of offsite-doses resulting.from radioactive gaseous.and liquid effluents,- 7 in the calculation of gaseous and liquid effluent monitoring Alarm / Trip setpoints, and.in the conduct of the' Radiological Environmental Monitoring Program. The ODCM shall'also contain j (1) the Radioactive Effluents Controls and Radiological , Environmental Monitoring Programs required by Technical' Specification 6.8.4 and (2) descriptions of the 7 j 1 a 3
<* - - w . _m m ..,,-...,w...~.,<w- , ,[ .. . . , ,
E- m, , . . , , . y,,,-..-.r- ,y , - , .,7
g .,;.. . . ~ m . _ _ _ , . I" o j - " ~
< ODCM Rev. 15 3 3- i Pag112 /94-M* ,
!T ,
E - information that should-be-included in the Annual Radiological.i : Environmental Operating and Annual: Radiological Effluent
^
-l-
= g"
~ Release . Reports required by Technical- Specifications 6.9.'l.7 -
- and 6.9.1.8. (3) description of meteorological monitoring:
e . controls. 1.10' OPERABLE - OPERABILITY A' system,Jsubsystem,-train, component or device.shalb be OPERABLE or have OPERABILITY whenilt is capable of performing.
-its specified functions (s)'and when all necessary attendant- '
instrumentation, controls,_ electrical power,. cooling or: seal.
, water, lubrication _or other auxiliary equipment that are required for the system, subsystem,; train, component or device-to. perform its-function (s) are also capable of performing their ~
related support function (s). .
'1'.11 OPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, _ i . e., CONDITION,.shall be any one
- inclusive-combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications. 1.12 PURGE - PURGING - PURGE or' PURGING shall be the controlled process of discharging.- air or gas'from a confinement to.' maintain. temperature, pressure, humidity, concentration or other operating condition,: > in such a manner that replacement air,or' gas is required to ' . purify-the confinement. 1.13 RATED THERMAL POWER See current LGS Tech Spec definition. ' 1.14 REPORTABLE EVENT A REPORTABLE EVENT shall be any of-those conditions.~specified
- in Section 50.73 of 10 CFR Part 50.
. 1.15 SITE BOUNDARY The SITE BOUNDARY-shall be that line as defined:in Figure.I2.2- q la. e r 4 a # e E T , ww-s ir--w- w-- + . m .-.i.4 +. -- %= .- 4 * - ..---.+w-e
< - - .- -.i- e -- %. . * - *=.
~ . ~ , .- _ .
g + e "
' l(
ODCM Rev. 15; e,4'
- l. -Pag 12 /94 1.16 SOURCE CHECE
# -A SOURCE CHECK chall be the qualitative' assessment ofl channel' response when tha channel sensor is exposed to a radioactive source. '
( , 1.17 THERMAL POWER J THERMAL' POWER shall be the total reactor core heat transfer i rate to the reactor coolant. 1.18 UNRESTRICTED AREA , p An UNRESTRICTED AREA shall be any area at or.beyond the SITE- 'i BOUNDARY access to which is not controlled by the licensee for'
. purposes of protection of individuals from exposure-to-4 radiation and radioactive materials, or any are within the SITE- ,
BOUNDARY used.for residential. quarters or for industrial, commercial, institutional, and/or recreational = purposes. J 1.19 VENTILATION EXHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM shall belany system designed and installed to reduce gaseous: radioiodine or q radioactive material in particulate form in. effluents by. ; passing ventilation or vent exhaust gases through. charcoal
' absorbers and/or:HEPA~ filters for the purpose'of removing =
iodines or particulates.from the gaseous exhaust stream priori to the release to the environment.(such a system is not considered to have any effect on noble gas: effluents). Engineered Safety Feature-(ESP) atmospheric cleanup' systems: > are not considered to be VENTILATION-EXHAUST TREATMENT SYSTEM components. , 1.20 VENTING , VENTING shall be the controlled process of discharging air'or gas from a confinement to maintain temperature,' pressure, humidity, concentration or other- operating condition, in such a. manner that replacement air or gas is not provided or required , during VENTING. Vent, used in ' system names, ~ does not imply' a-VENTING process. ,
- r. ,
s 1 P 5 a,+ ._ . _. _ _ _= __ _ _ _ _ _ -- _ -__ _ __ _____.__________.____m _s___ ____m__m-
v , J l, ' li 'ODCM Rev.Il5' l . m 35
-l Pcg/94 l12 -
'~ '
TARTR II .1 SURVEILLANCE FREOUENCY NOTATION s NOTATION FREOUENCY
-~S'(Shift)- At least once_per--12. hours.
D.(Daily) At least.once per 24-hours. W-(Weekly) At-least Once per.7 days. M (Monthly) At least once per 31, days. j Q (Quarterly) At least once per 92 days. SA (Semi-annual)- At least once per 184 days. 1' A (Annual) At least once per 366 days. E At least once per 18 months (550 days). R At least.once per_24 months (.731' days).. , S/U Prior to each reactor startup.- t P Prior to each radioactive release. N.A. Not applicable. f
?
e b 4i i-.?!i t
- ,- . - . .. - , ~. . .,
,, 1 ODCM Rsv. 15-i6 l Png/94-12 m.
2.0 BASIS FOR EFFLUENT MONITORING CONTROLS j 2.1 METEOROLOGICAL INSTRUMENTATION m : The OPERABILITY.of the meteorological monitoring .. j instrumentation ensures that sufficient meteorologica1' data is available for estimating potential' radiation doses to the jl public as'a> result of routine or accidental release of . i
-radioactive materials to the atmosphere. This capability.is i required to evaluate the need for initiating measures to; N protect the' health and safety of the public. This .. instrumentation.is consistent with the recommendations of-Regulatory. Guide 1.23 "Onsite Meteorological-Programs,"
February, 1972..; ] Site data compiled since January l1972 provide correlation l between Elevation 1-(Tower 1)'and Elevation 1 (Tower.2), and b between Elevation 2 (Tower.1) and Elevation 2 (Tower-2). This , correlation-serves as justification for.the use of the 7 appropriate Tower 2 instrument as a back-up to the Tower 1 1 instrument as shown in Table'I3.1-1 and Table-I3.1-3. 2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNn1RY-FOR.
- RADIOACTIVE GASEOUS AND LIOUID EFFLUENTS
.Information regarding radioactive. gaseous and;1iquid-effluents, which will allow identification of structures and release points as well as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF.THE PUBLIC, . I shall be shown in Technical Specifications Figures 5.1.3-la and R 5.1.3-1b. ']
The exclusion area and low population' zone.shall be'as shown in
~
l Figures I2.2-la and I2.2-lb. 'l 2 - 2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION; .l The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential > releases of liquid effluents. The alarm / trip setpoints for. these instruments shall be calculated in accordance with the-procedures in the ODCM part II to ensure that the alarm / trip.
~
will occur prior to exceeding the limits of-10 CFR Part 20.. , The OPERABILITY and use of this instrumentation is-consistenti. ' - with the requirements of General Design Criteria 60, 63,fand 64 of Appendix A to 10 CFR Part 50.
?
1 I J
l
,j.
ODCM R';v. 15 l a7 I Prg/94 12 ) (). I FIGURE T2.2-la EXCLUSION ZONE y,que,sr. . w '
- f L .L >% y m m
+ -
9
- 17 ?: ; 3 JlT ""t-j{" M * '~S's l'" "*b'hh - s.'s'
?
?'
/ j ;/-
%), ,anIi'Eu'E"Any e
~
p"{O , c',', d
<.', C .
E' . ft /.k. i
\x(,'I l A ;3 =
,,,,,,. ,)i a
.?43 v' c' /- '"
ln i
- 7. s
;C .
)- n' u ',, ! p i
,m$ t y a Y "' '
~
\ ;/
*/ /' t' y '?Y..: '- \ ) 3 e < %*at '
,9fy;,++
l',.. *; , y a. ..*9 ',y ( j,<NUCLEARTR
% amsC' '
- f, .
1 '" - 1b }a Cxs tSERICK Lock - GENERAMG STAT!p,
~
g
.' 4 (cEE0n -
.MsI ,
n ; v q w y ;, 3 , 7' ' %..f .ys x D.m &h r '(' Ds-
.' y ..l'\,d
,s .,- .
?. t' l'
.J ' -
\, 'G e'.
...Ali;,Q' n- ,.
a <\ y. . \ t n *
; y ,~
\
m _- J) *i \ Q[% L. ! p ' '. .%;',
- N.pg\ .Q '
.' j j l
NN; q' )w<.h%' N , .
\ 9f.'k ^ ,
'r ~N s
0 ,
$ y% 9 d h % - :.i ,..;
>W - e-l 'c&y.- \
\ egg c y >'- ~ N\ g
, p *** ,,h hg l" Y.. . ,:N,% S-Y " (Y
M 48 ODCM.Rsys 15 Paga 8 12/94 1 l FIGURE T2.2-1b LOW POPULATION ZONE J
'w- ,g j dY
)
i l i i
==. \,
l
- a. ...'
"~
. ja- t
==>- )\
'Cnv Ii l
3 3 vc 4; N: l' ODCM Rsv. 15 a 9: i m sli Pcg/94'
'12 l2.3.1 CONCENTRATION
- This control is provided to. ensure that the concentration of' radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels specified in 10 C"R Part 20, Appendix 'B, l Ta>1e II, Column :2.
This.-limitation provides additional assurance that the levels of' radioactive materials in bodies.of; water-in UNRESTRICTED AREAS will result in exposures within.(1) the Section'II.A . design objectives.of Appendix.I, 10.CFR Part 50, to a MEMBER OF
-lL THE PUBLIC, and (2) the limits of 10-CFR 20.1301(e) to the:
population.. The concentration limits for dissolved or entrained noble gases are based upon the: assumption that Xe-135-is'the controlling radioisotope and its MPC in air,was-converted to an equivalent-concentration in water using the? methods described in the International Commission on Radiological Protection.(ICRP) Publication 2. The: required detection capabilities for radioactive materials in liquid waste samples are tabulated in. terms of.the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL ProceduresL. ' Manual,-HASL-300 (revised annually), Currie, L.A., " Limits forf Qualitative Detection and Quantitative' Determination - . Application to Radiochemistry," Anal. Chem. 40. 586-93 (1968). and Hartwell. J.K.. " Detection Limits far Radionnalvtical Counting Techniques." Atlantic Richfield Manford' Company. Renort ARH-SA-215_(June, 1975). ; 2.3.2 DOSE This control is provided to-implement the requirements of Sections II.A, III.A, and IV.A of. Appendix I,-10 CFR Part 50. The Control implements the guides: set forth in Section:II.A'of Appendix I. The ACTION statements provide.the1 required
. operating flexibility and at the same time: implement the-guides <
set forth in Section IV.A of Appendix I to assure that,the releases of radioactive material in liquid effluents will be kept "as low as reasonably achievable". Also,-for' fresh water' , sites with drinking water supplies which can be potentially. affected by plant operations, there is~ reasonable assurance that the operation.of the facility will not result in rndionuclide concentrations in the finished drinking water that are in excess of the requirements'of 40 CFR Part 141. The dose. calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that
- conformance with the. guides of Appendix I be shown by ..
calculational procedures based on models and data, such that: the actual exposure of a MEMBER OF THE PUBLIC through. appropriate pathways is_unlikely to be substantially. !
" - underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with .
the methodology provided in Regulatory Guide 1.109, !
" Calculation of Annual Doses to Man from Routine Releases of 1 Reactor Effluents for the Purpose of Evaluating Compliance with
. .. 1'u _ _ . _ . _ _ _ _ - _ _ _ . . _ ._. .______ __
E 7>
- A , ,
q
-' y: '?
~
ODCM Rev. 15L E
- Paga 10-J14 12/94.
, '10.CFR Part 50, Appendix I," RevisionL1,' October, 1977 and-Regulatory Guide 1.113, " Estimating Aquatic -Dispersion' of: ._
^ Effluents from Accidental ani Routine Reactor Release: for the g cPurpose of Implementing Appendix I," April, 1977. 2.3.3 LIOUID RADWASTE TREATMENT SYSTEM ' ~ The requirement that the appropriate portions-of'this system be. used when specified provides1 assurance.that the releasesiof , ; b ' radioactive materials in-. liquid offluents will be kept'"as low; as-reasonably. achievable".. This specification implements the requirements.of 10 CFR 50.35a, General Design Criterion 60fof- E Appendix-A to 10.CFR Part'50 and the design objective giventin-Section-II.D of Appendix Iz to 10 CFR Part 50.: The.specified limits governing the use of appropriate portions of-'the liquid-1- radweste treatment system were specified as a suitable fraction. - F of the dose design objectives: set forth.in Section.II.A of Appendix I, 10 CFR Part 50, for liquid effluents. 2.4 RADIOACTIVE GARMOUS EFFLUENT MONITORING INSTRinntNTATION' 1
- The radioactive gaseous effluent instrumentation'is provided to~ -
. monitor and control, as applicable, the releases of radioactive
- materials in gaseous effluents during actual or.. potential releases of gaseous effluents. The alarm / trip-'setpoints for' ;
these instruments shall be calculated in accordance with.thei procedures in;the ODCM to ensure that the alarm / trip _will occur < . prior to exceeding the. limits of:10 CFR'Part 20. The . OPERABILITY and use of this instrumentation is consistent with" ! the requirements of General Design Criteria 60, 63, and 64~of: Appendix A to 10'CFR Part 50. t 2.4.1 DOSE RATE
- This control is provided to ensure that the dose at any time _~at~
and beyond the SITE BOUNDARY from gaseous effluents from the j site wall be within the annual dose limits'of.10 CFR-Part 20 to. 1 UNRESTRICTED AREAS. The annual ~ dose' limits!are the dose ~J . associated with the concentrations of . d 10 CFR Part 20, Appendix B, Table II, Column I. These limits provide reasonable assurance that radioactive material discharged.in gaseous effluents will not result in the exposure-i of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA,;either. , within or~outside the SITE BOUNDARY, to annual average >
, J - i- concentrations exceeding the limits specified in Appendix B, ll Table II of 10 CFR Part;20 (10 CFR 20.106(b)(1)). -For MEMBERS OF THE PUBLIC who may at times be.within the SITE BOUNDARY, the-g occupancy factor for that-MEMBER OF'THE~PUBLIC will usually be !
sufficiently low to compensate for any increase in the :) atmospheric diffusion factor-for above that for the SITE ') ' BOUNDARY. Examples of calculations for.such MEMBERS OF THE . l
- PUBLIC, with the apcropriate occupancy factors, are given in the ODCM. The speelfied release rate limits restrict, at all times, the correspanding gamma and beta dose rates above j be.ckground to a MFMBER OF THE PUBLIC at or.beyond the SITE l
' BOUNDARY to less than or equal to 500 mroms/ year to the total ) l h
Q} f + l ODCM rov. 15~
-Paga 11 l- 12/94~
, : body.or to11ess.than..or equal to"3000 mrems/ year to the/ skin; '
n These release corresponding rate' dose thyroid limitsrate.above also restrict,iat all times, background thev , ia to a child the-inhalation. pathway-to less than or equal to 11500~arems/ year.- I - -This Control' applies to the release of radioactive materials <in a 'gaseousLeffluents fromlall reactors at the site.
~
The required detection capability for radioactive materials in~~- gaseous waste samples are tabulated in-terms =of.the; lower. E limits.of detection (LLDs). . Detailed discussion of the LLD,. and other detection limits.can be found in HASL Procedures Manual, HASL-300 (revised annually),: Currie, L. A. , " Limits for-Qualitative Detection and Quantitative Determination - Application to' Radiochemistry," Anal. Chem. 40, 586-93 (1986). and Hartwell, J.K., " Detection T.imits for Radionnalvtical . Countina Techniaues."- Atlantic Richfield Hanford rwenany Reoort ARH-SA-215 (June 1975). 2.4.2 DOSE - NOBLE GASES
.This._ control is provided to implement'the requirements of Sections II.B, III.A, and IV.A of Appendix I,110 CFR Part 50.
The' control implements the guides set forth'in Section;II.B'of '~ Appendix I. The ACTION' statements: provide the, required ~ operating flexibility and at_the same time implement the guides set forth~in Section'IV.A of Appendix I to assure that the.
- releases of radioactive material in gaseous effluents will'be kept aas low as reasonably achievable".. The Surveillance Requirements implement the- requirements "in Section -III. A of Appendix I that conformance with the guides of Appendix-I be shown.by calculational procedures based:on; appropriate. pathways in unlikely to be substantially underestimated. -The dose
; calculation established in the ODCM<for calculating the doses due to the actual release rates of radioactive-noble gases in gaseous offluents are-consistent with the methodology.provided-in Fagulatory Guide 1;109,." Calculation of' Annual' Doses to Man-from Routine Releases of Reactor EffluentsIfor the Purpose.of:
Evaluating Compliance with 10 CFR Part.50, Appendix I," . Revision I, October 1977 and Regulatory Guide 1.111, " Methods; for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routing Releases from Light-WaterLCooled Reactors,"-Revision 1, July 1977 with siteLspecific_ dispersion . curves and deposition method: logy. The ODCM equations provided for determining the air doses at an beyond the. SITE' BOUNDARY. are based upon the historical average atmospheric conditions'.. k j'g'- ,
myn ~ i m- - --- n
]; ' '
ODCM Riv. 15
- a ,.
'Pcg3 12-
'l 12/94; .;
2.'4. 3 L DOBE : IODINE-131. IODINE-133. TRITIUM. AND BanIONUCLIDER'IN PARTICULATE FORM j This control.is provided to' implement the requirements of; Sections II.C,.-III.A, and IV.A'of Appendix I, 10 CFR Part 50.: TheLcontrols:are the guides: set forth in section II.C of' . , Appendix '. I . : .The ACTION statements' provide theLrequired' . operating flexibility;and at the'same time' implement.the guides set forth-in Section IV.A of~ Appendix.I to assure that'tho'.
' releases of' radioactive > materials.in gaseous offluents will~be .
< kept "as low.as is~ reasonably achievable." The ODCM calculational' methods specified in the, Surveillance Requirements implement the' requirements inLSection;III.'A of .
g Appendix I be shown by calculationalLprocedures i based on models' L and data, such that.the. actual' exposure of a: MEMBER'OF THE -' PUBLIC through appropriate pathways.is unlikely to be . substantially underestimated. The ODCM calculational methods 1 for calculating the doses due to the actual release' rates of- - i- the subject materials are consistent with the methodology._ provided in Regulatory Guide 1.109, Calculation of' Annual Doses; to Man from Routine. Releases of Reactor Effluents-for the l- Purpose of. Evaluating. Compliance with 10 CFR Part 50,cAppendix.- l I,". Revision I, October 1977 and Regulatory' Guide 1.111, b " Methods for. Estimating Atmospheric Transport:and Dispersion:of' - Gaseous Effluents in Routine. Releases from Light-Water-Cooled. Reactors," Revision 1, July'1977_with site. specific dispersion curves and deposition methodology. These equations:also provide for determining the actual doses based upon the i_ historical average atmospheric conditions.- The release rate ~ specifications for iodine-131, iodine-133, tritium, and-radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to-man in areas at andLbeyond the SITE BOUNDARY. The pathways. < which were examined in the development of'these calculations-were: (1) individual inhalation of. airborne. radionuclides, (2). deposition of radionuclides onto green-leafy vegetation with subsequent consumption by man, (3) deposition.onto grassy areas-where milk animals and meat-producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of. man.
- 2.4.4 VENTILATION MMAUST TREATMENT SYSTEM The requirement that the appropriate portions of this. system be' used, when specified, provides reasonable-assurance that the releases of radioactive materials in gaseous effluents wil1~be '
L kept "as' low as is. reasonably achievable." This. control implements the requirements of 10 CFR 50.36a, General Design . Criteria 60 of Appendix A to 10 CFR Part 50, and the design ' objectives given in Section II.D of Appendix I to-10 CFR Part 50. The specified limits governing the use i- , i
~
n - . ,- ~. __- - -- . ~ .- o J il: ODCM Rev.;15
~
Paga 13 ' l- 12/94 t
* .of appropriate portions of the systems were specified as a.
suitable fraction of the dose design objectives set forth in
-Section II.B and II.C of Appendix I, 10 CFR Part 50,1for
~
- gaseous effluents..
2.4.5 VENTING OR PURGING This control provides reasonable assurance that. releases'from drywell purging operations will not. exceed the_ annual dose ,' limits of'10 CFR-Part 20 for. UNRESTRICTED' AREAS. 2.4.6 TOTAL DOSE This control is provided to meet the dose-limitations of . 40 CFR Part 190 that have'been incorporated into 10 CFR Part 20 g by:46 CFR 18525. The control requires the preparation and: submittal.of a Special Report whenever the calculated doses _- '. from plant radioactive' effluents exceed twice the design
^
objective doses of Appendix I. For sites containing up to four; reactors, it'is highly unlikely that the resultant dose to a' MEMBER OF THE PUBLIC will exceed the dose limits of 40?CFR 190L if the-individual reactors remain within the reporting; requirement level. The Special Report will describe a course of action.that should c result in the limitation of the annual dose to a MEMBER OF;THE PUBLIC.to within the 40 CFR Part 190 limits.. . For the_ purposes of the Special Report, it may be assumed.that the dose- 4 commi+; ment to the MEMBER OF THE"PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear. fuel _ cycle: facilities at the-same site or within a radius of 5-miles must be considered.- If l the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR Part 190, the Special. Report with a request for1a variance (provided the release: condition - resulting in violation of 40 CFR Part-190 have not already been:
- corrected),.in accordance with>the provisions-of 40.CFR 190.11 and 10 CFR 20.405c, is considered to-be a timely' request and fulfills-theLrequirements of 40 CFR Part 90 until NRC staff ,
action is completed. An individual is.not considered a MEMBER OF THE PUBLIC during any period.in which he/she is engaged"in' carrying out any operation that is part of the nuclear fuel cycle. 2.5 RADIOLOGICAL ~ ENVIRONMENTAL MONITORING PROCRAM The Radiological Environmental Monitoring. Pro p am (REMP) required by this control provides representative measurements , of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation expecures of MEMBER OF THE.PUBLIC resulting from the station operation. This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by i verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected. . T
-- x -.
Sl .ODCMLRev. 15/ l pege 14; q {c L" l- 12/94: 3 s
'on the' basis of the' effluent measurements and modeling of the ja environmental' exposure pathways.
The: required. detection capabilities for environmental sample ' _ analyses are tabulated in-terms-of the lower limits of detection-(LLDs)._ The LLDs required by Table I3.4-3-are considered optimum for routine environmental measurements in:
' industrial'. laboratories. It should be recognized that the ILD -
is, defined as an.a priori (before.the fact) 1Luit representing the ca bility of a measurement' system and-not an after the-fact 1 it for a particular measurement. ia=- Detailed discussinn of the.LLD,' and other"detectionLlimits,,can ~, be found in HASL ?rocedures Manual, HASL-300 (revised' annually); Currie L.A., " Limits for< Qualitative Detection and Quantitative Determination - Application to Radiochemistry,"
- Anal. Chem. 40' .
586-93 (1968), and-Hartwell.~J.K., " Detection
-Limits for Radionnalvtical Countina Technicues." Atlantic
$ Richfield Manford Cnmpany Renort ARM-SA-215 (June.'1975). 2.5.1 LAND USE CENSUS , ) . This control is provided to ensure that_ changes in the use of[ areas at'and beyond the_ SITE BOUNDARY-are-identified and'that.. modifications to the monitoring program are made if required by-the results of the census. The best information'from the' door - to-door survey, aerial survey or consulting ~with local... , agricultural authorities or any combination of these methods shall be used. This census satisfies the requirements of- . Section IV.B.3 of Appendix I to-10 CFR Part 50. . Restricting the census to gardens of greater than 500_ square feet provides- , assurance that significant= exposure' pathways via leafy . vegetables will be identified and: monitored since a garden of this size is the minimum required to produce the quantity-(26-Kg/ year) of leafy vegetables assumed _in Regulatory ~ Guide 1.109; for consumption by a; child.. To determine this minimum gardenL size, the following assumptions-were used: (1).that 20% of the garden was used for growing broad leafy. vegetation-(i.e. similar to lettuce and cabbage), and (2) a vegetation yield of. j 2 kg/ Square meter. 2.5.2 INTERLABORATORY COMPARISON PROGRAM N
- The requirement for participation in an Interlaboratory j
(' Comparison Program ensures that; independent checks on the R precision and accuracy of the measurements of radioactive' i material in environmental sample matrices _are performed as part' of the quality assurance program for environmental monitoring; 1 in order to demonstrate that the results are reasonably valid for the purpose of'Section IV.B.2 of Appendix:I to 10 CFR Part-
~
50, 2.6 APPLICABILITY #
- 2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS l
.. v' c a . <
^
-+
- d09 -
1 <ODCM Rsv.f15' pig 3 1 15; 12/94"
<g L
I'['
- or.other conditions specified.therein; except that upon failure-to meet.the controls, the associated-ACTION requirements shall
~
be met. 2.6.2_'Non compliance,with:a control'shall exist when the. requirements-
~
1 of the-control 1and associated ACTION requirements.are-not performed'within the specified> time intervals. If the control: ' is restored prior to expiration of the specified time . intervals, completion of_the ACTION requirements is not
- required.
2.6.3 There are no actions in the ODCM which would_ require an- ' operational condition change. . 2.6.4 :There are'no restrictions on changing operating conditions in *
.any of the controls on the ODCM.
, 2.6.5 Surveillance Requirements shall be met'during the OPERATIONAL CONDITIONS or other conditions specified for individual . +
controls'unless otherwise stated in an individual Surveillance Requirement. P
'2.6.6 Each Surveillance Requirement shall be' performed within;the specified interval with a maximum allowable extension not to exceed 25%:of the surveillance. interval. 3 2.6.7 Failure to' perform a Surveillance Requirement within the ,
allowed surveillance' interval defined by control 2.6.6, shall- ' 3 constitute noncompliance with the OPERABILITY. requirements'for ; a control. The time limits of the' ACTION requirements are. . applicable at the time it is' identified that a surveillance ! Requirement'has not been performed. 'The. ACTION-requirements may be delayed for up to 24 hours to permit the-completion'of the surveillance when the allowable outage _ time limits of the : ACTION requirements are less than 24 hours. Surveillance -; requirements do not have to be performed on inoperable; -i equipment. 1 I
# The associated bases from the LGS Technical Specifications' .
applies to this section.
.8
. n
~ ~ ~ -
. . . 1
JR , ri l: ODCM rov. 15 Pcga 16.
'l -12/94-3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 3.1 .The-meteorological-monitoring instrumentation. channels shown in Table-I3.1-1 shall.be OPERALLE.
APPLICABILITY: At'all times. ACTION: , With.less than the minimum required instrumentation channels operable for more than 7 days, prepare and-submit a Special Report to the Commission pursuant to LGS Technical Specification 6.9.2-within,the'next 10 days outlining the-cause of;the malfunction and the plans-for restoring the instrumentation to OPERABLE: status. . SURVEILLANCE REOUIREMENTS 3.1-1 Each of the above required meteorological monitoring'- instrumentation channels shall be demonstrated' OPERABLE. by the performance of the CHANNEL CHECK and CHANNEL. CALIBRATION operations at--the frequencies shown.in Table ' I3.1-2.
, :. a- _ __ -. . . . , _ - _ _
L .~' ; l? ' ODCM.Rcv. 15'
' Pr.ge 17 .-
p . l. 12/94 T& ALE 13.1-1 METEOROLOGICAL MONITORING INSTRUMENTATION MINIMUM
-Tower 1 Tower 2 INSTRUMENT
, ' INSTRUMENT (Primary) (Backup) OPERABLE
- 1. . Wind Speed a '. Elevation 1 30'feetL 159 feet 1
- b. Elevation 2 175 feet 304 feet. 1 3
- 2. Wind Direction a.- Elevation 1 '30 feet 159 feet 1
- b. Elevation 2 175 feet 304 feet 1
- 3. Air Temperature Difference (AT)
- a. Elevations' 266 feet- 300 feet--
26 feet 26 feet 1 TanLE 13.1-2 METEOROLOGICAI. MONITORING INSTRUMENTATION SURVEIT.TANCE REOUIREMENTS - Channel- Channel INSTRUMENT Check CALIBRATION
- 1. Wind' Speed
- a. Elevation 1 (Tower 1 and Tower.2) D SA ,
- b. Elevation 2 (Tower 1 and Tower 2) D SA
- 2. Wind Direction
- a. Elevation 1 (Tower 1 and Tower 2) D~ SA
- b. Elevation 2 (Tower 1 and Tower 2) D SA
- 3. Air Temperature Difference (AT) ;
.a. Elevations 266 - 26 ft (Tower 1) D SA
- b. Elevations 300 - 26 ft (Tower 2) D SA j NOTE:
The meteorological towers shall be located-as shown on Figure I3.1-1. For backup sources of data retrieval, refsr to Table I3.1-3.
'1
_, - ., _ ;. . ... -_ , . _ _. .~
-l- ODCM Rsv.-15. l ' Pcgm 18 ~
- i. -ll ' 2/a d -~
i TABLE 13.1-3 METEOROIDGICAL TOWER DATA RETRIEVAL L INSTRUMENT TOWER 1. TOWER-2 DATA LOGGER-DATA RM-21A Channel # Wind Speed . 1.(TWR1).
-l -a. Elev. 1- Strip- Strip. _RM-21A '14'(TWR2)
Wind-Speed .. 5 (TWR1)
-l b...Elev. 2 -Chart. Chart-- RM-21A 21 - ( TWR2 ) ..
-Wind ' Dir. : 0 (TWR1) l a. Elsv. 1 Strip Strip .RM-21A~ 13 (TWR2)
Wind Dir. 4 (TWR1)
- l. b. Elev. 2~
Chart Chart- RM-21A 20-(TWR2) '
-DELTA T.
. Multi-pt Rec Multi-pt Rec RM-21A '
-7 (TWRl),
23-(TWR2) ERIMARY OPTION:
~l.IE DATA IS UNAVAILABLE-FOR TOWER 1 Strip Charts or Multi-Point Recorder, l'THER verify corresponding data available.on Tower 2 Strip Charts or Multi-Point Recorder.
SECONDARY OPTION:
.IE data-is not available1from. Strip Charts or Multi-Point Recorders, THER verify data on RM-21A.
TERTIARY OPTION:
.-IE RM-21A is not available, THER verify. data on Data Logger (corresponding channel numbers).
~
j
'l (i
- s. ..
+ ' - - -
t
;. ;7
.~ ~
--<f*., '
=v - , i
~~
.- ~i
.~ .i l?
ODCM R v. 15
, n .Pago 19 , , .1 -12/94 Fiaure I3.1-l' Meteorological Tower Location-W
- l 1
o iH l
. . I V,\ \ 'MW:'.:;.;;'(2Nggg%9itim!al ~
J I F,}l } \ \ ~r - b i\r,. ftM.~3 . 3M".LZ;6%giy.FAMl: . d '.L Wi l sv g /um t-w.s. pA o \ %g, in i::o 74 ;v . aM.7p:. = .7 :. . w*:e s
\ A p%gfp .
.e.'
a .
; 7'. x. :.1 --M n
u y ; .,m.sq u x.y.e . .y _ ,' gAp>g Nn s
\n;.g. -%.Mo.RwiN 1 u ' 'A \ Ai s em!5 4
-ej\
.y*s
' .:\r
. \a %w Uh g a n ,-::.,c t u a $ g e _v - + ,W$
$;'sustinis., , , . -
iy a ): s. s y a . i.- - . Li .tg 1t # e>
.-is A1 -
va L._.-ak .i s.M #a m " 1 ' Ti Tgk , r.VC- i ~T2.'?[us- o $ f,
<_ ]w-y1:v .-
(%..
~s
.)l . \ \n w.s. 2.f e. r e
e c r ~. ~. um ex=w _ . .,7xs s s N4*V6 V\ *E. N'e i W, -
)v W ? " ? ? M ', '"% \ : $ $ V h> h q & -
~ \ v y 5 9 ; / \ ,\, \V A . e =2 G ,h m; & L %u. ~u k--
.;s%gpW>2kt v.-
a :.r.oG, ma N E t Q. & T"g!
+
- v. y $ \g
. g if-r 'l= ):. x/ T 9A P G t 6h~; 1: 6 1:+ ej f 9 W M
~ m. rm .. , . .U
~
n . . . . . e 4
.nm e, ~ , , .
gt; ,
- yp r
. ;_ -l - -
ODCM'Rev. 15: 1
- Pcg3 20. 1
, I 12/94, '
3.2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS
;3. 2.1 The radioactive liquid effluent monitoring instrumentation-channelsishown in Table I3.2-1 shall be' OPERABLE with their:
-alarm / trip setpoints set to ensure:that' Control--I3.2.2.is not- :
exceeded. . The alarm /setpoints* of these channels shall be determined =and adjusted-in accordance with the' methodology and f ;
- parameters in.the ODCM;- Part II, Section'l'.2?
APPLICABILITY: At all times. ACTION:
~
- a. With a radioactive : liquid; effluent monitoring. instrumentation channel alarm / trip setpoint'less conservative than required-by the above control, immediately suspend the. release of-radioactive liquid effluents monitored by the affected channel, and declare.the: channel inoperable.
- b. With'less than the minimum number of radioactive liquid offluent monitoring instrumentation channels' OPERABLE, takes the ACTION shown-in-Table I3.2-1. Restore'the-inoperable
~
F ' instrumentation-to OPERABLE status within the time specified , l in the ACTION or explain;in the next Annual Radioactive ~ Effluent Release Report why this.inoperability-was not - corrected within'the time specified. SURVEILLANCE REOUIREMENTS 3.2.1-1 Each radioactive liquid effluent.monitoringi instrumentation channel shall be demonstrated OPERABLE
- i. by performance of the CHANNEL CHECK, SOURCE CHECK,;
l- CHANNEL CALIBRATION and CHANNEL-' FUNCTIONAL TEST : performance at-the frequencies shown:in Table I3.2-2. L l. i L
;
- Excluding the flow rate measuring devices which are not i
. determined and. adjusted.in accordance with the:ODCM. l
#-- y v e -g--4 -y--v--- es W y rw,u- u, w-vw , - --
l s
-ODCM R5v. 15-
^
Page'21' F- d. 12/94-TABLE'I3.2 ' RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION wn MINIMUM 1 CHANNELS-INSTRUMENT OPERABLE ACTION
'1. ' Gross Radioactivity Monitors /Providing Automatic' Termination of Release:
- a. Li 1- 100-
- b. A/ quid B RHR Radwaste Service Effluent Line- Line Water Effluent 1/ loop 101
- 2. Gross Radioactivity. Monitors-Not Providing Automatic Termination-of Release'
- a. Service Water Effluent'Line 1 101
- 3. Flow Rate' Measurement Devices
- a. Liquid Radwaste Effluent Line l' -102- .i
- b. Discharge Line 1; 102 ACTION STATEMENTS i Action '00-1 with less than the Minimum Required Channels operable, ;
affluent. releases may continue for up-to 14: days provided-that prior to initiating a release: . At least two independent samples are analyzed in a. accordance with Table I3.2-3, and .
- b. At least two. technically' qualified members'of.the
-facility staff independently verify.the release:
rate calculations and discharge line valving; otherwise, suspend release _of radioactive effluents via- . this pathway. Action 101- With less than the Minimum Required Channels operable,' . ! effluent releases via'this pathway may continue for up tor i 30 days'provided that, at'least once per 8 hours,' grab samples are collected and analyzed for radioactivity.by gamma isotopic analysis (Principal Gamma Emitters,-I-131,: -I and Dissolved /? Entrained Gases) as a Lower Limit of l Detection as specified in Table I3.2-3 or gross- :, radioactivity (beta and' gamma). fGross Beta-is analyzed ! at an LLD of at'least 1N7 microcurie /ml.- Gross Gamma is i analyzed at'an LLD of at least SN7 microcurie /ml.
; Action 102- With less than the Minimum RequiredfChannels operable, l effluent releases via this pathway may continue for up to l 30 days provided the' flow rate is estimated at least once 1 per 4 hours during actual releases. Pump curves
+
]
generated in situation may be used to estimate flow. -q i
-i
_ . _ , _ . _ _ _ 1 . . -- - - - . . ._ _ .c . . _
7'g-l 'ODCM Rev. 15 .c [ Page 22 l 12/94-- 1 TABLE I3.2-2 , RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIPEMENTS CHANNEL' CHANNEL SOURCE CHANNEL FUNCTIONAL. INSTRUMENT CHECK CHECK- CALIBRATION TEST
- 1. Gross Radioactivity Monitors Providing Automatic Termination of Release
- a. Liquid Radweste Effluent Line P' P R(3) Q(1) j b. RHR Service Water System Effluent Line- D M R(3) Q(1)~
- 2. Gross Radioactivity Monitored Not Providing Automatic Termination of Release-
- a. Service Water System-Effluent Line~ D' M 'R(3) Q(2)~
- 3. Flow Rate Measurement-Devices-
- a. Liquid:Radwaste-Effluent'Line D(4)' N.A. R. Q'
- b. Discharge Line' D(4) N. A. . R .
Q l l
; - - - .n. - - - - - - - . - --
ny n s Il' ODCM.Riv.115: PCg3 23~. b lL 12/94 Ilt- .. TABLE I3.2-2 (Continued)-
- TABLE NOTATIONS (1)The CHANNEL FUNCTIONAL TEST shall also-demonstrate.that automatic' isolation of this pathway and control room alarm annunciation will occur if any,of.the following conditions exists:
- 1. Instrument indicates measured levels above the alarm / trip setpoint.
- 2. Circuit failure.
- 3. Instrument indicates a downscale failure.
(2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any_of the following conditions exists:
. 1. Instrument indicates measured levels above the alarm -
- setpoint.
- 2. Circuit failure.
- 3. Instrument indicates a downscale failure.
(3) Tlie initial CHANNEL CALIBRATION shall'be performed using-reference standards certified by the National Institute of Standards and Technology (NIST) obtained from suppliers that participate in measurement assurance activities with NIST.- These standards shall permit calibrating the system over its , - intended range of energy and measurements range. For subsequent CHANNEL CALIBRATION, sources that have been 1 related to the initial' calibration shall be used.
.(4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release.- CHANNEL CHECK shall be made at-least once per 24 hours on days on which batch releases are made.
J e J
- e. - - , n- , - --, ,, - -- n~..e -,--- - , - - - -e e - ,~ - - - e e
.g , .
^ ~
g' s 6 h ODCM Rev. 152 P ge~24 , l 12/94;- ; 1 CONCENTRATION l CONTROLS 3.2.2 The concentration of. radioactive material. released in
-liquid _ effluents to UNRESTRICTED AREAS (see Figure I2.2-la,b):shall be limited-to the concentrations specified inj 10.CFR Part 20, Appendix B, Table II,: Column 2 fort 1 radionuclides other than dissolved or entrained nobles
. gases. For, dissolved-or entrained noble gases, the concentration shall be limited to 2E-4 microcuries/ml total activity.
APPLICABILITY: - At all: times. ACTION: With the concentration of radioactive material released:in
- 11guid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits or terminate the release.
SURVEILLANCE REOUIREMENTS 3.2.2-1 Radioactive, liquid wastes shall be sampled and analyzed according to the sampling and analysis. program of Table I3.2-3. 3.2.2-2 The results of the radioactivity analyses shall be used in accordance.with the methodology and-
- parameters in the ODCM Part II. Section 1.3 to
! assure that the concentrations at the point of release are' maintained within the limits of Control I3.2.2. -. Y t L 4
l ODCM Rev. 15 Page 25 l 12/94 TABLE I3.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Liquid Release Sampling Analysis Activity (LLD)* Type Frequency Frequency Analysis (uCi/M1) A. Batch Waste P P Principal Gamma SE-7 Release Each Batch Each Batch Emitters
- Tanks b I-131 1E-6 i
- 1. Floor or P M Dissolved and 1E-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters)*
- 2. Laundry P M H-3 1E-5 d
Drain Sample Each Batch Composite Tank Gross Alpha 1E-7 P Q Sr-89, Sr-90 SE-8 Each Batch Composite d Fe-55 1E-6 B. Continuous W W Principal Gamma SE-7 Release' Grab Sample Emitters
- I-131 1E-6
- 1. RHR Service W W Dissolved and 1E-5 Water System Grab Sample Entrained Gases Effluent Linef (GammaEgters)*
- 2. Service Water W M H-3 ( 1E-5 System Grab Sample Composite d Effluent Line f Gross Alpha 1E-7 W Q Sr-89. Sr-90 SE-8 GIab Sample Composite d Fe-55 1E-6 s.
4 i ODCM~R;v.;15 =
.-lf .n~
LPege 26
.f,l
-12/94-w .. . . .
Tanf2-13.2-3'(continued) yy TABLE NOTATIONS o a. The LLDlis defined as the. smallest concentration.of radioactive. material in'a sample that will yield a net count, above system-background,-that will be detected with 95% probability with only-54 probability of falsely concluding that a blank observation-represents a:"real" signal..
~
For'a. measurement system, which may include radiochemical' separation: (2.71 + 4.66s ) (1-exp(-AAta )); LLD = E * .V 2.22E6
- Y * [exp -(-AAtj)]( AAta)
(2.71 + 4.66 s ) LLD (Grab Samples)= E
- V 2.22E6 Y .(exp .- AAt3 )
Where: , LLD is thela nriori lower limit of. detection as defined =above ( as microcurles per unit mass or. volume),- s, is the standard deviation of the background counting- rate' or: of the counting rate of blank sample as appropriate-(as counts-per minute), E is the counting efficiency, as' counts per' disintegration, V is the sample size, in units of mass or volume, 2.22E6 is the number of disintegrations per minute per. microcurie, Y is the fractional radiochemical yield, when' applicable, A is the radioactive decay constant for the particular radionuclide, and At for the plant effluents is the elapsed time between the end of,the sample collection and the time of counting. At for the plant effluents is the elapsed time between the end-of,the sample collection and the start of sample. collection. Typical values of E, V, Y, At3 and At, should be used in calculation. It should be recognized that the LLD is defined as an a nriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. q l
l
!~ ODCM Rev. 15 Pags 27 l 12/94 TABLE T3.2-3 (Continued)
TABLE NOTATIONS
- b. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling.
- c. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, 2n-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144.
l The dissolved and entrained noble gases (gamma emitters) for I which the LLD specification applies include the following l radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m, Xe138. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Semiannual Radioactive Effluent Release Report pursuant to Control 3.6.
- d. The term " Composite Sample" means a combination of individual samples obtained at regular intervals over a time period. Either the volume of each individual sample is proportional to discharge flow rates, or the sampling interval (for constant volume samples) is proportional to flow rates over the time period used to produce the composite.
- e. A continuous release is the discharge of liquid wastes of nondiscrete volume, from a Volume of a system that has an input flow during the continuous release.
- f. Whenever effluent releases are in excess of the monitor's setpoint.
~v y; w . - ; _ y, -
,. .g ,
y 4 -' 'l :y.. b [( [ .ODCM-R v. 15. Page 28' 12/94-7 5
- f. ' '
g DOSE
., CONTRCf1-t . , , ,
3.2.3 The' dose or~ dose commitment to a MEMBER.OF.THE PUBLIC from' p.- radioactive' materials.in-liquid.' effluents' released from the
. site to UNRESTRICTED AREAS _(See Figure I2.2-la).shall1be
[. "
- limited b'
a.: During any calendar quarter to less than or equal _to. 3 nrems to the-total body and to less.than or equal to 10~mrems to any organ, and L; -
- b. During any calendar year to less.than or equal to !
mrems to the total: body and to less than or equal to 20 a j mroms to any organ. APPLICABNLITY: At all-times. ACTION: With.the. calculated dose from the release'of. radioactive materials _.in' liquid offluents: exceeding' any of the above limits,' prepare-and:-submit:to the. Commission'within 30 days, pursuant to Technical. Specification 6.9.2,.a Special-Report which identifies the cause(s) for exceeding the limit (s): and defines the corrective actions that:have been taken to reduce - the releases and the proposed corrective-actions to be j taken to assure that subsequent releases will.be-in-- -I compliance with the aboveLlimits._ This Special. Report' shall also~ include the radiological impaction' finished'
-drinking water supplies at-the-nearest downstream; j drinking water source.
SURVEILLANCE REOUIREMENTS 3'.2.3-1 Cumulative dose contributions from liquid effluents l for the current calendar? quarter.and the current calendar year shall be determined using i ST-0-104-878-0 at least once per 31 days. i i l i i
>s ,
gjk - . x zy; s c$ <
.ODCM Rev.".15
'Prge 29 ,
[W
;l.. :12/94 y
LIOUID RADWASTE TREATMENT SYSTEM CONTROLS
>q -3.2.4 .The-liquid radwaste treatment system shall-be'Id .
. l i
SERVICE and appropriate portions.of the system shall - be used to reduce the radioactive' materials'in: liquid. waste priorito their discharge when the. projected doses due.to the liquid; effluent, from the site, to . UNRESTRICTED AREAS-(See Figure I2.2-la);would exceed ; 0.06 mrem to the total body or 0.2 mrem to-any organ; ; in a 31-day period. APPLICABILITY: At all' times. ; ACTION:
- a. With radioactive: liquid waste being discharged without' ,
f treatment or in excess'of the above limits, pursuant. to Technical Specification.6.9.2, prepare a special- O Report which includes the following information: , i
- 1. Ex '.anation ot;what liquid radwaste was being .;
di,scharged wip out treatment,' identification of-any inoperable equipment or subsystems,'and the
~
,j reason for the inoperability. ;
- 2. Action (s)'taken to restore the inoperable ,
equipment to OPERABLE status, and : 7
- 3. Summary description of action (s) taken to-prevent a: recurrence
- b. Submit report to Commission within'30 days. 6 SURVEILLANCE REOUIREMENTS
' 2.4-1 Dose due to liquid releases from the site to ; UNRESTRICTED AREAS -shall be projected at least once-per 31 days.using ST-0-104-878-0.
l 4
- f. , d i i
ww ,
, 7 ~- ; - - .
7 -. -
;I M', s '
> .ODCM Rev. 15; )
cQ l- ,
- -P ge 30: H
~
*1 ,
, :12/94; r1
,s 3.3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CONTROLS ,
3.3.'1 The radioactive gaseous effluents. monitoring instrumentation ' channels'in Table.I3.3-l'shall be OPERABLE with1their clarm/ trip'setpointsLset to ensure-that the~limitsLof ODCM g i A' Control Part I Section 3.3.2.are not> exceeded.. The ala trip. setpoints of the applicable' channels shall be determined n
^
naccordance with.the methodology and parameters in the<ODCM. Part II, Section 2;2. , MPLICABILITY: .As shown in Table I3.3-1.~ ACTION: 3 With-a radioactive gaseous offluent armitoring a. instrumentation channel alarm / trip set, nints :less " [ conservative than required-by Part II SA H on . 2. 2, ' immediately suspend the release of' radioactive gaseous i ' effluents monitored by the affected channel or declare : ' - the channel inoperable. 4
~
- b. With..less than the minimum number:of, radioactive ~. +
gaseous offluent monitoring instrumentation channels - OPERABLE, take.the: ACTION-shown in Table I3.3-1. . i Restore the inoperable instrumentation-to OPERABLE r s status within the time..specified'in the-ACTION. If: 1 the inoperable instrumentation is nottrestored.withinL i the time specified in the ACTION statement:- create.an AR in PIMS to ensure an explanation is written byLthe responsible System' Engineer and'is. included in AERR by ' 1! the Effluent Physicist. SURVEILLANCE REOUIREMENTS
- 3.3.1-1 Each radioactive gaseous effluent monitoring '
instrumentation channel:shall be demonstrated' OPERABLE' by performance of the CHANNEL CHECK, SOURCE CHECK,. CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST
- operations at the frequencies shown in Table I3.3-2. ;
.k P
4 t
'I .'s.
i e ?
, u- A ,. E _ . _ _ - ~ . ,, ,m.- -_ _ , _ . _ .
~ . - - . . . . . - . . .. ~ . . . , . - ..
~ ~ _'__
_ L .
'y ODCMjR3v. 15. ,
um T!73 l ^, '~ Page 31?
~ - -
~
l 12/94' - Tanr2 13.3-1 , RADIOACTIVE GASEOUS EFFLUENT MONITORTNG INSTRUMENTATION. ,
' MINIMUM CHANNELS INSTRUMENT OPERARTR APPLICABILITY ACTION SOUTH STACK EFFLUENT MONITORING SYSTEM 111 1 *
. a. Noble Gas Activity Monitor
- b. Iodine Sampler 1
- 112
- c. Particulate Sampler 1
- 112 si
- d. Effluent System Flow Rate Monitor 1
- 113
- e. Sampler Flow Rate Monitor 1
- 113 ,
NORTH STACK EFFLUENT' MONITORING SYSTEM'# . a. Noble Gas Activity Monitor .
* ' 114
- b. Iodine Sampler 1
- 112. >
- c. Particulate Sampler 1
- 112 -
- d. Effluent System Flow Rate Monitor' .1
- 113
' e. Sampler Flow Rate Monitor .1
- 113 '
HOT MAINTENANCE SHOP VENTILATION-EXHAUST' RADIATION MONITOR **
- a. Iodine' Sampler 1 - 112- 1 b.-Particulate Sampler .
1 ** 112-113
- c. Effluent System Flow Rate Monitor 1 -~ * *
. d. Sampler Flow Rate Monitor 1 113 s 9 The-(A or B). North Stack Normal' Range Radiation-Monitors ORLthe Wide Range Accident Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring -
j System.
. NOTE: 'With regard to Actions- 111,'112,.113, and 114;-with less than the minimum Required.ChannelsL j l
operable forl greater than 30 days prepare and submit a Special Report to.the Effluent - Physicist within: the next 101 days outlining the cause of the ~ malfunction and the plans for. ie instruments:to-OPERABLE Status.- Sampling shall continue.until the minimum'
.. restoring .
l
- , . camarel . operability requirement is met. -
K
*' At all times.- q
.. **" During operation.of the hot maintenance shop ventilation system.3 9'
_.--..,.a _-o m- .m_- _ _ . a__._2____2_m om_.___m_____._ _ _ _ _ . _ _ _ _ _ __ __ +a.-..v-- -v vw.4 s v.., y . ,m e . fm, , . - + , 3
I: ODCM Rev. 15'
-PCg3'32 il 12/94
~
TABLE 13.3-1(Continued) TABLE NOTATIONS ? ACTION STATEMENTS ACTION.lli - With less than the minimum Required Channels (SS Noble Gas) OPERABLE, effluent releases via this pathway. may continue for up to 30' days provided grab samples.are taken.per ST-5-026-580-* at least once per 8 hours and these samples are analyzed for gross activity within 24 hours. ACTION 112* - With less than the minimum Required Channels. (Iodine & Part.) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided samples are continuously collected with , auxiliary sampling equipment per St-5-076- l 815-*, ST-5-076-820-* as required in Table I3.3-3.
.IE the Sample Pump is operable, a particulate and iodine sample can be obtained; AHD the Minimum Channels Operable.
requirements are satisfied. : ACTION'113* - With-less than the minimum Required Channels (Eff. & Smpl. OPERABLE, effluent releases.via NS, SS or-EMS t Flow Rate) may continue for up to 30 days provided the. flow rate is estimated by adding the nominal flow rates indicated in P&ID M-26 for each , in-service fan. -This shall be documented in the MCR operations Shift Log at least once per 4 hours. ACTION 114 - With less than the minimum Required Channels , (NS Noble Gas) OPERABLE, effluent: releases via this pathway may continue for up to 30 days provided grab samples are taken per ST-5-026-580-0.at least once per 8 hours and these samples are analyzed for gross activity within 24 hours. The Mechanical Vacuum Pumps may not be operated during this LCO.
- If release point is the Hot Maintenance Shop, Then secure ventilation because no menns exist to alternate]y sample the ventilation.
1 ' s
- $f,
.:.i.}
;p
~ '
l
. ODCM R:v..15' :
-Page 33 .
- m. '
l 12/94 TABLE 13.3-2 RADIOAr'TIVE cAREOUS EFFLUENT MONITORING INSTRUNRuTATION SURVEIT.TANCE REQUIREMENTS . CHANNEL MODES IN WHICH. CHANNEL SOURCE CHA!!NEL FUNCT. SURVEILLANCE INSTRUMENT CHECK CHECK CALIBR. TEST- IS REQUIRED-
- l. SOUTH STACK EFFLUENT ~ MONITORING SYSTEM *
- a. Noble Gas Activity Monitor D M R(2) Q(1) ,I N.A. * .;
- b. Iodine Sampler W(3) N.A. . N.A.
N. A. . '*'
- c. Particulate Sampler- W(3) N.A. N.A.
- d. Effluent System Flow Rate Monitor.
D N.A. R Q *.. ' e., Sampler Flow Rate Monitor D N.A. R Q
- 2. NORTH STACK EFFLUENT MONITORING SYSTEM i ~*
- a. Noble Gas Activity Monitor = D M R(2) -Q(1)
- b. Iodine Sampler W(3) N.A. N.A. N.A.
N.A. N. A.: *,
- c. Particulate Sampler W(3) -N.A. i D ' N.A. R Q *
- d. Effluent System Flow Rate Monitor i
- e. Sampler Flow Rate Monitor D N.A. R Q .
- 3. - HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR
- a. Iodine Sampler W(3) N.A. N.A. N .' A ' ' ** -
- b. Particulate Sampler . N.A. N.A. N.A. **
W(3) **
- c. Effluent System Flow: Rate Monitor D .N.A. R Q
- d. Sampler. Flow Rate Monitor ~ D~ .N.A. R Q
# ~ Wide Range Accident Monitor 1 (WRAM)' surveillance is-specified in Technical l Specification 3.3.7.5.
- At all. times.
- ** During operation.of the' hot maintenance. shop ventilation. exhaust' system.
ww- e_ e e,we .e e*we ,.e srv . .w -
.w =~-r+,,<-, m ce r e w ..eg #W e,~5 avc.- e -se .. -ew w on F =i* w t e w
3 yn ; n (cwn s s. l ODCM Rev. 15 ' POge 34-l- 12/94 F ' TABLE I3.3-2fContinued) TABLE NOTATIONS , _ (1) The CHANNEL FUNCTIONAL TEST shall also' demonstrate that
,L
^
~ control room alarm' annunciation' occurs if any of the following conditions exists:
li Instruments indicate measured. levels above the-alarm / trip setpoint.. ' 2.. Circuit-failure.
- 3. Instrument indicates a downscale failure. ,
- 4. ' Instrument controls. not' set in operate mode.
(2) The initial-CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified'by the National Institute of-Standards and Testing (NIST) or using.
' standards that have-been obtained-from suppliers that' participate in measurement assurance activities.with WIST.
- These: standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that are traceable. 1~
to the~ initial calibration shall be used. (3) The iodine cartridges and particulate filters will-be-changed and analyzed at least.once per 7 days. , k 4 d
' ^ - '-'
W/, . lL ODCM R;v.115~ Pcga 35 ,[ l :- 12/94 GkSEOUS EFFLUENTS' CONTROLS 3.3.2 The dose rate due to radioactive materials released in-gaseous effluents from the site to areas at or beyond the SITE BOUNDARY (See Figure'I2.2-la) shall be limited to:: '
- a. For noble gases: less than or equal to 500 mrems/yr to the total body and less than or equal '
to 3000 mrems/yr to the skin,-and
- b. For iodine-131, iodine-133, tritium, and for all. '
' radionuclides in particulate form with. half-lives " ' greater than 8 days: less than or equal to 1500 mrems/yr to any organ. (Inhalation pathways only.) APPLICABILITY: At all times. ACTION: With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above-limits. SURVEILLANCE REQUIREMENTS 3.3.2-1 The dose rate due to noble gases in gaseous .. effluents shall be determined to be within the l above limits using ST-0-104-879-0.
< 3.3.2-2 The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with. half-lives greater than 8 days in gaseous effluents shall be determined to be within the above limits using ST-0-104-879-0 by obtaining ,
representative samples and performing analyses in , accordance with the sampling and analysis program specified in Table I3.3-3. , s I j l
.1
jg 10 , w .e ODCM R v4315
':l. =P ge 36x v 7:,- l-l ~: ,
12/94-. . s TABLE T3.3-3 .q
-RADIOACTIVE CAREOUS WARTE ' EAMPLING AND ANALYSIS P8N:DEM1 Lower Limit ~ '
Minimum . Type of - of' Detection! '
. Gaseous Release ' Sampling Analysis Activity (LLD)*~
Type . Frequency- Frequency Analysis '(uci/M1). I
.A. Containment P P Principal Gamma 1E-4. ..
Purge Each' Batch Each Purge - Emitters", f - -d Release Grab Sap 1. +
^
B.' North Stack / Continuous d Q Gross Alpha 1E South Stack Comp. Part. - Sr-89, Sr-90 1E-11 Sample 6 M. I Grab Smpl. M6 Noble' Gas 1E-4 H-3 1E-6 Continuous d W* Char. Smpl. I-131' 1E 712-I-133 1E-10 Part. Smpl. Principal Gamma Emitters ~1E-11 Continuousd Continuous Noble Gas Noble Gas Beta or' Gamma 11E-6 Monitor. '(Based on n Xe-133); j C. Hot Mainten. Continuous d Q Gross Alpha . 1E-11 , Comp. Part. - Sr-89, Sr-90 1E-11 .l Smpl. , l Continuousd W Char. Smpl. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma . Emitters 1E , 1 M + y o - , ,om,- . 4 - e a-- ---,o-.A v w- -, se = ~ - -
'l l
'i ODCM Revi)151 1
-P2ge 37 J k, :l! 12/94 a
-f
.TARTE T 3 . 3 -- 3 (Continued) .j
<. 4 l- TABLE NOTATIONS f- The LLD is: defined, as the smallest concentration'of
- a. i radioactive. material in a sample that-will_ yield a net count, j above system background, that will be detected.with-95%- 1 probability with only 5%~ probability.of falsely concluding.
l L that a blank observation represents'a "real" signal.- It- . '1 [ should be recognized that the LLD is defined as an'a-nriori
'(before the fact)' limit representing the capability of a measurement. system and'not as an after the fact limit for a particular measurement. .-
For a particular measurement system, (which may include 1 radiochemical separation): (2.71 + 4.66s s) (1-exp(-1At ))a 1
~'
LLD = - J E V 2.22E6 Y - (exp (-AAt )]( AAt,) 3
-i l
l LLD (Grab Samples)= E . V -- 2.22E6 4 Y (exp - AAt ). 3 Where: s LLD is.the A,oriori lower limit of detection as defined'above ] ' (uCi/cc or uCl/mL), 1 se is the standard deviation of the background counting rate or of the counting rate of blank-sample as appropriate (as epm), shall be based on the. actual observed variance of.the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance. E is the counting efficiency, as cpdis, V is the sample size,.in units of.cc or m1, 2.22E6 is the number of dpm/uCi Y is the fractional radiochemical yield, when applicable, 1 is the radioactive decay constant for the particular radionuc1ide, and At, for the plant effluents is the elapsed time between the : end of the sample collection and the time of counting. ] i F attfor the plant effluents is the elapsed time between the I end of'the sample collection and the start of sample collection. Typical. values of E, V, Y At and Ata should be used in calculation. 3 ,
?
, 'hY ' '
't J
T , lODCM:Rsv. 15
- Pcg3.38; 1 l
y
, ' l? 12/944
- nnt.w ' T 3 . 3-3 ' ( continued)
TABLE NOTATIONS
-b.; ' Sampling and analyses shall also'be performed following ,
shutdown,~ startup,.or a' THERMAL POWER change exceeding 15% of;
theLRATED THERMAL POWER within a-1-hour period usings
.RT-5-000-876-*. This requirement does not. apply;if (1) analysis'show that~the. DOSE' EQUIVALENT I-131: concentration'in the primary coolant has'not increased more than a. factor of'3;:
! and-(2) the-main condenser offgas pre-treatment radioactivity-monitor shows that offluent activity has not increased.more than a' factor of 3.
o ~
- c. Samples.shall be changed at least once.pery7 days and analyses shall be completed within 48 hours after changing, or~after removal from sampler. Sampling shall also be performed;at t least once per.24 hours for at-least 7 days following~each; .
shutdown, startup or THERMAL POWER change exceeding 15% of- .; RATED THERMAL POWER in 1 hour and analyses completed within~48 hours of changing.. When samples collected for.24' hours are
- analyzed, the corresponding'LLDs may be increased by.a factor ofilo. This requirement does not apply if-(1) analysisishows that the DOSE EQUIVALENT I-131 concentration in'the primaryc coolant has not increased more than a factor of 3;'andE(2) the '
noble gas-monitor shows-that effluent activity has not s increased more than a factor of 3. . g d. The ratio of the1 sample flow rate to:the-sampled stream flow j rate shall be known for the time period covered by'each dose- ' L -or dose rate calculation made in'accordance with controls 3.3.2, 3.3.3, and 3.3.4.
- e. The principal gamma emitters for which the LLD, specification applies include the following radionuclides: Kr-87, Kr-88,'Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for, gaseous emissions l and Mn-54, Fe-59, Co-58, Co-60,.En-65, I-131, Cs-124, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does ,
not mean that only these nuclides are to be considered. Other; gamma peaks which are identifiable, together wj:h the above 1 j l nuclides, shall also be analyzed and reported in'the. Annual Radioactive Effluent Release Report, pursuant to Control 3.6' ,
- f. Under the provisions of footnote e.-above, only. noble gases ~
need to be considered. .i L g. Required for the hot maintenance shop ventilation exhaust only during operation of the hot maintenance shop ventilation -f exhaust system. f a 4 h P-
+
mm ,___s______,__________._______b______-_ __ _ . '- - . , . ,* ,,,--m..,e 2 - . -- _ w - -
* ' ^~ " ~ ^ ~ ~ ~ ~ ~ ~ ^ ^
_[ :y [{%
+ ,.7 '4'y ' ODCM R';.v. 15' Tl :'
_M Piga'39
'l1 '12/94 ,
DOSE - NOBLE GASES
" CONTROLS
- 3.3.3 - The air dose due to noble gases released in gaseousLeffluents, from the site lto' areas at and beyond the SITE BOUNDARY <(See
- Figure I2.2-la) shall be limited to the:following:
a.; ; During any calendar quarter: less than or equal:to. 10 mrads for gamma radiation and less.than or equal to 4 - : 20 mrads for beta radiation, and ,
- b. During any. calendar year: less than..or equal' to 20 mrads for ganura radiation and-less than.or equal to .
40 mrads'for bete radiation.-
~
APPLICABILITI: At all times. ACTION: :
- a. With-the calculated air dose from radioactive noble gases in gaseous effluents exceeding any-of the above' -
limits, prepare and submit to the Commission within 30
- days, pursuant to Technical Specification 6.9.2, a-Special Report which identifies the cause(s) for.
exceeding the limit (s) and-defines the corrective r , actions that have beet taken to reduce the-releases' ~ and the proposed corrective actions to be taken to-assure that subsequent releases will be in-compliance with the above limits. SURVEILLANCE REQUIREMENTS 3.3.3-1 Cumulative dose contributions for;the-current quarter ' i and current calendar year for noble gases shall be' ll- determined using ST-0-104-879-0 and ST-0-104-883-0 every 31-days, ' , ? s I e
-p i
u
-4 - -
4 t v 4 y pp w c- _- - . p ., c - , - -
UE
-}^ :bi.', . . .
'. l ?
ODCM-Rev. 15 A- .PIge 40
.l-
-- ,12/94.
L
- DORE -- -IODINE - 13 3. TRITIUM. AND'RADIONUCLTDES IN'PARTIctILATE FORM CONTROLS The dose to'a MEMBER OF THE PUBLIC from iodine-131, iodine-
~
13.3'.4 133,.. tritium and all-radionuclides in particulate form with ,
. half-lives greater than 8 days in; gaseous ~ effluents released-from the site to areas at or beyond;the SITE BOUNDARY (See- ,
Figure:I2.2-la) shall be-limited to the:following:-
'~
- a. During any calendar' quarter: :lessLthan or,equalito 15 mrams'to any organ'and,.
m
, b. During any calendar year:: 'less.than or equal to -'
.i
. 30'mrems'to any organ.
APPLICABILITY: At all times'. ACTION:
- a. With the calculated dose from the' release of iodine -
.131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8' days.
in gaseous-effluents exceeding any of.the above limits,. prepare >and submit to the Commission within 30. days, pursuant-to Technical Specification ~6.9.2, a Special~ Report which identifies the cause(s)Jfor; exceeding the. limit and defines the corrective actions that-have'been taken to reduce the releases and the
. proposed corrective actions to be-taken-to~ assure that
- subsequent releases-will be in compliance with the-above limits.
SURVEILLANCE REOUIREMENTS L . T 3.3.4-1 Cumulative dose contributions for the' current: calendar-quarter and current calendar year for' iodine-131, iodine-133, tritium and radionuclides in particulate form with half-lives greater than 8. days shall be determined using ST-0-104-879-0 once per 31 days. '4 1
p S7% < <
]
3 m: '
#" . ;j '
ODCM Rev.'15 P2g3 41! li I 11' 12/94 r VENTILATION EXHAUST TREATMENT SYSTEM n CONTROLE~ 3.3.5' The VENTILATION EXHAUST TREATMENT' SYSTEM shall be IN SERVICE and appropriate portions of the system shall.be used~to reduce radioactive material-in gaseous waste prior to their discharge
'when the projected doses due to gaseous offluent releases, from -
the site to areas at and beyond the SITE BOUNDARY (See Figure '
.I2.2-la) when averaged.over.31 days would exceed 0.6 mrom to any' organ in a'31-day period.
APPLICABILITY: At all times. ACTION: With gaseous waste being discharged without treatment, or
~
a. in excess of the above limits, prepare and submit to the Commission.within 30 days, pursuant to Technical' Specification 6.9.2, a Special Report which' includes the
.following information:
'1. Explanation of why gaseous radwaste was being discharged without treatment, identification of any f inoperable equipment or subsystems, and the. reason for i 1- the inoperability.
- 2. Action (s) taken to restore the inoperable equipment to-1 OPERABLE status, and 3.- Summary description.of action (s) taken to prevent'a o recurrence.
i SURVEILLANCE REQUIREMENTS 3.3.5-1 Doses due'to gaseous releases fromLthe site:to' areas- ? at and beyond the SITE BOUNDARY shall be projected'at ! least once per 31' days using ST-0-104-879-0.
~
3
' )
)
;:n, , ^
l' ODCM R".v. 15--
, pig 2 42 12/94 :;
. l' VENTING OR PURGING CONTROLS
. 3.3.6 The VENTING or~ PURGING of.the Mark II containment shall be through the standby gas treatment system.
APPLICABILITY: . Whenever the containment is. vented or. purged.* ACTION:
- a. With the requirements of the'above specification not ;
satisfied, suspend all VENTING and PURGING of the containment. SURVEILLANCE _ REQUIREMENTS 3.3.6-1 The. containment shall be determined to be aligned for. VENTING or PURGING through the standby gas treatment system within 4 hours prior.to start of and at.least-once per 12 hours during VENTING or PURGING'of the containment. 3.3.6-2 . Prior to use of the purge system'through the standby gas treatment system assure that:
- a. Both standby' gas treatment system trains are OPERABLE whenever the purge system is in use, and
- b. Whenever the purge. system is in use during OPERATIONAL '
CONDITION 1 or 2 or 3,.only one of the standby gas. . o treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during-this configuration).
- Except after Containment is deinerted and purged while the reactor is in OPCON 4 or 5 QR for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters when used for containment pressure control and nitrogen make-up operations.
L 4 f .b
< 4 - - - . . , , . . . - ,__ _ . . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
% ld t '
, y .-
7 ;. Q ODCM Rev./15 Pag 3'43 "3 12/94-c,: l RADIQACTIVE EFFLUENTS TOTAL DOSE j CONTROLS ., I' , 3.3.7: .The annual-(calendar year) dose or. dose commitment to-anyL 1 l MEMBER OF THE PUBLIC, due to releases of radioactivity and h radiation, from uranium fuel cycle sources shall.be, limited to. less than.or equal-to 25 mrems to the total body.or any organ, except the thyroid, which shall be limited to less than or i equal to 75 mrams. APPLICABILITY: At all times. h ACTION: .1
- a. With the calculated doses from the release of radioactive materials in liquid or. gaseous effluents exceeding twice the limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b, I3.3.4.a or I3.3.4.b, calculations shall~be made including direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of-ODCM Control 3.3.7 have been exceeded. If such is the case,-
prepare and submit to the Commission within 30 days, pursuant to Technical Specific & tion 6.9.2, a Special Report that' defines the D corrective action to be taken to reduce subsequent relectes to I prevent recurrence of exceeding the above limits and includes- l the schedule for. achieving conformance with the above limits. l This Special Report, as defined in 10 CFR 20.405c,-'shall include 3 an analysis that estimates'the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and: direct-radiation, for the calendar year that includes the release (s) covered by this report. It shall also describe levels of radiation.and concentration of radioactive material involved, and the cause':of the exposure levels or. concentrations. . If the estimated dose (s). exceeds the above limits, and if the release condition resulting. I in violation 40 CFR Part 190 has not already been corrected,-the l Special Report shall include a request.for a variance in- _. 3 ) accordance with the provisions of 40 CFR Part 190. Submittal of 1 the report is considered a timely request,:and a variance is l granted until staff action on the request is complete. SURVEILIJ KE R"OUTREMENTS 3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0. 3.3.7-2 If the cumulative dose contributions exceed the limits defined in 3.3.7a, Cumulative dose contribution from direct radiation from unit operation shall be determined using ST-0-104-878-0, ST-0-104-879-0. L 1
= -
p. l: ODCM Rev. 15' ' Page 44 '
- l. 12/94-3.4 RADIOLOGICAL ENVIRONMRWTAL MONITORING PROGRAM (REMD)
CONTROLS
'3.4.1.The monitoring program shall.be conducted as specified in Table-I3.4-1.
APPLICABILITY: At all times. ACTION:
- a. With the radiological environmental monitoring program not being conducted as'specified.in Table.I3.4-1, prepare and submit to the Commission, in the Annual Radiological Environmental Operating Report per ODCM Control 3.5, a description of'the reasons for not-conducting the program as required and the plans:for preventing a recurrence.
- b. With the level of radioactivity as the result of plant effluents in an environmental sampling mediumLat a specified location exceeding the reporting levels CME Table I3.4-2 when averaged over any. calendar quarter, prepare and submit to the Commission within 30 days, pursuant to Technical. Specification 6.9.2, a.Special Report that identifies the.cause(s):for exceeding the limit (s) and defines the. corrective? actions to be taken to reduce radioactive effluents so that the potential-
- annual dose to a MEMBER OF THE PUBLIC is less,than the calendar year limits of ODCM Controls ~I3.2.3, I3.3.3 and I3.3.4. When more than one of the. radionuclides in~
Table I3.4-2 are detected in the sampling medium, this report shall be submitted if: concentration (1) , concentration (2_) + 4 reporting level-(1) reporting level (2) . . .M.0 When radionuclides other than those in Table I3.4-2 are detected and are the result of plant effluents, this i- report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCM Controls I3.2.3,- I3.3.3 and I3.3.4. This report is not required if the measured level of radioactivity was not the result of plant l effluents; however; in such an event, the condition l shall be reported and described in the Annual Radiological Environmental Operating Report. I
,7 c .a r
' llI 'ODCM Rev. 15'-
'Pcga 45 l: 12/94'-
7
. RADIOIDGICAL ENVIRONMlldTAL ' MONITORING (Continued) -
;With milk or. fresh leafy vegetab el samp es~ unavailable-
. c. l from oneJor more of the sample locations required by:
Table.I3.4-1,.:. identify: locations for' obtaining.- replacement ~ samples..and add.them to the radiological environmental monitoring program within 30: days.. The specific. locations from which samples were unavailable' may then'be. deleted from the monitoring program. Pursuant to Technical Specification 6.14, submit.as-a
- . !=
part of or_ concurrent with the Annual Radioactive Effluent. Release Report,.a complete,' legible copy of~ the entire ODCM, including a revised figure (s) and table for the ODCM reflecting the new location (s). SURVEIT.TANCE REQUIREMENTS' 3.4.1-1 The radiological environmental' monitoring samples shall be collected (using ST-0-104-800-0) pursuant to Table I3.4-1 from the specific locations given in the~ table and figure (s) in the ODCM and shall be analyzed' pursuant to the requirements of Table I3,4-1, the detection capabilities required by'the Table I3.4-3. a i 1 1 l l + 1 i. 1 4
- _ _ _ _ _ _ _ . . _ _ _ , = _ . _ y
y __ .,
.z . ,
w.2 g{:; . j .: ' ODCM'Rev.'15 PageT46 ~ i
-j - 12/94 ,
TABLE'I3.4-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE. EXPOSURE PATHWAY SAMPLES-AND SAMPLING AND , TYPE'AND. FREQUENCY-'
~ '
SAMPLE LOCATIONf*) -COLLECTION FREQ. OF ANALYSIS _ AND/OR SAMPLE , 4
- 1. DIRECT RADIATION N 40 routine monitoring stations At'least Quarterly. Gamma' dose'at'least-either with two or more dosi- . quarterly.
meters or with one instrument for measuring and recording dose rate continuously _placed as follows: (1)-An inner ring of stations, one in each meteorological ~ sector, in the general area of the SITE BOUNDARY: (2) An outer i ring of' stations, one in each meteorological sector, fin the - - 3-9 mile range from the. site;
-V-(3) The balance of the stations '
4 placed in special interestr areas such as population centers, nearby residences,, schools and:in 1 or 2. areas.to serve as control stations. _ l 1 A p_ _L / r- ..ms w u - - " * "' ~ vr r
- F4 3 ?:-m'--
- - a%- - --m' --- - $-
~
.; r ODCM R;v.-15
.l .
Page 47
! 12/94 TABLE 13.4-1 (Continued)
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND ' SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION M COLLECTION FREQ. OF ANALYSIS-
- 2. AIRBORNE Radioiodine and Samples from 5. locations: Continuous sampler- Radiciodine canisters:
Particulates a.3 samples from close'to the. operation with sample I-131-analysis 3 SITE BOUNDARY locations (in collection weekly, or weekly. different sectors) of the more frequently if highest calculated annual required by dust Particulate Sampler: average _ ground level x/Q. loading *. Gross beta radio-activity analysis , b.1 sample from the vicinity following. filter. community having one of the highest calculated annual _ change:d ground level x/Q. Gamma isotopic 1 sample from a control loca- analysis' of J tion, as for example 15-30 km composite-(by distant and in the least pre- location) at least-
-valent wind direction.. quarterly l
l l
- m . .- - __ _
p ,~
$ .~ i n,
~
[ ODCM.Rev. 15
-Page 48-
, j. 12/94 TAnr.R I3.4-1 (Continued) . RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM
-NUMBER-OF REPRESENTATIVE EXPOSUP.E' PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY 2 i
SAMPLE LOCATION (*3 ' COLLECTION FREQ. OF ANALYSIS AND/OR SAMPLE i
- 3. WATERBORNE 1
- a. Surfacef 1 sample upstream composite sample Gamma isotopic analysis' 1 sample downstream over 1-month monthly. Composite'for-periods. tritium analysis quarterly.
- b. Ground Samples from 1 or 2 sources Quarterly.
only if likely to be affectedh
- c. Drinking 1 sample of each on 1 to 3 of Monthly. I-131 analysis.on each of the nearest water-supplies. (Composite) composite when the dose'.
that could be affected by'its calculated for.the con-- discharge. sumption'of.the water is greater than 1 mrem per 1 sample from a control -year.1 Composite for gross-location beta and gn==na isotopic' analysis monthly. . Comp-osite :for tritium . analysis. quarterly.;
- d. Sediment from i sample from downstream area' ' Semiannually. '
Gamma isotopic analysis' shoreline with existing;or! potential semiannually. i' l ,.
~
_ _ . . _ _ ._i_. _ 1._ ill __. . -
,~ .. ; =
.f 4 , s .' +(k[
%., ~
ODCN Rsv.:15 --
^ - -
.l ~Page 1:1
.12/94 C l
9,. TABLE'13.4-1 (Continued) 'i
' RADIOLOGICAL ENVIgnNMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE ,
EXPOSURE PATHWAY SAMPLES'AND SAMPLING AND TYPE AND FREQUENCY SAMPLE LOCATION (*3 COLLECTION FREQ. OF. ANALYSIS AND/OR SAMPLE
- 4. INGESTION Gamma isotopic' and I-131
~a.~ Milk Samples from milking animals Semimonthly when in 3 locations within 5 km animals are on analysis semimonthly-when:
distance having the highest pasture,. monthly
. animals are on pa.sture dose potential. If.there are at other times. (April 1 .Oct. 1):-
none,.then 1. sample-from monthly.at'other times. milking animals.in each of 3 areas' between' 5 to 8 km distance where dose are cal- , culated'to be greater.than 1 mrem.per year.i 1: sample-from milking animals at a control. location ((15-30 km distance):and in the 11 east wind direction..
- b. Fish and- 1 sample-oi two-recreationally Sample in season, Gamma isotopic
- Invertebrates important spcies in vicinity -or semiannually analysis on edible 1 of plant discharge area. 1 if they are not; port. tons.
sample of-same: species in area seasonal. not-influenced by plant discharge.
. .i beBid.iBed
y y; 3 _ ' . ~Jf _ 4 E ODCM Rev. 15, l ~ ~
'Page 50 ~
,l 12/94-J.
TARTR I3.4-1 fContinuedi RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM-
~
1- ,- NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY-SAMPLE' LOCATION (*' COLLECTION FREQ. OF ANALYSIS AND/OR SAMPLE
- 4. INGESTION (Continued) t I
~'
- c. Food Products Samples of 3 different kinds of Monthly when avail . . G a num a -- i s o t o p i c
- a n d broad leaf vegetation grownL -able, if milk sampling I-131 analysis.
nearest each of 2 different- is not preformed. J offsite locations.of highest predicted annual ~ average ground level D/Q if. milk sampling-is not preformed. 1 sample of each of.the similar Monthly when avail- Gamma isotopic' and bread leaf vegetation grown. able, if milk sampling -I-131 analysis. is not performed. u 15-30-km distance in the least prevalent-wind direction if milk sampling is not performed.- e_
*e 4
ar-
.a.. . >---a ~: vna.m, .._%,,,,__
_ ,,_ g_, _ _ _ ,
% ~ ;- . - , . _ _ . _ , - - . . _ . _ _ .- ..-- . _
7 lkg., ' '
~%- Xbs
'.ODCM R3,v. 15 ll( <
Page'51 jc ~l -12/94 L,
, 'RADIOLOGICA7iENVIRONMENTAL MONITORING TABLE T3.4-1 (Continued) ,
TABLE NOTATIONS
;a.- Specific parameters of~ distance and direction sector form the centerline of the two reactors and additional description where-pertinent, shall be provided for each and every^ sample location ,
in Table I3.4-1 in a table and figure (s) in the ODCM. Deviations-- are permitted from the required sampling schedule if -specimens are unobtainable due to hazardous conditions,-seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens'are unobtainable due to .' sampling equipment malfunction, every effort shall be:made to-complete corrective action prior to the end of the next sampling period. All deviations from the sampling' schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. . It is recognized-that,-at times, it may not be possible or practicable to continue to i obtain samples of the media of choice at the most desired . location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within.30 days in the ' radiological' environmental monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent- ' l with-the next Annual Radioactive Effluent Release Report a complete legible copy of the ODCM including a revised figure (s)~ and table for the ODCM reflecting the new location (s). ',
- b. One or more instruments, such as a pressurized ion chamber, for !
measuring and recoding dose rate continuously may be used_in place of, or in addition to, integrating dos heters. For the j l purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet j are considered as two or more dosimeters. Film badges shall not
=
be used~as dosimeters for measuring direct radiation.
- c. Methodology for recovery of radioiodine shall be described in the ODCM.
- d. Airborne particulate sample filters shall be analyzed for gross 1 beta radioactivity 24 hours or more after sampling.to allow for radon and thoron daughter decay. If gross beta activity is air particulate samples is greater that 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples.
- c. Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be !
attributable to the effluents from the facility.
'1
y - ' I ODCM Rsv.-15 P2ga'52 1 12/94
, 4
- f. -The " upstream-sample" shall be.taken-at:a distance beyond
~
significant: influence of the discharge. -The " downstream sample"
.shall be taken in an. area beyond but near the mixing zone.
I g.- A composite' sample is one in which the quantity -(aliquot) of liquid sampled'is proportional to the quantity of flowing' liquid. and-in which the method of sampling employed results in a- 1 specimen that-is representative of-the liquid flow. . In this program composite sample aliquots shall be collected at time
-intervals'.that are very short.(e.g., hourly) relative to the- ,
compositing period (e.g. , monthly) in order to assure obtaining a
-representative sample.
'h. . Groundwater samples shall be taken when this source is tapped.for~
drinking or irrigation purposes in areas where the hydraulic gradient or. recharge properties are' suitable for contamination.
,l :
- 11. The dose shall be calculated for the maximum organ and age group, F using ST-0-104-878-0.
1 9 4 7 t [
'h
W;;y"'
?
n, v , .
'l; ODCM rov. 15 P3gs 53
-l f12/94 TABLE T3.4-2 RRDORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES 1 ReDorting Levels AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS (ANALYSIS .pCi/L)
( GASES (pCi/m3 ) (pCi/kg, wet) (pCi/L) (pCi/kg, wet) H-3 20,000* Mn-54 1,000 30,000 Fs-59 400 10,000 C -58 1,000 30,000 C3-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400** I-131 2 0.9 3 100 Cs-134 30 10 1,000 60 1,000 _C3-137_ 50 20 2,000 70 2,000 BO-La-140 200** 300 0 .Far drinking water samples. This is 40 CFR Part 141 value. If no drinking pathway exists, a value of 30,000 pCi/L may be used.
** Total for parent and daughter.
l l ~
ep fAime n g. : e: i' 1 s .< l
$6 ' 1 ' ;ll
-ODCM'R0v.,15L 'l '
Pag 3 54
, 1
-f' '12/94~ 0-
, , tl s_
~ h TA]g2 13.4-3: _;
I
' / . DETECTION CAPABILITIES FOR ENVIpnuwirwTAL RAMPLE ANALYSIB *3 Lc4er limit. of Detection (T.T.n)(b)(c) ,
AIRBORNE ' FOOD .. WATER PARTICULATE or FISH MILK-- PRODUCTS SEDIMENTS i LANALYSIS (pCi/L)1 l GASES (pCi/m3 )' (pCi/kg, (pCi/L) (pCi/kg, (pCi/kg,, < wet). wet) . dry) , 5 Gross' Beta 4 0.01 .,
'1
'2,000 $
j.H-3 Mn 15. 130 , Fa-59' 30 260'
'Co-58,60 15 130 ;
En-65 30 260 ' l
- Er-95 30 .:
t Nb-95 " ~ 15 i.
- I-131 1(d) 0.07- 'l 60 ,
Co-134 '15: 0.05 130 15 60 150
.i
- - Cs-137 -18 0.06 150 18 80 180 Ta-140 ,
60 60 La-140 15 15 i i i J f i
7a 9
]
jL ODCM Rsv. 15 ) E
' Paga-55 ')
l
, 12/94 5
TABLE 13.4-3 (continuedi l TABLE NOTATIONS l 4 (a)~ This list dose not mean that only these nuclides are tx) considered. ;Other peaks that are identifiable at 95% confidence , level,.together with those of the above nuclides, shall-also be analyzed and reported'in the Annual ~ Radiological Environmental-Operating report pursuant to ODCM Control 3.5. Require'd detection capabilities for thermoluminescent dosimeters
'(b) used for environmental measurements are given in Regulatory-Guide 4.13.
(c) -The LLD is defined, for purposes of these controls, as the smal2est concentration of radioactive material in a. sample that will yield a net count (above system background) that will'be , detected with 95% probability with only 5% probability of falsely concluding that a blank observation representsDa "real" signal. For a particular measurement system (which may include radiochemical separation): , 4.66s a LLD-E V 2.22 Y exp (-AAt) 1 Where: LLD is the a nriori lower limit of detection as defined.above (as picoeuries per unit mass or volume), 3 s is the standard deviation of the background counting rate or , o$ the counting rate of blank sample as appropriate (as counts ; per minute), ; E is the counting efficiency (as counts per disintegration), V is the sample size (in units of mass or volume), 2.22 is the number of disintegrations per minute per picocurie, Y is the fractional radiochemical yield (when applicable), , A is the radioactive decay constant for the particular i radionuclide, and At for the environmental samples is the elapsed time between sample collection (or end of the sample collection period) and time of counting.
.E Typical values of E, V, Y, and At should be used in calculation.
f
, , , ,.m_.._,,_-- _ _ -
m-- y .- , - . , _m. . . ,. -
s . , , . , -_ _
, . _ . . ~ .- . _
l
/.ii / - l; ODCM R3v. 15
' pig 3 56 i
]?
12/94; .j TABLE 13.4-3 (Continued) l w TABLE NOTATIONS It.should be recognized that the LLD is defined as an a nriori. (before the. fact) limit representing the capability.of a. measurement system and-not as an after the~ fact' limit for.a- ~
-particular measurement. Analyses shall be performed in.such a -
manner that the stated LLDs.will be achieved under routine conditions. Occasionally background fluctuations, unavoidably; small sample sizes, the presence of interfering nuclides, or-- other uncontrollable circumstances'may render these LLDs . . unachievable. In such cases, the contributing factors shall be
~
identified and described in the Annual Radiological Envirorunental Operating Report pursuant to ODCM Control 3.5. . (d)- LLD for drinking water samples. f 9 b i e i l 1 l 1
ODCM R2v. 15 l Pag 3 57 l 12/94 RADIOLOGICAL ENVIRONMENTAL MONITORING LAND USE CENSUS l CONTROL 3.4.2 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each of the 16 meteorological sectors) of the nearest garden
- of greater than 50 m2 (500 ft2) producing broad leaf or vegetables.
APPLICABILITY: At all times. ACTION:
- s. With a land use census identifying a location (s) which yields a calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the l new location (s) in the next Annual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.
- b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained in accordance with ODCM Control'3.4.1, add the new location (s) to the radiological environmente.1 monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which this land use census was conducted. Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Annual Radioactive Effluent Release Report a complete, legible copy of the enti :e ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).
SURVEILLANCE REOUIREMENTS 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
- Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Qs in lieu of the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples.
- - . - ~ .-. - - . .. ,,
~
. a- !
'. l ,..
'l '
ODCM Rsv. 15 Peg 2 58~.
.l 12/94 RADIOLOGICAL ENVIRONMENTAL MONITORING
.INTERLABORATORY COMPARISON PROGRAM CONTROL 3.4.3 In accordance with LGS Technical Specification 3.12.3, analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved by the Commission.
APPLICABILITY: At all times. ACTION: with analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
' SURVEILLANCE REOUIREMENTS 3.4.3-1 The Interlaboratory Comparison Program shall be documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2. A summary of the results shall be included in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
l I
, w~ __ _ _ - _ - - - - - - - _ - . _ _ - - _ - . . - - - - - _ . _ _ _ _ _ _ _ _ . - _ - _ _ - - _ _ _
Ll' ODCM Rsv.)15- ; PRg3 59 :
- l. 12/94 L -ANNUAL' RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT
- l L3.5. Routine Annual Radiological Environmental Operating Report-covering the operation of Unit 1 and Unit 2 during the previous calendar year. i shall be submitted prior to May 1 for each year. The initial' report-was submitted prior to May 1 of the year following initial criticality (1984).. A single report is submitted for a multiple unit station. -The Annual Radiological Environmental Operating' i Report shall-include summaries, interpretations, and an analysis of r trends of the results report period, including a comparison (as appropriate), with'preoperational studies, operational controls and ,
previous environmental surveillance reports and an assessment of the j observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required by ODCM Control 3.4.2. -The Annual Radiological Environmental Operating Report-shall include the results of all radiological 4 environmental samples and of all environmental radiation 1 measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE.DDSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the
~
Radiological Branch Technical Position, Revision 1, November 1979. :t In the event that some individual results are not available for inclusion with the report, the report shall be-submitted noting and- i explaining the reasons for the missing results. The missing data i shall be submitted as soon as possible in a supplementary report. The report shall also include the following: a summary description of the radiological environmental monitoring program and at least two legible maps. One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed dictant stations.
~
Covering all sampling locations keyed to a table giving distances , and directions from the centerline of the reactor: plant; the results of licensee participation in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion <of all deviations from the Sampling Schedule of Table I3.4-1;.and discussion of all ,
-, analyses in which the LLD required by Table I3.4-3 was not >
achievable.
)
i 4 l l l l
J l, ODCM rov. 15 i Pag 3 60- 1
,l-12/94: l ADMINISTRATIVE CONTROLS
.l:;3.6 ANNUAL RADIOACTIVE EFFLUENT RRLRASE RRPORT ;
A Routine AnnualiRadioactive Effluent Release Report covering the 4 foperation of Unit 1 and' Unit 2 during the previous 12 months of ; operation _shall be submitted within 60 days after January 1 of. . eachLyear.- The period of the first report shall begin with the-date>of initial criticality. ST-0-107-992-0 shall be used to generate the report. A single unit submittal is made for the 2 .;' unit station. The submittal-combines those sections:that are- - The Annual Radioactive .
'l common to all units at the station. j Effluent Release Report sh^11-. include a sunmary of the. quantities.
of radioactive liquid anf .sseous' effluents and_ solid waste-released from the facility-as outlined in Regulatory Guide-1.21,.
" Measuring, Evaluation, and Reporting Radioactivit in Solid Wastes and Releases of Radioactive Materials'in Li id andi Gaseous Effluents from Light-Water-Cooled Nuclear Power, Plants","
Revision 1, Jun( 1974, with data summarized on a quarterly basis following the format of Appendix B thereof.
' j' The Annual Radioactive Effluent Release Report to be submitted 60'
~ days after January 1 of each year shall include an annual summary ;
of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour-list?%g on magnetic tape of wind'apeed, wind direction-and atucapheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind - direction, atmospheric stability. The licensee has the option of : retaining this summary of required meteorological data on-site in a file that shall be provided to the NRC upon' request. This'same report shall include an assessment of the radiation doses'due_to-the radioactive liquid.and gaseous effluents released from both- 7 units during the previous calendar year. This same report shall_ also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE.PUBLIC due to their activities inside.the SITE BOUNDART (Figures I2.2-la F and I2.2-lb) during the report period. All assumptions used in , making these assessments 'shall be included in these reports.- The assessment of radiation doses shall be performed in accordance + with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM). 4 b i t f 5 B F
l ODCM rov. 15 Pega 61 l 12/94 l The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year shall also include an assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977. l The Annual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period:
- 1. Total volume, activity and estimated total % error for each waste type:
- a. Spent resins filter sludges, evaporator bottoms, etc.
- b. Dry compressible waste, contaminated equipment, etc.
- c. Irradiated components, control rods, etc.
. . __d. Others (describe).
- 2. Activity and percentage of each principle radionuclide
(>1%), for each individual waste type as defined in
- 1. (a-d) above.
- 3. The disposition of solid waste shipments (identify the number of shipments, the mode of transport, and the destination).
- 4. The disposition of irradiated fuel shipments (identify the number of shipments, the mode of transport, and the destination.
l The Annual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period. l l The Annual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2. l The Annual Radioactive Effluent Release Reports includes an j explanation as to why the inoperability of liquid or gaseous j effluent monitoring instrumentation was not corrected within the j time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and i description of the events leading to liquid holdup tanks or gas I storage tanks exceeding the Control limits. i l
u< . ' bb 4~ 5..
~ ~ ~ '
^= ' ~ ~ ~
~~n -
" ' ~ - ' "
y.yg lW - IODCM Rev. 15. e<
> > [li
~ >
Pcg3 62
. .Jgj...
' .sfG .
- -12/94:
f3.7 . MAJOR' CHANGES TO' RADIOACTIVE'WARTE TREATMENT'SYSTEME-d
- LLicensee-initiated major changes to the'. radioactive;wasta systems-(liquid,/ gaseous,.and solid):. .
l ~ a.. ' Shall be. reported to the Commission in.the Annual-
' Radioactive Effluent: Release' Report;for'the periodlin 4
' which the' change was made effective. 'The discussion of
.eachLchange shall'contain':
li'
- l. LA'~ summary of_the evaluation that;. led to the determination that the change could be made'in. ,,
accordance with 10 CFR.50.59;
- 2. Sufficient: detailed information to totally: support the reason for.the change'without benefit of
~
additional or supplemental information;
- 3. A detailed description of the. equipment,.
components,.and processes. involved and the interface with other' plant systems;a i
~
An evaluation of the change which shows the
- 4. .
i- predicted releases.of radioactive ~ materials-in U liquid and: gaseous effluents;and/or quantity of , solid. waste.that differ from those.previously' l predicted =in.the license application and amendments thereto-
- 5. An~ evaluation of the-change which shows the
. expected maximum exposures'to individual in the ?
UNRESTRICTED AREA and to the general' population-that--differ from those previously' estimated in'the.
. license application and amendments thereto;_ ,
- 6. .A comparison ef the' predicted releases of radioactive materials, in liquid and gaseous i
effluents and in' solid waste,,to the actualu releases for the period prior to when the changes , are to be'made; ;
- 7. An estimate of the exposure to plant operating j personnel as a result of the change; and
- 8. Documentation of the fact that the change'was ~
reviewed and found acceptable by the PORC.
- b. Shall be reviewed and accepted by'the PORC prior to implementation.
i
- H c. Shall be documented by Recurring Task Action Requests: ;
G0000126, G0000072, G0000128, G0000074, G0000075, .; G0000076 and G0000077. ; r
+
4 -
-,w .m r w- m- -va 4- - -- + _ __ ,-- ___------------------------_r
I I i l l
'l I
i PART II CALCULATION METHODOLOGIES W
3 , ,, y,
~_ _
- ~
->;n->
[@ ' , . V '"' "
!( :ODCM R0v. 15' Paga.63 J
pall 12/94.
~
* 'l
- 1. 0 ' LIOUID EFFLUENTS 21.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS ,
s .
-1
,% The? liquid ~ effluent monitoringiinstrumentationiand controls at. Limerick for controlling and monitoring normali ,
< radioactive material releases--in accordance with the , ' M Limerick Technical ~ Specifications are summarized as follows: y 4 .1) Liquid Radwaste System: .The liquid radweste. discharge. monitor (RISH63-0K604)'provides-an' alarm'and~ automatic: termination of: radioactive-material-releasec from the- - liquid radwaste system-as required by.. Technical: Specification 6.8.4.d.1. . Additional design features: [ of the liquid radwaste system which prevent'. . .. inadvertent-relee.ses to:the environment include:1)1 redundant discharge valves, 2)' single.. discharge linei with loop. seal and siphon breaker to eliminate. i probability of inadvertent discharges, 3) Low Cooling' Tower Blowdown flow. interlock which isolates the : radwaste. discharge line.' _ . . 2) Service water Svstem:' The~ Service' Water discharge; monitor.(RISH10-1K605-AND RISH10-2K605) provides an alarm upon indication of activity in the service water system.as required by: Technical Specification 6.8.4'.d.1.- While the service water system:is not a normal release pathway, the monitor provides'an-indication.of potential problems due to excessive leakage of the heat exchangers. 1In addition,;the service.. water side of the fuel pool heat exchangers is: 1 kept at'a higher pressure than the shell side to: !
- prevent potential radioactive contamination.of.the.'
i service water.
- 3) RHR Service Water System: The'RER Service Water ,
1I
. Radiation (RHRSW) Monitors (RISH12-0K619A, RISH12- i
,- OK619B, RISH12-1K619C, RISH12-1K619D,-RISH12-2K619C? AND'RISH12-2K619D) provide alarm and automatic
] ,
termination of radioactive material release from the 1 RHRSW system, as required by. Technical' Specification j 6.8.4.d.1. While the RHRSW system'is not a normal , ) release paths y, the monitors provide-indication'of-potential problems due'to excessive leakage.of the' 1 heat exchangers. j l l l
.I
)
Ykh,h # '
+-
gf ' E-3;y . , , %g;
, e - "
^ ~i' (lf
.ODCM'R":v.~ 15 U Pcg1 64' ap JE u.fl 12/94:
13.2" LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION j s, . 1 1Per L thel requirements of LTechnical; ~ Specification ; 6.8. 4'.d.1~, 4
' alarm setpoints shall be. established.forfthe liquid' . -
effluent; monitoring.-instrumentationito ensure that the. releassiconcentration. limits of Specification 6.8.4.d.2 and(6.8.4.d.3.are met-(i.e.,sthe. concentration'of-radioactive material released in, liquid effluentsLto l UNRESTRICTED AREAS,shall be limited to the' concentrations'. specified in 10'CFR'20,. Appendix B, Table II, Column 2,. - Jfor radionuclides'and 2.0E-04 pCi/ml,for' dissolved or: > entrained noble-gases). i 1.2.1 Radwasta Discharae Monitor and Discharae Flow Rate') , -- RISH63-OK604 ]
-The setpoint for-the(11guid'radwaste discharge
. monitor and flow-rate element are determined by-the following equations. -The'radwaste discharge- . .
monitor-high-high alarm / isolation setpoint.is- ~' l evaluated at least monthly based on isotopes c detected in the. liquid radwaste sample tanks j released during the previous month or onsany'. m- specific sample' tank being released (EC,), .the Required minimum cooling tower blowdown flowLat' ' time of. discharge.(CTBD),--and average liquid- ; radwaste discharge flow-~(RR). The flow rate.. determinationLis calculated.for each release and' the MPC fraction'calcu3ated includes,11n the, concentration mix, the'most recentoresults from
- 1) the quarterly; composite for SR-89, SR-90 and- -
Fe-55,.and 2) the monthly composite for H-3, andL : I 3) theLsample(s) for dissolved and entrained noble !
;. gases.
If1the: calculated-setpoint is less than the existing setpoint, the aetpoint will be reduced.to the next value. If!the calculated setpointiis: greater than the existing'setpoint, the setpoint, may remain at the lower value or increased'to.the
, calculated value.
.The actual setpoint may be reduced to a value less-than the calculated setpoint'at the discretion of:
Supervision. " If there were no sample. tanks released cn no .
, activity detected during the previous' month, then' the calculation is performed using release data from the most recent month'during which. isotopes ; were detected. In addition, if there were'no- :
sample tanks released during the1 previous month, chemistry supervision may substitute'more , restrictive values (e.g., tritium) based on the: plant sampling data. j s c
y ' f
- l:
ODCM~Rtv. 15-Paga 65-
;l' 12/94-l.2.1-1 setnoint ! Determination ~RISH63-OK604 r The setpoint for the liquid radwaste discharge monitor is: determined by'the following equation:-
. CPNgwy s (S) (RR) [E (Cm a)/NPCm a)) ~ (EC3 ) (RR+CTRD)
'(1-1)
C ,/NPC ,) +BKG("I (RR+CTBD) (S) (E) (RR). [E j j , where: , CPM cu,) = Calculated liquid radwaste. discharge monitor (RISH63-0K604) count rate attributable to the gamma emitting radionuclide, cpm EC'" = the sum of the concentration of the identifled gamma emitting nuclides (pci/ml), CTBD = the required minimum cooling tower blowdown rate at time of discharge (gpm), RR = average liquid-radwaste discharge flow (gpm),'
~
BKG gg,) = background' count rate of liquid radwaste discharge monitor'(CPM), E = the_. gross detection afficiency of the liquid radwaste discharge monitor (pci/ml/ cpm), and
'l S = 2; margin of safety factor to assure':
that the release is terminated prior to 10 CFR 20 limits being exceeded. Included in this factor are errors associated with monitor uncertainty', sampling uncertainty, flow rate uncertainty,.and the contribution of other release paths (Service Water and RHRSW) which are not normally contaminated.
= the effective gamma MPC ratio for the E(C' " /MPC' " ) mixture of radionuclides in the liquid radwaste discharge line (unitless).
~
ftpt s,
, -} ,
,- y .I N - lI; -
ODCM-R$v. 15.
' .91g3 66:
-* 12/94.-
}lJ ;._
where:1 i yg ' y.
, .y b
a' C
= the concentration of^each identified gamma emitting radionuclide"i in the ,
~
liquid effluent (undiluted);(pCi/ml) j MPC, , = the MPC value' corresponding to :' 4 radionuclide.iLfrom 10 CFR.20 Appendix s Bi Table II, Column 2T(dissolved.and entrained noble gases MPC = 2.0E~
'pci/ml) '(pCi/ml).
E(Cijg,/MPC,%) = the effective -nongamma MPC ratio for thei ; mixture of radionuclides in the' liquid radwaste discharge line (unitiess) i where: ; 3
- C,w, = the concentration of each identified nongamma radionuclide.i.in the liquid effluent'(Undiluted).(pci/ml)* i MPC,w, = The MPC value-corresponding to radionuclide i form 10 CFR 20,. Appendix-$
E B, Table II, Column 2~(dissolved and
- i. entrained' noble gases MPC =.-2E 4 pCi/ml) ' '
(pci/ml) .
- NOTE: The concentration mix must include the most recent sample
(. data for-H-3, Sr-89,:Sr-90,.Fe-55 and gross alpha. , u . 1.2.1-2 Flow Rate Determination' l l
- NOTE: E the effective MPC ratio'for.the mixture .)
of radionuclides ..[E(C,/MPC Y)) Jis 11.0, THEN a flow rate setpoint, determination is not required,i.AMD- . there is.no limit on dischargr flow rate. . E a flow rate: determination is required, . THEN the setpoint'for the liquid radwaste flow rate is determined for each release by the following equation:- FLOW (* s (SF) [E (C /NPC ) -13 (1-.2 ) 3 3
]
l where: 's 1 FLOW gt ,,3 = How 1 M t M ra @aste E s darge :1 line (gpm). l- CTBD = required minimum cooling tower blowdown flow for p time of release (gpm). j SF = 2; margin of safety factor to assure that the release does not exceed 10 CFR 20 limits. L-f y !. 1 i
er i 3,7
~ < >
c . , , " x J.d 'd ? ' , g47 sl: . ODCM.R;vW l5'
;POga: 67-a .; -9 '
1- .12/94-
~
- E (C,/MPC,); = the' effective'MPC retio'for.the mixture of-2P_ radionuclides in the. liquid'radwastel discharge. ,
- f. ,4
'line7(unitiess)
- where:
C, = the concentration:of.each identified ra'dionuclide-iDin the-liquid effluentf(undiluted) (pCi/ml)*' MPC, = the MPC value correspondingito radionuclidefi from I CFR 20 Appendix B,. Table II, Column'2,- (dissolved and entrained ncble-gases NPC = 23r' pCi/ml)(pci/ml).-
~* NOTE: .The concentration mix must include the most recent sample data" for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble' ,
gases. ~
- 1.2.2 Service Water Radiation' Monitor - RISH10-1K605; -
2K605 The Service' Water Radiation Monitorfhigh-high' , setpoint is. determined by the following equation. *
.The monitor high-high alarm setpoint is calculated
- monthly based.on a maximum background. count' rate .;
o of 300 CPM.- The setpoint is evaluated every'18'., months to assure that_a high background count rate. does not prevent adequate monitor sensitivity {in. 4 order to meet'the requirements of Tcchnical ; Specifications'6.8.4.d.2 and-6.7.4.d.3.-
-1.2.2-1 Setpoint Determination 4
The setpoint for the Service Water > 4 . Radiation' Monitor is determined.by the.- ;
- following equation:
CPM ,s.2 ,(CRB ,) ' (1-3) 1 where: . CPM" = Calculated Service Water ' , Radiation Monitor'(RISH12-1K605, -2K605) count rate, CPM. , 1 l
; I 1
s 4
-- .y p- v g
g...
, -- u- a f i ,
y .i vi q .4 ,7-- m- - t1. 4 e,. ODCMR0v.1155] Pagi 68: :; s .
. . l -.
12/94' .
^
E, .=: 3,. multiplier to establish =
~
monitor setpoint count rate-. ' above background _ count rate.
- (unitiess). 'T CRB ,= Service Water monitor (RISH12-1K605, -2K605) count rate
+ ~ attributable to background',
--radiation,. CPM
~ ~
1~.2.3 RHR' Service Water Monitor -RISH12-OK619A '-OK619B'.
-1K619C. -1K619D. -2K619C, -2K619D- 1 The RHR-Service-. Water Radiation Monitor high-high1 I setpoint is determined by the following. equation. o The monitor high-high alarm / isolation setpointLis ,
calculated based on a maximum background > count - rate of 300 CPM. The setpoint-is-evaluated.every, e 18 months to assure ~that a high background counta : does not prevent adequate monitor sensitivity in:
~
order to meet the Technical Specifications' 6.8.4.d.2 and 6.7.4.d.3. , l 1.2.3-1 Setpoint. Determination' . . j The setpoint for the RHR" Service' Water. !
- Radiation Monitor is determined by the-following equation:
~
CP#m ;s Zw (CRBw) ' (1-4 )
~
where: . i CPM ,, = . Calculated RHR Service Water Radiation' Monitor.(RISH12-- : OK619A,D-0K619B, -1K619C, --
> 1K619D,c-2K619C, -2K619D);. ,
count rate,: CPM.. E, =- ~3, multiplier to establish-monitor setpoint count' rate
'r above background. count rate- ' - (unitiess).
- i '?
i i L
,, ,y ,,.....s. .---.,.n....v- .
~ ' ~ ' ' ~ ~ ~ ~
s') ' [L eg@ - , s ; , 4 . h
~
lg ODCM R:v.y15' q
%. ,Paga:69 12/9.4f g,
d *
,y "d. , y:
[' CRBm= RER? Service Water: Radiation-Monitor-m
. 0K619B ,i1K619C,*-1K619D,.:'--
-(RISH12-0K619A, i- -
l% 4
'2K619C, -2K619D)> count rate m - , . attributable to background-
. radiation, CPM.
. _ 1.3- Liould Effluent i nosa calculation --10 CFR 50 .,
;1.3.1 wa= harm of the Public' Dose it ODCM I3.2.3-limits-the dose or dos'e commitment'to <
. MEMBERS OF'THE PUBLIC from radioactive materials.
'in liquid effluents.from' Limerick Generating-
=/[ #-
Station to:-
- n. S .
.- during any calendar. quarter,
~
. s 3 mram.to total body-k s10 mrem to any organ. ,
- during any calendar year.
s 6'arem'to total body. ; s20 mrom to total organ.
~
I Per-ODCM I3.2.3.1 the cumulative dose contribution ' i: from liquid effluents for the current calendari
- quarter year.shall be determined at'least once per- -i 31 days:in accordance with the'.following' .
calculation methods.-'These. equations are for the three aquatic-environment exposure-pathways (potable water, fish, shoreline exposure)Lin the: .A Limerick aquatic environment. Only real' pathways - are addressed for each receptor. 'The: receptors L and associated pathways are-listed below. Doses from each real pathway are. summed to give dose at the receptor. The monthly results are,accumulatedE , to g2.v_e the quarterly. doses'and the. quarterly. results.are accum"' .ed'to give the annual doses.. Rsceptor Dist. ways , Location (mi) Potable We- Fish ' Shoreline LGS'Outfall O X X Citizen's Utility 2.5 x X X
.Phoenixville Water 9.0 X X X Phil. Sub. Water 13.6- X X' Crew Course 37.8 X 4
h
e lii ~ . ' l -l ODCM'Rev. 15':=
>- Page~70 '
12/94.' 0~ .l: 1,3.1-1 Potable Water */athway Rg = 1100 b EOj ug D 'exp (-Aj (12))- (1-6)" N,F 1 s l'.3.1-2 Fish-(Aquatic Food) Pathway U
. Rg = 1100 88 ' EOjBj,Dgg exp (-Al (80 )
(1-6) NJ 1 1.3.1-3 Shorellne Deposition Pathway . Rg = 110,000 EOjTjDug exp (- Al "p) [1-exp (-Aj (1.7sas+s) ) ) ' (1 7) M,F i where: B,, = equilibrium- bioaccumulation factor for nuclide i in pathway p, e ressed as the ratio of the concentration in biota, in pCi kg, to'the radionuclide' concentration in-water, in pci liter (liters /kg) f
9d 1 0 . [ ;lI ~ :ODCM R;vf'.15
.PCge 71'- l
- l. '12/94 1 g
- BIOACCUMULATION FACTORS (pCi/kg/pCi/ liter)
FRESHWATER SALTWATER E12 MENT ' ' FISH FISH H- 9.0E-1 9.0E-1
.C- 4.6E 3 1. 8E -3
'Na 1.0E-2 6.7E-2 a P 3.0E 3 -2.9E 4-Cr 2.0E 2 .
4.0E 2' Mn- 4.0E 2' 5.5E-2 Fe 1. 0E . 2 3.0E 3
Ru . 1.0E 1 3.0E 0: Rh 1.0E 1 1.0E 1. Te 4.0E 2 1.0E'1 ' I 1.5E 1 1.0E 1 Cs 2.0E 3 4.0E 1 Ba 4.0E O 1.0E 1 LA 2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1 Nd 2.5E 1 2.5E 1 ' W 1.2E 3 3.0E 1 Np 1.0E 1 1.0E 1 Rof: 1) U.S.N.R.C Reg. Guide 1.109, Rev. 1, Table A-1
- 2) Letter LTR 881209L001, from R.J. Clark, U.S.N.R.C.,.to G.A. Hunger, Philadelphia Electric ~Co., December 9, 1988, transmitting evaluation of Limerick ODCM. ;
yo ,g e ,
- - - " - ' ' ' ~
m g, , , , q 7 LW
- l. ODCM Eve 15 ; 4
- N " > l:i?
+ '
P:ge.72? " g}4 ll} ,
- 12/941
$s A Dgi,3 ; . =.Edoselfactor specific to a.given age'groupia,Jradionuclide -
o- '
-1,: pathway,p, and organ j which can be'used to: calculate ,
radiation-dose-(1)ifrom an' intake of.a radionuclide, fin-3 - , ; mrem /pci, or.'(2) from exposure to atgiven concentration-
'of_.a radionuclide in sediment,L ni mrem /hr_'per pCi/m2.. ~~ .
' values are listed by age group in, Table 1-1.
~
>> F- = . waste dilution flow rate'of~ liquid offluent" dilution 3
flow / number of batches c (ft /sec) . M,' = ' dilution factor.at point of' exposure or'at point of;
withdrawal of drinking water.(dimensionless).' Values are' graphically listed by receptor. location in Figures 1.3.1 :
1 to 1.3.1-5. -Value will be based onLaverage monthly'a: '
- river flow.
Q, = total release.of nuclide 'i' for time period'.(C1). . R,,3
= total dose for calculation time period.to organ j ofL '
individuals of age group-a from all nuclides 1.in pathway. b (mrem). - T, = radioactive half-life of nuclide i-(days).
~
usage factor specifying exposure time or intake rate for
=
U,, ' tin individual.of age group a associated with pathway p. i , (hr/yr, liters /yr,.or kg/yr). Pathway Infant Child Teen- Adult Fish -- 6.98 16' 21' Potable Water . (1/yr) 330* 510' 510" 7308 - Shoreline Recreation .
. 12* ,
(hr/yr) - 14' 67* Shoreline . Recreation
'(hr/yr) --
90b - .G00b - 600 b
.Ref:
- Regulatory Guide 1.109, Rev l', Table E-5
.b EROL Tabic 5.2.A-3
!- w = shoreline width factor (dimensionless) = 0.2. . . Ref: ' Regulatory Guide 1.109, Rev.; ' 1. 1.752E+5 = time period during which sediment is exposed to contaminated water-(hrs) (midpoint of plant life = 20 yrs)
=
1, t i radioactive nuclide 'i' decay) (hr- ' constant of
[L - , , q , c .
/
t
.ODCM R0v. 15
' 4%_ .POgs 73' aft . f: .12/94-7 9 12 , -=
delay time for potable' water . h pathway;in hours,to:allowxfor. N
-nuclide' decay ^'during transport-
.s. through.the' water. purification-plant and the.. water distribution system, ' Ref : ; Regulatory : Guide
'~
m .l.109,.-Rev. 1, Lapp. A.' 3p 24 =. delay time-:for potable fish' pathway;in; hours to allow for: nuclide decay..during transport
.through'the food: chain,1as well as during. food preparation'. .. !
Ref: Regulatory Guide :1.109, ' Rev. : ! 1,. App.LA.
~
i 1100- = factor to convert from Ci/yr-per-
' ft 3/sec to pCi/ liter.
110,000 = ' factor to convert from'Ci/yr per ft3 /sec to pCi/ liter 1 and to account for proportionately; constant:(100) used-in sediment! radioactivity,model. j
' ' ^ " ' ^ ~ " ^ ^ ^ ^ ' ' ' '
p;rW,K F ,
$D M ' ', ' 7'.
; +
r) D C M R ; v ..' 1 5 ' ll -
;PagD'741
'lf 12/94' e ,
s
~C .fl.4: L Liailld Ef fluent Dome Proiactions1 -
~
y
-ODCM I3.2.4'e'equ_ ires that the'~ liquid'radwaste-treatment system:
2 shall be operable.and appropriate portions ofLthe systems used "to reduce the radioactive. materials 11n liquid waste prior to: their discharge when.the projected' dose's due.to thet. liquid' i , ' ~ effluent to UNRESTRICTED' AREAS would' exceed:'
,. - 0.06= mrem /31 days'to the total body.
or. - ,
- 0.2 mrem /31 days to any. organ. 4 The applicable liquid radwaste treatment processing equipment- r for maintaining radioactive materials-~ releases ALARA are delineated.in Figure 1.4-6..
Dose projections are made at'least once per 31-days by thel following: equations:
. o D,, . = d)
- 31 days -(1-8)
D, = (Dg/d) ( D,
- 31 days (1-9)
I where: D,g = the total _ body' dose projection for!the current 31-day period:(mrem). D tb = the total body dose projection for'.the current calendar' quarter as determined ~by equation.1-5, - 1-6,.and 1-7 (arem). D, = the maximum organ dose projectionJforl
.the current 31-day period'(mrem). ;
D. = the maximum" organ dose.to.dateffor the' current. , calendar quarter ascdetermined by: equations 1 - 4 5, 1-6, and 1-7 (mrem). d = the-actual number of days in the current-calendar quarter at the end of the release.. . i' (days). The minimum time elapsed is_seven (7) days. 31' days = the number of' days of concern 4 d Y j, i
)
_ ~ - - . . . _ _ _ , _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ . _ _ _ _ _ _ _ . _ _ . . _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _
gg3p yy . x - s
- ~ '~ ~
~'
w . a -. Q'/ t < g
,; b: 1
/ODCM Rev. 15' l}
y$ y a
- , ,i y3g,/94; s 12 L
,b ;, y i i !?/ w ,
, [2iG GASEOUS EFFLUENTS
?a . Vl
.2.17: Radiation-monitorina' instrumentation and Controls;
~
.The-gaseous offluent; monitoring' instrumentation and: controls at?
- Limerick for controlling monitoring radioactive' material -
releases in accordance with?the ODCM Part 1 are summarized'as " follows: '
- 1) North Vant Ic --an): The plant gaseous'dischargesLvibthis , . ' .
vent are monitored by two Particulate,' Iodine and Ges (PIG).
-monitors ~(RY26-075A and RY26-075B) in parallel.and by1thou Wide Range-AccidentLMonitor-(WRAM)"(RIX26-076).- The PIGS have separate Particulate,--Iodine,' and. Gas sampling-andl -
monitoring channels but the Station:ODCM Controls require- 1 only particulate and iodine sampling:and noble gas 1 monitoring. The.WRAM hasLextended range (via three. 1 J channels) noble gas monitoring'and particulate;and' iodine
. sampling capability. In: addition, the WRAM provides an-isolation (Group A) of the large Drywell Purge and Vent: N valves.
d-
- 2) South vant tone nar unitit The plant gaseousidischargesJvia!'"
a_ each South-Vent are monitored by two redundant PIG monitors (RY26-285A,B).- As is the case of:the North Vent,Joach: PIG has separate particulate, iodine, and gas sampling and' I monitoring channels but the Station ODCM.Part I requires _, only particulate and iodine sampling with gas' monitoring. 3)- Hot Maintenance Rhnn ft%==ani! .Due to;the' composition of: the radioactive materials in the effluent steam (i.e.,-very.
-low potential'for noble gas), this release point'is' sampled for particulate and iodine (P&I). monitors'(RY26-025). :The. 4, iW PEI monitor has a separate' particulate and iodine sampling
~
and monitoring channels but Station ODCM Part:I requires ' only particulate and iodine sampling.
- j. 2.2 CASEOUS EFFLUENT MONITOR SETPOINT DETERMTNATION.
l; ODCM I3.3.1 requires that'an alarm setpoint be-established'for: the noble gas affluent monitoring channels-(RY26-075A',B,;'RY26-185A,B,; RY26-285A,B,; and RIX26-076)lto ensure that the~ release rate of radioactive materials..does not' exceed-the limits of ODCM 13.3.2.a, which corresponds >to.a' dose rate at p"6 the SITE BOUNDARY of 500 mrem /yr to the total body or 3000 . l mrem /yr to the skin. This specification also states that the L dose rates from I-131, I-133, Tritium, and all' radionuclides in-- particulate form with half-lives greater than eight days, shall be limited to a maximum of 1500 mrem /yr to any organ (inhalation pathway only).
gy- t 7 y~ '
= m- m " vix p
*? - ,
~
WM s ' - gw
'[ , ,
ODCM R2v. 157 ,=
, 90 ,W,,f.
jl% ; _
'Prga 76; g
~
4
' 12/94-
, ]l * <
~
N * - 'ODCH Part;I limits are; expressed:in terms of: dose l rate,.whilei
,W
} .thrcinstruments which monitorfoffluents produce. data.inEuni ts of concentration or release rate..It:is.therefore necessarycto- r
~ identify the isotopes'and. calculate the corresponding _ release =
e frate.which will~ result in the dose rate: limit:being.reachedfat the-site boundary._ This calculation is~made moreLcomplex by; '
- thetuse of multiple releaseipoints at' LGS. ,
j.
-Calculation Bases The' alarm setpoint calculation'is: performed' monthly"and'is -
based on! analytical results of grab samples from the.. appropriate release point. The concentration'of each . . . . _ . identified radionuclide'in the grab samples lis determined,--and' ' 'j~ l- .the data are used.to' perform a-setpoint calculation for;that' nuclide mix and release point. The highest calculated annual average: concentration3IX/Q) for-an' area at or beyond the site boundary (l.lE-05sec/M , NE sector) is used in the setpoint calculation. Maximum flow rates through the North'and South ventstare-used-in alarm setpoint calculations.: This is necessary'since; flow can vary. 'By using maximum values,:any flow;less_than the maximum will assure that the monitor.will alarm before release: rate limits are exceeded.. For each. release point the noble gas release'which would causex a SITE BOUNDARY total body'doseLrate ofL500 mrem /yr and a skin dose'of 3000 mram/yr is determined. The fractional contribution.of noble' gas is calculated for each1
= release point. The fractional contribution to the whole body; and--skin dose rates due to noble gases is.. calculated-by taking
~
'the' product of this fraction and the limiting release = rate. 'A comparison of this release rate =for whole;bodyTand' skin = dose rates due to noble gas release is made :to determine if the -
whole body or skin dose limit will'be mosttrestrictive.. It is. expected that the whole body limit will always be'mosti restrictive, but.the comparison'is necessary to assure . . compliance with ODCM I. The sum'of the contributions from each; a release point, independently: calculated:for iodines and: noble gases, will equal the maximum instantaneous! release rate allowed from the site. The purpose of calculating the. release rate which corresponds + to the site boundary dose limit is not to determine an ' . acceptable release rate, but to determine the =awhaum relea'se-rate which may be exceeded. It is not intended that-releases, will be maintained at or near this limit, and in fact, requirements to maintain offsite doses As Low As Reasonably-Achievable (ALARA) are specified in ODCM I3.3.3 and ODCM I3.3.4.
.p,. L- , '
x <~ - ~ -
.~ - - - ~ - -
; + +
,Mi ~
A~ ~ g " m;g % Q ~ 1 -
; ODCM 'R0v..! 15 6
, , f5C & : 9:ge ' 77 - '
", - ' Ql.i.
- c. s .
. , 12/94!
2'.'2 kli; i North' Vent Moble Can' Ef fluant Monitiers - RY26-0751-31 i RY26-075B-3,-AND RTI26-076 ' k' ' ' N 4 .The North. Vent' Noble;GasjEffluent monitor'high-high
~
setpoint is calculated monthly based 1on the-grab'. sample, si .results performed infaccordancetwith-ODCM Table:I3'.3-3.- J Due to the _ incorporation of the AIARA_ philosophy in the
" + design and operation of.the. Limerick effluent' systems,7 1 m release point grab, samples may not identify any-
~
radionuclides. In this-situation,_ chemistry may'use-the results:of:the last_ grab-sampleLwhich. identified: radionuclides;or use the default setpoint which is. based on expected concentration ratios as:reportedfin-the UFSAR._ If any! calculated. alarm setpoint is less.
'than.the.' existing monitor setpoint, the setpoint=will-
-be reduced to the new value. If the calculated?
setpoint.value is greater than the existing value, the'- setpoint may remain at'the lower'.value or_ increased to;
~
r 4 14 the'new value.
.2.2.1-1 Setpoint Determination
- l' The High-High setpoint is calculated per equation (2-la).- The basis for the High-High.
' i[-
.setpoint is the Unusual Event.. Emergency'-
l Action' Level Site Boundary Dose Rate.of-0.114'-
- l- : mrem /hr. ..The High setpoint:for theLNorth i Vent Noble gas Effluent Monitor is set at;orf below'the-lesser of the NVSP OR NVSP ,
value.: (per equations 12-1 ort-2) * (VF ] [500] [ECm] yygp" g ) , (3.4475E9] E [ (Cm) (Kj) ] -
'[500] [EC#] (2-la') :
NVSP(Hi-Hl)" s [3.4475E9] E ( (Cm) (Kj) ) [2] _ 1 gp" (VFa] [3000] [ECm] -2) l (3.4475E9] E { (Cm) (Lj+1.11Mj) ] l
- l l
- where: )
l NVSP , = North Vent High Setpoint - Noble Gas Whole' Body (pci/cc) R
,~
~
q)=; : :
- la , ,: :'
3':- r y_, *.
~
e p@l , 4 , ;(. - < ODCM Rev. 15; - j' , M ,
'Page178
%%; 3ll , f .
/ , 112/941
]lj 4 LNV8P 4 j= iNorth' Vent.High.Setpoint' . Noble'. Gas SkinL'(pCi/cc)
' NVSP l(Hi-Hi)M' = North Vont High-High(Setpoint ' Noble'. Gas l j'.l WholeiBody'-(pCi/cc).
u VF,,, E=? Fractional-contribution toisite boundary noble. gas; ll dose rate from the' North. Vent-as~ calculated-'in: . equation'2-7.-"(unitless). l 500: := ,-Total body. dose rateslimit-(arem/yr)' , I 3000 =. . Skin Dose rate limit.(arem/yr)
. . n
. Ici , = Total noble gas. activity from-North Vent!grabisample a (pCi/cc).
Multiplication Factor to' correspond to Unusual Event
~
2 = Emergency Action-Level-Site; Boundary. Dose Rate Value! of 0.114 mrem /hr. (Unitiess) , 3.4475E9 =- Conversion' factor (PCl) (cc) m3 ) (pCl)
=(1.1E-5 sec/m3 ) (1E6 pCi/pCl) (664,000 cfm) (1/60 min /sec) (2.832K4 cc/ft 3
)' y
.(2-3) where:
1.1E-5 sec/m 3 = highest annual average X/Q (NE Sector). . 1E6 pCi/pCi = units conversion-664,000 cfm = maximum' North Vent flow rate for two unit ; operation 1/60 min /sec = units conversion 2.832E4 cc/ft 3 = units conversion-C,, = concentration of noble gas nuclide ias determined by radioanalysis of North ~ Vent. grab sample'(pci/cc) 4 K, = Total body dose conversion factor3 for noble-gas nuclide 1 (mrem /yr per pC1/m , from Table 2-1). Li = Beta skin dose conversion factor noble gas 4 . nuclide 1 (arem/yr per pCim3 , per Table 2-1) .
, - , . . . ,w -- ,, o,,
* '~ -' ' ~' ~ ~ ^ -'
W./ ', ,
.2-1, ' ,
o ,
.i " "
3
, s
- s -
w gf7' ; 4[;;ll- J_ tO ,
- OLCM Rev. ::15 --
y < q m. page 79 s,lj L12/94
, L M(
- Gamma Jair dose l conversion factor for' noble:, ,
.gasinuclide it (mrad /yr per pCi/m3 ,; per ,
Table-2-1). 12'.2.2 South vent Noble' Gas Effluent Monitors -RY26-185A-3. RY26185B-3. RY26-285A-3. AND RY26-785B-3 fEach' unit's South Vent Noble' Gas Effluent monitor.:High'
~
l:l Q setpoint-is calculated monthly based on.the grab: sample ' results performed-in accordance with ODCM I3.3-3;:'Due to. .
~
the incorporation:of.the:ALARA philosophy in the. design:and; operation of:the Limerick offluent systems, release point =.'
~
t ~ grab samples may not: identify any-radionuclides. With this~~ - situation, chemistry may use the results of the grab samplei which: identified radionuclide or-u.e s the default setpointl which is based on expectedLconcentration ratios.as reported' in the UFSAR. .If'any calculated alarm setpointTis less than~the existing monitor setpoint, the setpoint will-be.
= l. reduced to the new value. .If theLcalculated.setpoint.value -
is greater:than the existing:value, the setpoint-may' remain at the lower value, or increased to the new:value. , 2.2.2-1 Setpoint determination
. l- The High setpoint for the South Vent. Noble Gas Effluent' Monitor is= set'at'the lesser of the- ' SVSP and SVSP~ value.- SVSP and SVSP" are .
calc Eated for eE h unit's Sout D ent.-- - 4 The High-High'setpoint is. calculated'per equationL (2-4a). The basis.for the High-High setpoint is the .
. Action Level Site' Boundary :
Unusual Dose Rate Event Emergency of 0.114 mram /hr.
" I
-(2-4),
SVSP " s [1. 2149E9] E [ (C ,) (Kj) ) 3 i.
'" ~
' (2-d a) -
SVSP(Hi-Hl)" s [1.2149E9] E [ (Cjn) (Kj)] [2] - I 1 4 Y
,n- e- r--. -
, . + , _ . .
m .
.c .
r ,- i
, .l
, , LI: ODCM Riv.L15 1 Pr.g3 80'
< (. '
- s. - r '!
- l :t . 12/94- H
** 'Y
% SVSP " $ [1. 2149 E9] E [(Cj,) (Ly+3 .11Ng) } . - ( 2 -5 ) '.f . W "r 4 where: SVSP m = South Vent Setpoint - Noble Gas-Whole Body. 1 (pCi/cc) SVSP a = . South Vent'Setpeint - Noble Gas Skin'(pCi/cc)- -; VF m = Fractional ~ contzibution to site' boundary noble yas dose rate from the Unit's: South vent as ealculated in equation 2-8 or .. . 2-8a (unitiess? 500 = Total body dose rate limit (mrem /yr)' 300.0 = Skin dose rate limit (mrem /yr) EC,,, = Total noble gas activity from each unit South. . Vent grab sample (pCi/cc). 2 = Multiplication Factor to correspond to Unusual Event. Emergency Action Level Site Boundary Dose Rate-Value of 0.114~ mrem /hr. ' (Unitless) i 4 1.2149E9 = Conversion factor (pCl) (cc) ,
, (m3 ) (pCi) ,
= (1.1E-5 sec/m3) (1E6pCi/pCi) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/fts) - (2-6) _
where: 5 1.1E-5 sec/m3 = highest' annual average.X/Q (NE Sector)-. 1E6 pCi/pCi = units conversion 234,000 cfm = -maximum South Vent flow rate 1/60 min /sec = units conversion 2.832E4 cc/ft3 = units conversion C , ,,
= concentration of nob 2e gas nuclide i determined by radioana2ysis of South 1 Vent grab sample (pCi/c:)
l' CDCM Rev. 15 P2ge 81 j
~j- 12/94 j o
K4 = Total body dcse conversion factor for , noble gas nuclide 1 (mrem /yr per pCi/m3 , l from Table 2-1). .j L'
= .Bata skin dose conversion factor3noble gas nuclide i- (mrem /yr per pCi/m , per i Table 2-1).
N'
= Gamma air. dose conversion factor for 3 ,
noble gas nuclide i (mrad /yr per pCi/m , l per Table 2-1). 2.2.3 .Egble Gas Effluent Fractional Contribution The noble gas effluent fractional contribution is calculated monthly using results of the grab - samples-performed in'accordance with ODCM I3.3-3. The results of this calculation are used in equations 2-1, 2-2, 2-4, and 2-5. This methodology assumes that the total body dose is limiting for ., noble gas releases. If equations 2-1, 2-2, 2-4, ; and 2-5 show that the skin dose is limiting, fractional skin dose should be substituted for the whole body values used in equations 2-7, 2-8, and 2-8a. 2.2.3-1 Calculation'of VFe, VFm ,.and VFm E ICiuv) (K )3 3 g_g yy" " , Z [ (Cjuy) (Kg) ] +E { (C f2,y) (Kj) ] +E [ (C 2,2v) (K3) ]
'28" '
(2-8) VF*#" = E i (C 2,y) (K 3)] +E [ (C 32,y) (Kj) ] +E [(C f2 sv) (K )4 3 EIC12sv) (K f) 3 (2-8a) yy'# " , E [(Ciuv) (K2 ) ] +E [ (Cf2,y) (Kg) ] +E [ (C32,y) (Ky) ] l
~ -
y ,;
- q. ' >
&L > '
ODCM R2v. 15' _ 1: Prga 82
^^
12/94
-l
[ where:.
= ' fractional contribution to.'siteLboundary noble VF. gas total body ~ dose rate from the North Vent
-(unitless).
VF3 ,,, = fractional' contribution:to site boundary noble' gas-total. body dose rate.from the Unit 1 South-Vent-(unitiess). VFaswe . = fractional contribution to site boundary noble gas total' body dose rate.from the Unit 2 South Vent (unitiess).-.
' concentration'of' noble gas nuclide'i'.as
=
C, determined b dioanalysis ofl North Vent grab
. sample'(pci/y cc) ra K, = total body dose conversion factor3for' noble gas radionuclide 1 (mrem /yr_ per pCi/m )
i C y ,y = concentration of noble gas nuclide i'as
- .- determined by radioanalysis of Unit.12 South-Vent grab sample (pci/cc) ..
concentration of. noble gas nuclide'1:as Cg,y =. . determined by radioanalysis of Unit 2 South-: Vent grab. sample (pCi/cc) 2.2.4 Noble Gas Effluent Default Setnoint
.This methodology may be.used when grab sample-results from-either the North Vent or the South Vent do not identify any radionuclides.' This' methodology!is basedLon. expected release concentration ratios'as-outlined in section 11.3, .
of the Limerick UFSAR..
~
2.2.4-1 North. Vent Noble Gas-Monitors..(RY26 . 075A-3 and RY26-075B-3). The default l High setpoint fdr the North. Vent noble gas offluent monitor is set at or below,
.l the NVSP , value. ; (per equation 2-9).
gp" , (8.[3.4475E9] 9 0E-1]'[500] [1.15E-6] [4. 3 0K-9] . (2-9) The Default High-High'setpoint:for the' North. , Vent Gas Effluent Monitor is calculated per equation (2-9a). The basis for the Default High-High setpointi is the Unusual Event Emergency Action Level Site Boundary' Dose Rate of 0.114 mrem /hr.
---__._1._ 2. __.___ _ __-__ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ . , , , . - . _ . , , . - _ . . y , . , , , , , _ :. --w, < . . _ , ,
4 1 { g LIE ODCM Rev..15-
~ ..~
Pcge.83 r
!l~, 12/94
[500] [1.15E-6] (2 -9 a) NFSP(RJ-RI)" g [3.4475E9] [4.3 0E-9);[2] '
.where: ;
~l NVSP , = Default North Vent High Setpoinh. - Noble Gas (pCi/CC)
NVSP(Hi-Hi) ,,_ = Default North Vent High-High Setpoint'- Noble. , Gas (pCi/CC) 8.90E-1 = Default fractional' contribution to site boundary? l noble gas total body dose rate.from the North Vent-(unitless) 4 . 3 0E-9 (4. 3 0E-9 ) + (5. 31E-10 ) : 4.30E-9 = Summation of'the North Vent concentration of' - noble gas nuclide i multiplied by the corresponding whole-body dose factor. (pci)~(mrem) (m3 ) (cc) (yr) (pci) l 5.31E-10 = Summation of the South Vent.(Unit 1 & 2) concentration of-noble gas nuclide 1.' multiplied ; by the corresponding whole body dose factor.
~
' ~
I (pci) (mrem) (m 8) (cc) (yr) (pci) Ref: a) Based on expected annual release from ) UFSAR Table 11.'3-1. !
~b) . Based on maximum North Vent flow of-664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.
i c) ODCM II Table 2-l'. 500 = Total body dose rate limit (mrom/yr) 4 4
. . , , , , y.
1
,; ;. J.
ODCM Rev.-15'
.Pcg3 84, l .12/94
1.15E-6. = Total noble gas concentration from' North . U Vent-(pCi/cc) !
- r: Ref: a) Based UFSAR Table'11.3-1.
b) Based on maximum. North Vent flow of' i 664,000_cfm . 2 = Multiplication Factor to correspond to Unusual i Event Emergency Action Level Site Boundary Dose j
. Rate Value of 0.114 mrem /hr. (Unitless) 4 j
3.4475E9 = Conversion factor -;
' (pc.f ) ( cc) '
, (m2 ) (pci) .
4.30E-9 = Summation of:the North Vent concentration'of ! noble gas.~nuclide-1 multiplied-by the' corresponding whole. body. dose factor. (pci) (mrem) (m 8)
. (cc) (yr) (pci)
Ref: a) Based UFSAR Table 11.3-1. : , b) Based.on maximum North Vent flow of 664,000 cfm. c) ODCM II Table 2-1. b 3
' ~ ~~
u ODCM ' R0v.< 15.- M ; /r: l .PIge 85- , uO ' -ll 12/94; 2.2.4 South Vent Noble Gas Monitors'(RY26-185A-3,
'RY26-285A-3, RY26-185B-3, and RY26-285B-3).
;The' default.High setpoint for each Unit's.
-li South' Vent noble gas effluent monitor is' set '
~
K
.at-or below the lf SVSP,, value. (per equation 2-10)
~
~
[5.49E-2] [500] [7.14E-B] L
""' [1. 2149E9] [2. 6 5E-10]
~
1 - . The default High-High setpoint for each units' : South Vent-Noble' Gas Effluent' Monitor is' calculated per. equation (2-10a). .
-The-basis for the. default'High-High'setpoint.
is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr. (500] [7.14K-8} (2 -10a) SFEP"" s [1.2149E9] [2.65E-10] [2] where: SVSP,, = Default South Vent Setpoint - Noble Gas (pCI/cc) a SVSP(Hi-Hi),a = Default South Vent Setpoint - Noble-Gas.(pCI/cc) 5.49E-2 = - Default fractional contribution to site boundary noble gas total body dose rate'from l the South Vent (unitless)
, 2.65E-10 (4 . 3 0E-9 ) + (5. 31E-10 ) '
where: 2.65E-10 = Summation of the Unit's South Vent , concentration of noble gas nuclide 1. multiplied by the corresponding whole body dose factor.
. (pci) (mram) (m ) 3 (cc) (yr) (pCl)-
I 1 4.30E-9 = Summation of the North Vent concentration of j noble gas nuclide i multiplied by the , corresponding whole body dose factor. l 1 l s l
.f )
i i W:N m
'l: -ODCM Rev. 15 .
' Pege 86 : fi
-l 12/941
'(pci) (mrom) (m 8) ,
' - (cc) (yr) (pCl) 5'. 31E = ' Summation of the' South Vent'-(Unit 1 &:2) concentration of noble gas nuclide:i .
4 multiplied by the corresponding whole; body; '
. dose factor.
o . (pCl) (arem) (m 3) ' (cc) (yr) (pci) .
~
Ref: a) Based on-expected annual. release, from-UFSAR Table 11.3-1. . b) Based-on mavimum North Vent flow of 664,000 cfm and South Vent-flow of . 234,000 cfm'for Unit 1-::and Unit: 2.' vents. , c) ODCM II Table 2-1. , 500 = Total body. dose rate: limit (mrom/yr) 7.14E-8 = ' Total noble gas' concentration from North Vent 1 (pCi/cc) ' Ref: a) Based UFSAR Table 11.3-1. _.. b) Based on maximum North Vent flow ofa 664,000 cfm. 1.2149E9 = Conversion factor (PCl) (cc) (m3 ) (pci) . Ref:- a) ODCM II equation 2-3 2.65E-9 = Summation of the North' Vent concentration of noble gas nuclide i multiplied by the . corresponding.whole. body dose factor. j
~
' (pci) (cc)
(m3 ) (pCl) .
. Multiplication factor to correspond.to Unusual = l - 2 =
Event Emergency Action Level Site Boundary ' Dose Rate. (Unitiess) ; 4 ;
7 *
't' t
- a ; ll ODCM R7v. 15
- P193 87 L!. :12/94.
w 'Ref: a) ; Based UFSAR Table li.3-l'. ~D b) Based on maximum NorthLVent flow lof' ; ', 664,000 cfu. . c) ODCM II' Table 2-1.. L 2.2.5~ Wide Danae Accidant Monitor' Noble Gas Effluent Monitor (RTX-26-076-4) The Wide' Range Accident Mon'itor (WRAM)' noble (gas total effluent channel displays the North Vent, noble gas release rate.. This monitor.has Main : Control Room Annunciation as.well as a p oup 6A'
. isolation function on_the primary containment 4
l purge and vent valves. The isolation'setpoint [ value of $2.1 pci/cc specified in Technical-Specification'3.3.2-2 is based on-the-accident - dose limits for containment purge during an accident (Ref:- UFSAR Section 1.13). For routine. 'r operations the total effluent alert.and:high , setpoints are based upon the methodology of Sections 2.2.5-1 and 2.2.5-2. The setpoint units are in microcuries.per.second using the two unit maximum North Vent flow rate of 664,000 scfm.- The-total effluent channel High-High setpoint.is1 set-l at a'value less than or.. equal to ten. times the. l l :High setpoint.(not to exceed the.2.1:pci/cc- . . n equivalent using the two-unit maximum North Venti flow rate). These values are always more .
' conservative than the Technical' Specification. l Table 3.3.2-2 required value of s 2.1pci/cc. .;
If the calculated setpoint value is less1than the. j existing monitor setpoint, the setpoint will be- 9 reduced to the new value. If the calculated setpoint is greater than the existing value, the l setpoint may remain at the lower value, or- l] increased to the new value. u 1
.l 1
J 4
/
t'
4.
?I{ ODCM R;v..!15 a
- Pag 3 88.-
e '
.l' 12/94
~
2 1, 2.2.5-1 Routine Operations High Satpoint Determination
~
- 7- <
!!' For routine operations,-the High setooint for'the WRAM Noble Gas total effluent channel is set at or below the
, lesser off the; NVSP OR NVSPag --value. [VP,, l .[500] [ECsl .
" " ' ' [3.4475E9] E [ (Cm) (Kj) ) .
l
-[VF,,,) (3 000]:(E Cs] ' _
[3.4475E9] E [ (Cm) (L2 .+ 1.11N2 )) where: North' Vent Setpoint - Noble ~ Gas Whole
~
=
NVSP . Body (pCi/cc) <
._ NVSP ,
= North Vent Setpoint - Noble Gas Skin (pci/cc) .
VFm = Fractional contribution to sitelboundary 1 noble gas dose rate:from the North Vent- ' as calculated in equation.2-7. (unitless).
~
9 500 = Total body dose rate' limit (mrem /yr) 3000 = Skin Dose rate limit'(mrem /yr) . EC, = Total noble-gas activityLfrom. North Vent grab sample (pci/cc). . 3.4475E9 =- Conversion factor).
~
(pCl) (cc) (m3 ) (pCl) . - = (1.1E-5 sec/m8) (1E6pCl/pCl) (664,000 cfm) (1/60 min /sec) (2.832Ed cc/ft2)- (2-3) where: l.1P.-5 sec/m 3 = highest annual average X/Q (NE Sector) lE6 pCi/pCi- = units conversion. ; 664,000 cfm = maximum North Vent flow rate for two unit operation 1/60 min /sec = units conversion
..__m'__._
_.__._m . _ _ - , . , , , . . ,.. + ...,c. ..r..,,,m+, &
?
'?l
?
ODCM Riv.'15-
,Page 89 1l~ -12/94-2.832E4~cc/ft 3 =. units. conversion
~ concentration of noble gas nuclide i-as.
=
C, determined by radioanalysis of North
..U vent grab sampleJ(pci/ce)
' K'
= Total body. dose conversionifactor for-noble gas nuclide i-(mrem /yr per pCi/m ,.. 3 from Table 2-1).
L'
= Beta. skin dose conversion factor 3noble gas nuclide 1 (mrem /yr per pCi/m , per Table 2-1).
-M i = Gamma air dose conversion factor for .
noble gas nuclide 1 (mrad /yr per pci/m , 3 per Table 2-1).
,i The setpoint.-values are converted from pCi/cc to pCi/see using-the maximum'two-unit North Vent flow rate:
NVSP 3 , = [NVSP ] [3.134E8) . (2-14) NVSP um. = (NVSP,g) [3.134E8]- (2-15)' where: NVSP 3 ,
= WRAM total- effluent channel North Vent -
l High Setpoint - Noble Gas Whole Body (pci/sec). NVSP ng = WRAM total effluent channel North Vent' l High Setpoint - Noble Gas Skin (pci/sec). NVSP , = North Vent High Setpoint - Noble Gas Whole Body (pci/cc). NVSP ,g = North Vent High Setpoint'- Noble Gas Skin-(pCi/cc). 3.134E8 = Conversion factor (cc/sec).
=
(664,000 (2.832E4scfm)})1/60 cc/ft min /sec) _(2-16)'
' ~
1* W ?l1 9'
- ODCMiRdv;.'15 Paga 90'
'l;
, 12/94~
'l 2.2.5-2. Routina Onarations Hinh-Hinh Satooint
~ ~
l Determination '
.l-.. For routine operations,.the High-High setpoint_for the WRAM Noble' Gas total 3 effluent channel'is set at or below ten times the lesser of the routine operations NVSP un- r or NVSP uu value. j NVHPuu = (NVSP ) (10) -(2-17)
NVHP n , = (NVSP,,) (10). (2-18)-- where: NVHP um = WRAM total effluent channel North' Vent' . l High-High Setpoint Noble Gas WholeLBody. (pci/sec). NVHP uw = WRAM total effluent channel North Vent-l High-High Setpoint Noble Gas Skini O (pCi/sec). NVSP,, = WRAM total effluent channel North' Vent. ; Setpoint - Noble Gas Whole Body (pci/sec).. NVSP ,, = WRAM total effluent channel North Vent setpoint - Noble Gas Skin ~(pCi/sec). 10 = multiplication factor to calculate High" value (unitiess) 1 4 2.3 Gaseous Effluent Dose Evaluation The Annual gaseous-effluent dose evaluations are performed' using the computer based RM-21A report; processor. . Instantaneous offsite Dose Calculations:are' performed,with , the MesoRem Jr Common Dose Model' computer. program. The following sections describe the computational models,. assumptions and bases. Emergency dose calculations are. performed using the MesoRem Jr' Common Dose Model computer, program. Monthly dose calculations are performed based on limiting sector average annual meteorological dispersion ~ parameters. For the--noble gas monthly dose calculation, effluent release data are based on the latest grab-sample-analysis for radionuclide composition and the hourly average effluent monitor response for. total release. activity. For the' iodine and particulate monthly dose ' calculations, the effluent release radionuclide composition and release activity are based on the < continuous composite samples for the time period of the dose calculation. L
---.u.-----__---.__-------__A------___'-- -w, e -
g ,4
~. ,, . - --
"~ :ODCM R:v.%15-
. i l
PIge 91-
'^ ,
l 12/94 The quarterly dose calculations are a summation of the-applicable monthly. dose results, i The annual dose calculations are-based on the actual' I meteorologica1' conditions concurrent with the effluent - releases. . Wind direction,_ temperature lapsefrate, ambient-temperature, ground level windspeed, and releaseLelevation- ,
- windspeed.are provided for each hour of the year. 1The
~
i meteorological dispersion values.(X/Q, inked with thedepleted X/Q,'and
, D/Q)' are calculated for each hour and-l .
' corresponding release data. The effluent release. .
radionuclide composition and activity are_ based-on_the same-parameters as the monthly dose, analyses. I 2.3.1 Site Boundary Dose Rate-- Noble CasesL ODCM-I3.3.2.a limits the dose rate at the SITE' ' BOUNDARY.due to noble gas' releases to $500'mram/yr' total body and $3000 mrem /yr skin. Radiation , monitor alarm setpoints are established to' ensure - l that these release limits are not exceeded. , Simultaneous releases.from the. North and South vents are considered in evaluating compliance with - the release rate limits of ODCM I3.3.2.a.following ', any releases exceeding the' alarm'setpoints. Monitor indications'(readings) are averaged over ; i time periods-not to exceed 15 minutes when determining noble. gas release rate based on . ; correlation of the monitor reading and monitor . sensitivity. The 15-min averaging allows for. i reasonable monitor response to potentially changing radioactive material concentrations.and to-exclude' potential electronic spikes in monitor readings that may.be. unrelated to radioactive ' material-releases. When identified, electronic. spiking monitor responses are being excluded from= the dose calculation. NOTE:- For administrative purposes, more- 1 conservative alarm setpoints~than-those0 l required'to meet 10 CFR 20; Dose Rate limits : are imposed. However, conditions exceeding ] ' these more limiting alarm (setpoints do not q nece' arily indicate radioactive material :i vele.4e rates exceeding the dose limits _of. , ODLd I3.3.2.a. . Provided actual releases do )'
-not result in radiation monitor indications;
. exceeding values based'on the dose rate-limits of ODCM I3.3.2.a, no further .
analysis are required for, demonstrating compliance'with the limits of ODCM'I3.3.2.a. j f
. , , ,. ,w, , ,_ -,v.-- ~.,.p_.-g- , .-m-
j l
?l1 ODCM Rev. 15 P:g3 92 l 12/94.
In'the event of a noble gas. effluent release exceeding the setpoint value specified.in ODCM II l' sections 2.2.1 or 2.2.2,.the site boundary dose rate from the release.is calculated using the
-methodology stated below.- This methodology is based on' worst sector (NE) annual average meteorological dispersion but, if further refinement is required to meet the. requirements.of ODCM I3.3.2.a, actual meteorological data.from the time period of concern may be used to calculate ,
actual meteorological dispersion. De ns= (53. 882) (X/0) '17(( (F,) (03 ,) + (F2n) (0 42 n) + (F SF) (012sv)] Kj]~ (2 ,h3
'17 E [ [(F,) (Oj,y) + (F 1SV) (Oj2,y) + (F SV) '(Oj,n)]Lj] +
#~'
Dp,g= (53. 882) (X/0) '
'(SF) [(F,y) (0,)
3 + (F SV) 1 (Oj2,y) + (F 2s v) (0 32 sv) lNJ (1 11) _ (2-23)^ where: D TPM " Total Body Plume Dose Rate (rem /hr) ,. D,, = Skin Plume Dose Rate (rem /hr) 53.882 = Units conversion factor rem-m'-pCl-yr-min-cc '
,pCl-br-mrem-m -sec-ft' X/Q = 1.lE-05 highest annual average relative.
concentration (NE Sector) (sec/m3) Fw = North Vent Flow Rate (cfm) concentration ofl noble gas nuclide'l during-
~
=
Qwi period of release from~ North Vent (pCi/cc) Fy3
= Unit'l South Vent Flow Rate (cfm)
Qttsy = Concentration of noble gas nuclide i during period of release from Unit 1 South vent (pCi/cc). F2sv = Unit 2 South Vent Flow Rate (cfm) Qt2sv
= Concentration of noble gas nuclide i during i
.. _. , -+ --- , , _ - , ,. -, - . 4 -,
g, ** m ~ " ^ '~-~~ ~
- ~ *~
4; '
l .'
ODCM R v..15
-P ga 93 12/94' o !
period.of release from Unit 2 South' vent
' ' (pci/cc).
e ' Kp = Total body dose factor for noble gas nuclide
<- 1. Values are listed in Table 2-1.
3 mrem-m '
,pci-yr, o
L, = Skin ~ dose factor for the beta contribution for noble gas-nuclide i. Values are listed! . in Table 2-1. mrem-m'
,pCi-yr.
c 1.11 = the average ratio of tissue to air energy absorption coefficients -(mrem /arad) - (Ref: Regulatory Guide 1.109 Section'2.2) SF = 0.7 is-the attenuation factor that accounts for.the dose reduction due to shielding provided by residential structure (dimensionless).(Ref: Regulatory Guide 1.109-- Table E-15). M, = Gamma air dose factor for noble gas nuclide
- 1. Values are listed in Table 2-1. '
mrad-m3 pCi-yr, 2.3.2 Site Boundarv Dose Rate Radiciodine and'Particulates l ODCM I3.3.2.d limits the dose rate to $1500 mrem /yr to any organ (inhalation pathways only) for_I-131, I-133, q Tritium, and all radionuclides in particulate form with' ' half-lives greater than 8 days in gaseous' effluents.. q compliance with ODCM I3.3.2.d is determined monthly by-- -l performance of ODCM II section 2.3.4. Simultaneous releases from the North and South-Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.b. Release activity is based upon the results of the continuous composite sampler analysis performed in accordance with'ODCM Table I3.3-3.
Tl ODCM RSv. 15 ' Pcge 94 l' ~12/94
^ This methodology is ba' sed on the worst sector(NE)-
annual average meteorological dispersion but, if' :A. further refinement is required to meet the limits of ODCM I3.3.2.b, actual meteorological data-from the time period of. concern may be used to calculate actual meteorologica1' dispersion. 2.3.3 Noble Gas Air Doses' _ ODCM'I3.3.3 limits the air dose due to noble gases-released in. gaseous affluents-(from both reactor 1 units) to areas at or beyond the SITE BOUNDARY to: s 10 mrad gamma for any quarter.- s 20 mrad beta for.any quarter s 20 mrad gamma during any calendar _ year
*= s 40 mrad beta-during any' calendar year-AsLrequired by ODCM 13.3.3.1 Surveillance Requirement,-
these doses are calculated at;least once per 31 days-using the results of.the most'recent grab samples for isotopic composition-performed;in accordance with ODCM Table 13.3-3 when release point grab samples do not identify.any radionuclides. Total release activity. is based upon the hourlyLaverage-effluent monitor-response. As identified, electronic _ spiking monitor responses are excluded from.the release. activity-analyses. The monthly = dose calculation is performed. using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the summation of the applicable monthly results. The annual dose calculations are based upon actual release meteorologica1' conditions as described in section . 2.3.5. The monthly' dose calculations are performed in : accordance with the methodology below. D, AIR = (0.114) (1.11E-5) (47 2) E [ (F,). 3(C ,) + 2(F ,) (C 32 ,) + (F3 ,) (C 33
,) ] Nj - (2a24 )
2 t Dp AIR = (0.114 ) (1.11E-5) (472) E [ (F,) 3(C ,) +1(F ,) (C32n)+(F n)(Csa)3N i 4 (2-25) where: D,,u, = Gammaairdosefromnoblegasreleases'(rad /hr)j D gu, = Beta air dose from noble gas release (rad /hr)L 0.114 = Units conversion -> rad-pCl-yr }
, p Cl-hr-mrad) 1.1E-5 = Highest average annual 3 relative concentration' (NE Sector)(sec/m ) r
+F
~
ODCM.Rev. 15'
- g. . 1( -Pige.95-
-- l : ' 12/94 472' = Units 1 conversion -
~
' min /sec
,sec-fc3 F, = Average North. Vent Flow rate for period of release (cfm)
. C,, = Concentration of. noble gas nuclide iffrom North ~~ ' Vent' effluent (pCi/cc) Ff, = Average Unit 1 South' Vent flow rate-for period. of release (cfm)- C, n
= Concentration of noble. gas nuclide i from Unit 1 South. Vent effluent-(pCi/cc)
Faw = . Average Unit.2 South Vent flow rate for period of release (cfm) C,,, = Concentration of noble' gas nuclide i from , Unit 2 South Vent effluent (pCi/cc) M,' = Gamma air dose factor for noble gas nuclide 1. Values are listed.in Table 2-1.. i 1 mrad-m3 pCi-yr. Ni = Beta air dose factor for noble-gas nuclide 1. f values are listed in. Table 2-1. mrad-m3 PCi-yr . 2.3.4 Radiciodine and Particulate Dose Calculations ODCM I3.3.4 limits the dose (from both reactor units) to'a MEMBER OF THE PUBLIC from I-131, I-133, Tritium, and all radionuclides;in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond the SITE BOUNDARY to: l s.15 mrem to any organ during any calendar ! quarter s 30 mrem to any organ during any calendar year As required by ODCM I3.3.4.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the continuous composite sample analysis performed in
.,,,,_,m.. , . . . . - , _ , . . . . . -
kh' _
,- : ll-f 4 ODCM R0v. 15 1 , ;~ > _ P ge 96 ;
cl; '12/944 i f , accordance with ODCM Table'I3.3-3.::Due to-the.
-incorporation of the ALARA philosophy'in thel 1 4
' design and operation of.the Limerick offluent: l
;;', systems, these composite samples may not identify 1 any radionuclides. Total release activity is ,
. based upon detectable concentration of the; continuous composite. samples and average- '
appropriate: vent: flow:during the sampling period;
'The monthly' dose calculation'is.performediusing' the most limiting average annual meteorological" dispersion values.- The quarterly doses:.are based: -
on the summation ofithe-applicable monthly .. results.. The annual dose calculations are; based upon. actual' release meteorology as~ described--in Section.2.3.5. The monthly dose calculations-are , performed in accordance with the methodology { Total' organ. dose;is obtained by the-L below. , summation of the-organ dose from each pathway for. I each receptor.-- 2.3.4-1 Ground Pathway. ! Darm " .(3.6E-6) (472) (1; 82K-9) E e F L as -- (Onsv) + (F v)as(Oassy) + (Fm)(0 1s)3DFr,r,z,x E :(Te ); -(2-26) p1,I(F )(Om)+(Fisv) wv
' 2.3.4-2 yeaetation, Meat, cow Milk, and coat Milk Pathway l o Dy,u' = - (3 . 6 E-6 ) (47 2 ) E '
p ' E [ (F,y) (Oj,y) + (F1 ,y) (pu,y) + (F,,y) (pu,y) + (Fm) (Ojan) ] (1.1E-5) DFy ,g,g,, + , ( T,) l~ , 35 E (F,y) (Oj,y) + (F1 ,y) (pg ,y) + (F,,y) (gj ,) + (Fm) (Om) ] (1. 82K-9 ) DF y,1,3,,,
- i. . .
L (2-27)!
- n. -
L L lL
.I r
l a .:
h
) s1 ODCM Rev. 15
, Pzg3'97 3 'j. 12/94 2.3.4-3 Inhalation Pathway D,,, = - (3. 6E-6 ) (47 2) E e ,
l *2 [ (F,) (0 ,)3 + (F ,y)3 (0j3,y) + (F,,y) (Oss,v) + (Fm) (03 ) } (1.1E-5)DFr.s.n +
~W) 9 . 3, Z [ (F,) (0 ,)3 + (F ,y) 2 (Oj3,y) + (F 2,y) (Oj,,y) + (Fm) (Om) ] (1.OE-5)DFr,s.x .
,j (2-28) where:
D ep,, = dose from ground pathway due to release of particulates and iodines (rem). D yp,, =- dose from vegetation, meat, cow milk, and goat milk, pathways due to releases of particulates, iodinea, and tritium (rem) D gp,, = dose from inhalat. ion pathway due to release of particulates, iodines, and tritium (rem) 3.6E-6 = units conversion factor rem-Cl-sec'
, hr-mrem-p Ci, 472 = units conversion' factor
' min-cc' sec-ft, 1.82E-9 = highest average annual deposition (ESE Sector) i
_1_ m2 j I = summation for each release time period q t (unitiess).- Fw = average North Vent flow rate during release I (cfm). ! Q,, = concentration of nuclide I from North Vent effluent (pci/cc). i
m; - - -
- 4 i
I}:: , :l / ODCM R;v. 15'
.Page 98
" ~
, 'l-
-12/94-F,3
=. _ average Unit 1 South Vent flow rate during release (cfm).- ,
Qf3, = concentration of nuclide i from Unit 1 South
. Vent' effluent (pci/cc).
F2n = average, Unit.2 South Vent flow rate during release (cfm). Qg, = concentration of nuclide l'from Unit 2 South Vent effluent (pCi/cc). F ,s = average Hot Maintenance Shop flow rate during release-(cfm). Q lms
= concentrat' ion _of nuclide l'from Hot Maintenance; '
effluent (pCi/cc). DF,ygy = dose-factor for organ type k, age group 1, pathway. number n; dose' factors are based on a - computer. program which is similar to the NRCs ' program GASPAR results from this. program provide input data in the' form of a lookup 1 . table - values of DF un are provided in Table 2- . 2. 4 i = isotope number ~(1 through 35)(3 through 17 are. . noble gases). K = organ type'(1 through 8, where total body = 1, GI tract = 2, bone = 3, liver = 4, kidney = 5, [ thyroid = 6, lung = 7, skin = 8). L = age group (1 through'4, where adult = 1, teen = 2, child = 3, infant = 4). N = pathway number (1 through~7). T, = time duration of' release (hrs). , 1.1E-5 = highest average annual Y./Q (NE Sector)(sec/m3)'. l 1.0E-5 = highest average annual depleted X/Q-(NE Sector) (sec/#) . 2.3.5 Annual nome Evaluation ODCM I3.6 requires an Annual Dose evaluation'be performed and reported in accordance with. l Regulatory _ Guide 1.21 in the' Annual Radioactive Effluent Release Report submitted 60' days after the first of each year. _This dose evaluation is
- processed by.the RM-21A. In the event that this computer model is unavailable, this analysis can l be performed using the same methodology. The .
L liquid portion of this annual dose calculation is deccribed in Section 1.3 of ODCM II. The annual
q 4 ODCM Rov.- 15 Pnge 99'
}, .12/94 gaseous. dose calculation.uses the--same' methodology
' described in Section! 2.3.1,:2.3.3, and 2.3.4 with the^ exception of. meteorology; which is based.upon actual sector average:atumspheric dispersion-values using the guidance of Regulatory _ Guide-1.111 - ( Secta.on C. lc) . :. Finalized hourly, values of
' wind direction, ground level and release elevation
-wind speed, ambient temperature, and temperature ,
lapse rate (for P-G stability class)sare provided
. annually using thefinstrumentation specified.in ODCM I3.1-1. These values are calculated for;each
-hour and-linked to the corresponding hourly averaged affluent-release-rate.'. Doses.are then calculated for each. hour-at the various receptors-of interest (depending upon release. direction)..
Radioactive material release: rate is. calculated as > described in Sections 2.3.3-and 2.3.4'.~. Dose at: - each receptor is accumulated for the year,and the. : maximum dose for plume, inhalation,'and inge'stion. , pathways are reported. . The gaseous-. effluent dose- - receptors are listed in-Table 2-4-and the dose'is calculated using the methodology below.- 2.3.5-1 Plume Pathway 17 D,m= (3.6E-6) (472) E (X/0)c2E3 [(F w ) (Ojw) + (Fisy) (022sy) + (Fasv) (012w) 3
.e
[e Fil) *)h )(DFm) t T e) (2 -29 ) ,
- 2.3.5-2 Ground-Pathway
# I" * "
D,m= (3.6E-6) (472) E (X/0) E (DFm) (T )e . e e2-3, (p,,y) (Oj,,y) + (F,) (O,) . (2-30) i 2.3.5-3 vegetation, Meat, cow Milk, Goat Milk Pathway Dy ,m = (3.6E-6) (472) E , r
+
E [(F,) (Ojyy) + (F1 ,y) (Ojj,y) + (F as v) (012,y) + (Fm) (Qjm)] [ (X/De)] (DF i,r,s,x)
.i = 1 (T e)
' 35 E [ (F yy) (Og,y) + (F1 ,y) (Oj2,y) (F,,y) (Oj,,y) + (Fm) (Ojm) ] [D/0] e (DF 1,r.L,x)
,1-is -
(2'-31) . i w =, . --m, ,, ~ - -
u_ l
'ODCM Rsv.? 15 Pcga-100' l' 12/94 2.3.5-4 Veaetation. Meat, cow Milk coat Milk-Pathway D,m = (3.6E-6) (472) E a;
+
E [ (F,) (0 ,)3 + (F ,y) 2 (0 ,y) 32 + (F ,y) 2 (Oj,,y) + (F g) a (Ojag) l' ( (X/De) ] (DF A,r,z,n)
'* 1 (Te)
' 35 ' .
E ( (F w) (Ojw) + (F ,y) 1 (Oj2,y) + (Fasv) (Ol s,y) + (Fan) (Ojan) } (D/Og] (DFA ,r,r,#)
-(2-32$
where: D,, = annual dose from plume pathway (rem), D ,,,, = annual dose'from ground pathway (rem) D, yp
= annual dose from vegetation, meat, cow milk,'_1 and goat milk pathways-(rem)
D,,, = annual dose from inhalation pathway-(rem)- , 3.6E-6 = units conversion factor
' rem-Cl-sec hr-mrem-pCi i 472 = units conversion factor
' min-ce'
, sec-f e.
I = summation for each release time period t (unitless). (X/Q), = relative concentration for time. period "t" 3 (sec/m ) . F, = average North Vent flow rate:during release-(cfm). Q, = concentration of nuclide i from North Vent effluent (pci/cc). a F,,y = average Unit 1 South Vent flow rate during release (cfm). Qn,y = concentration of nuclide i from Unit 1 South Vent effluent (pci/cc)'. F2sv = average Unit 2 South Vent flow rate during release (cfm).
r . }ll @ 3." tl) .ODCM Rev.315-- ) s s. .Pcg3 101 i '?g ,
- lj '12/94- (j z.
Q,,, . = l concentration'of~nuclide l'from Unit 21 South.
~
Vent effluent-(pci/cc).. l l 11 = decay constant of .nuclide i ;(sec-1) . . , i dr. ' = ' ' distance to receptor "r". a u,- = average.windspeed for' time period "t" j (m/sec). 1
'DF g,y = dose factor for organ type k,; age group 1, pathway number n;; dose'. factors are based on4 1 results.of a computer program that.is based ~ I
' on and is similar to the NRC program GASPAR results.from this program provide input data- 1 in the form of a lookup table - values of
~DF , are provided-in Table 2-2.
i = isotope number (1 through 35)(3 through'17-are noble' gases). K = organ type (1 through'8) where total
-body = 1, GI tract = 2, bone = 3,' liver ~= 4,-- '
kidney ='5, thyroid --6, lung _= 7, skin =1~ 8). L = age group (1 through 4, where adult = 1, teen = 2,? child = 3,'infanto=:4). N = pathway: number (1-through 7). T, = time duration of release (hrs).- , F ,, = average Hot Maintenance Shop flow rate. during. release (cfm). Q, .. = concentration of'nuclide 1 from Hot
-Maintenance Shop effluent (pci/cc).
(D/Q), de sition concentration for time period "t" '
=
(1 m a), (X/Qg) = relative depleted concentration for time'
. period "t" 3 (sec/m )'.
2.4 Gaseous Effluent Dose Projection ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT. . SYSTEM be used to reduce radioactive material levels prior to discharge when projected doses from both units to areas at and beyond the SITE BOUNDARY would exceed 0.6 mrem to any organ in a 31 day period. i:
yc ' q ODCM R",vh15' . : '[ >
; Piga 102' 1 y _
12/94
~T he applicable gaseous. processing systems for maintaining radioactive material releases ALARA-are the~ Gaseous.
Radwaste--Treatment. System and Exhaust Treatment' System-in Figures:2-1 and 2-2. A dose projection.is performed at least once per 31-days by the following equation: Dmaxp = (Dmax/d) = 31d -(2233) where: Dmaxp = maximum organ dose projection for current 31-day. period (mrem); Dmax = maximum organ. dose to"dateLfor current calendar quarter as determined by equation (2-26)(2-27) or (2-28) (arem). d = number:of days remaining in current cale'ndar quarter. The minimum time elapsed is seven<(7)L . i~ days. t 31d = the number of days of concern. ., 3.0 Snecial Dose Analysis-3.1 Total Dose to MEMnRRS OF THE~PUBLIQ m .t ODCM I3.3.7. requires.that the annual dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases ofJ radioactivity and radiation, from the' uranium fuel cycle shall be l M ted to: s 25 mrem whole body or any. organ except thyroid-s 75 mrem thyroid ODCM I3.3.7.2 Surveillance Requirement requires'that cumulative dose contributions from direct radiation from. - operations be evaluated when:the calculated dose from the
~
release of radioactive materials in liquid or: gaseous effluents exceed twice the limits of ODCH:I3.2.3.a,
- ~ 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or.3.3.4.b~. The-direct. radiation contribution'shall'be' determined by the- ,
methodology described below. This methodology calculates _ " the direct radiation contribution which then must. be added ' : to the dose or dose commitment determined in accordance: . with sections ODCM III.3.1,,2.3.3, and.2.3.4 to determine'- This' evaluation of direct- - total ~ dose-from all pathways. radiation contribution.is in accordance with. . l ANSI /ANS 6.6.1-1979 Section 7. The error using this. method is estimated to be approximately 84. The following. ' f evaluation is performed for each receptor of concern. D,,3 =Dm o1 -D x as - D 3 ,,,g
. (M) 1
.c
f4, ,y ,
- r
-ODCM Riv.J15
, ll " * :Page 103 il- 12/94
.where:
D,g = cumulative dose contributionLfrom direct
. radiation at receptor 1 (mram)..
NOTE: Due to the statistics oferadiation measurements and to the conservation of effluent calculations it is may yield a negative value.- In this plausible situation the theva D ,lue for D ,( shall be reported as.
-zero(0).
D nu = total dose at receptor'of interest (as evaluated by TLD measurement)(mram). NOTE: If there is not a TLD location'at the actual receptor location, a more conservative. location will be used to evaluate Total' Dose. D,,, = mean of the_ background dose as evaluated by TLDs at. background sites (mrem). D urrL = effluent contribution to dose (as evaluated in sections 2.3.3 and 2.3.4.1). 3.2 Doses Due to Activities Inside the SITE BOUNDARY
- l. In accordance with ODCM I3.6, the Annual. Radioactive effluent Release-Report-submitted within 60 days after-January 1 of each year-shall include an assessmeri of' i radiation dose from radioactive liquid-and. gaseous' effluents to MEMBERS OF THE PUBLIC due to their-activities inside the SITE BOUNDARY.
There are three locations within the SITE BOUNDARY: that are accessible'to MEMBERS OF THE PUBLIC;for. ; activities unrelated to the. operation of Limerick Station. These locations are: 1) the railroad tracks which run along the-river.within the SITE BOUNDARY;
- 2) the Limerick Atomic'Information Center, on Longview Road next to the 500kv substation; and 3) Fricks Locki environmental laboratory, operated by-RMC~
Environmental Services, Inc. 'Of these'three-locations, the railroad tracks are the closest to the plant confines. The highest annual dose for the three locations should be determined by calculating dose at the railroad track location. , l l o l
.( ,
- , , .. - - - . . -. . ~ .- n.. ~ >.
@ . .g (l? [' ,
-ODCM Rsv.[15 N- P ge 104'
. , W 4 4 12/94- , m The f011owing methodology.is used-to evaluat'e. dose at' the railroad tracks, Information. Center, and Fricks Lock locations.- This dose assessment is' based on-the + -
, .results of the annual dose evaluation outlined in ODCM Section 2.3.5. The maximum dose-calculated-will be;
. 1 , reported, m D ,sar." Usar *. = 0.25; / (3 -2)'- where:' ' 4 D,, = Dose to: MEMBERS OF THE.PUBLIC within'.the SITE' 4 BOUNDARY in Sector"X";(mrem).: D. = Dose at SITE BOUNDARY in' Sector "X" (arem)'. X/Q, = Relative average annual atmospheric dispersion
- for year of interest3 at SITE BOUNDARY in i Sector "X" (sec/m ) .
X/Q W
= ~ Relative average' annual atmospheric dispersion:
h . for. year of' interest at' railroad, Information Center or Fricks Lock for distances. 3 listed? below in Sector "X"- (sec/m ) l
- - Sector ' Distance to Location (nr j' Railroad Tracks
- - S 300 -
L SSW 225~ SW 225 , I WSW , 225 W '225 i' WNW 345 NW 450 Information Center - ESE .884 Fricks Lock WSW 450 0.25 = maximum occupancy factor for. railroad tracks,-Limerick Atomic Information Center or Fricks: Lock Environmentali Laboratory (unitless). k h--.re_ ,# a ei ..--.-._-___a -
- _ _ _ .- -_.-m_. . .-_ _a - _ . _ .- _m- . - . . - -_ . _ . , _ . .-- - - , - - *
. .- - .. ~ .
1 , llL 'ODCM-Rev. 15-Pr.ge 105-llf 12/94'
, s... 4.0'. Radioloalcal Environmental Monitorina Procram
' 4.1; Emmnling Procram -
~ The operational' phase of the RadiologicalJ .. .
Environmental, Monitoring Program _(REMP)-is conducted < in accordance with the requirements of ODCM ::3.4-3. The objectives of the program are: To provide' data on measurable-levelsLof radiation and radioactive materials'in the site environs. ,
- . To evaluate the relationship between quantities: of.
. radioactive materials released from LGS and resultant radiation doses to individuals from principal pathways of exposure. The sampling requirements (type _ of samples, collection frequency,.and analysis) and. sample locations are presented in Appendix B. 4.2 Interlaboratory ca=narison Procram-
- - Technical-Specification 6.8.4.e.3. requires _ analyses be'-
performed ~on radioactive material supplied;as part of.an Interlaboratory Comparison.- l Participation in an approved Interlaboratory Comparisoni Program provides a check on the preciseness'of.-- - measurements of radioactive. material in' environmental ~ samples.. A summary of the'Interlaboratory Comparison-
- Program results is provided in the Annual Radiological, Environmental Operating Report pursuant to ODCM I3.5.
a d i som
I'"' .... I,,' Il TABLES
'l i
i l l 1 l
=~
;o, yt :4,. .
, s r.a' . 4
". .:l-? , s ODCM~Rev.'15' ;
-PIge ' 107 '
i:
'.l -12/94' . -;
i s p , 6' .s -
, - TABLE 1-1~.
INGESTION -INDIVIDUAL. DOSE FACTORS (Dg ,3) .- For' liquid-effluents 1 i i.;. Units ~For All-Ingestion'1 Pathways are:. mrem /pci l L' 9 4 F _ . - - - - - - - - - - - r- , ., ., -n.- ,--e e a,,, , , . . , , ,.r. w w w , , . . ,, , , , , . . , , ,.m.,.
-[ ODCM.R2v. 15 Pzga 108 j'
12/94 Table 1-1 Liquid Dose Factors 1
.From Table 3-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:
BONE LIVER T. BODY THYROID KIDNEY LUNG .GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E C14. 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07
. Na24 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06
~P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00'2.170E-05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06
. Fs55 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 Fe59- 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 Ni65 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00.0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 En69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br63 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00-Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+00 0.000E+00 4.160E-06' Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E '
Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05
- Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.191E-04 Sr91 5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-10 0.000E+00 0.000E+00 0.000E+00.1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 g Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Er95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E Er97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 i Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07
-Tc101 2.540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870k-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 Ta125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 Ta127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E Ta127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4.480E-07 0.000E+00 8.680E-06
~Te129m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4.800E-05 0.000E+00 5.790E-05 Tal29 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08
d
-l ODCM rov. 15 P2ga 109 l 12/94 Table 1-1 (Continued)
Liquid Dose Factors Frem Table E-11 or Reg. Guide'1.109 Ing stion Dose Factors For Adult: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Ta131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E+00 8.400E-05 Ta131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 Ta132 2.520E-06 1.630E-06 1.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 1130 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 I131 4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000Ev00 1.570E-06 I132 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.310E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 I135 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 Ca134 6.220E-05 1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cc136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Cs137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 C3138 5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Bn139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11 1.720E-07 Bn140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.180E-05 B2141 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 B3142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 Ln140 2.500E-09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 L2142 1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 Co141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 Ca143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 Ca144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.E30E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-10 0.000E+00 2.400E-05
. .. . .. _ ___ _ _- _ _ _ m _ _.
l 1 , Ll . ODCM RSv. 15 ; Pag 3 110' ' l 12/94 Table'1-1 (Continued)
~
Licuid Done Factors
- .From Table E-12 or Reg. Guide 1.109 ';
Ingestion Dose Factors For Teen: BONE LIVER .T. BODY THYROID KIDNEY- LUNG GI-LLI t
. H3 0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E C14- 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 Ns24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06
-P32 2.760E-04'1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 l Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 )
(Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05: ' Mn56 0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 FOSS 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06 , i LFoS9 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00:5.190E-06 Cu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E En65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 . , Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00: , r Br84 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E-08.4.540E-08 0.000E+00:0.000E+00 0.000E+00 7.300E-15 ! Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17' Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 : Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 ; Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E
- Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E .
Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04.
- I Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09:
l Y91 2.010E-07 0.000E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00'O.000E+00 3.320E-05 : Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0,000E+00 1.170E-04 ) Er95 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Er97 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 ; Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 ; Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 , Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07 Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 ' Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 - Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 Ta125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 l Tol27m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 ' Ta127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 Tal29m 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 Te129 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880E-07 0.000E+00 2.450E-07 . Ta131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-05 0.000E+00 9.390E-05 c Ta131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-07 0.000E+00 2.290E-09 ! Ta132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05
)
_. .= - _ _ _ . _ _ _ _ - - _ _ _ _ _ _ _ _ - _ _ - _ _ _ _ _ - - - _ - _ _ . . . _ _ .
- . . =~ -
it: 'ODCu Rsv. 15-PXga 111' l'~
!. 12/94 Table 1-1 (Continued)-
Linuid Dose ~ Factors Frdm Table E-12 or Reg. Guide 1.109 Ing2stion Dose Factors For Teen: BONE LIVER T. BODY- THYROID. KIDNEY LUNG GI-LLI I130' 1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 0I131 5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06' JI132 2.790E-07 7.300E-07-2.620E-07 2.460E-05'1.150E-06 0.000E+00 3.180E-07 I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 'I134 1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 i 1135 6.100E-07 1.570E-06 5.87.0E-07'1.010E-04 2.480E-06 0.000E+00 1.740E-06 , ~Cs134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 '! Cs136 8.590E-06'3.380E-05 2.270E-05 0.000E+00.1.840E-05 2.900E-06 2.720E-06 ! Co137 1.120E-04 1.490E-04 5.190E-05 0.000E+00-5.070E-05 1.970E-05 2.120E-06
'C0138 7.760E-08 1.490E-07-7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 B3139 1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 ~B2140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Ba141- 6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 1 BR142; 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 l Ln140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 .La142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 ~Ca141 1.330E-08 8.880E-09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Ca143- 2'.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Ce144 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00'1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 Pr144 4.300E-11 1.760E-11--2.180E-12 0.000E+00 1.010E-11 0.000E+00 4.740E-14 ,
Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05' ! W187 1.400E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E ,
ODCM R::;v. - 15__ s Paga 112 g 12/94 , Table 1-1 (Continued) .
- Liould Dose Factors :
;From Table E-13 or Reg. Guide 1.109 ;
,, Ingestion Dose Factors-For Child:
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 , C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06. Na24 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 i
~P32 '8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05, j Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.0203-09,4.720E i Mn54 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06' [
Mn56 0.000E+00 3.340E-07 7.540E-08 0.000E+00 4.040E-07 0.000E+00 4.840E-05 > 1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 , FOSS Fs59 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 l CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05 Co60 0.000E+00 5.290E-06-1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E-05 Ni63 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 ' Ni65 2.220E-06 2.090E-07'1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05 ' Cu64 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E-05 Zn65 1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06 , Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00.0.000E+00 0.000E+00 0.000E+00 Br84- 0.000E+00 0.000E+00 1.980E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00. [ 2 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 i Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 ; 0.000E+00 1.900E-07 1.320E-07 0.000E+00.0.000E+00 0.000E+00 9.320E-09 Rb88 Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00-0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00 3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05: J Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E , Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 - Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04 , Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 i .Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00 0.000E+00 8.020E-05 i l ~ Y92 3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040E-04 l 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04 '
~
Y93 Zr95 1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 , Er97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 Mo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.00CE+00 2.630E-08 9.190E-10 1.030E-06 Tc101 1.070E-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 i
-Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 Rul05 6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 '
Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05
,Tc125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 Te127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 Tol27 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05 Te129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 Te129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 Ta131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 Ta131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07 Ta132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05 l - - - . . _ .
l~ ODCM k;v. 15 Paga 113 1 12/94 Table 1-1 (Continued) Liquid Dose Factors From Table E-13 or Reg. Guide 1.109 Ing2stion Dose Factors For Child: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Cs134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.270E-05 2.070E-06 Cs136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130F-06 2.270E-06 Cs137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 C2138 2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 B2139 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05 B2140 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 B2141 2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 B2142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 L2140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05 Cs141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 C3143 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 Ca144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05
1- ODCM R n. 15.! - Paga 114 :
.l 12/94-Table 1-1 (Continued) ,
Liould Dome Factors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant: LIVER THYROID KIDNEY LUNG GI-LLI . BONE T. BODY ] H3: 0.000E+00 3.080E-07 3.080E-07 3.080E-07~3.080E-07 3.080E-07.3.080E C14 2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 ; Na24 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 Cr51 0.000E+00 0.'000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07 .
- Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E "
4 Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 Fe55 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 Fe59 3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05. CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06 Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05--; 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.9505-06. Ni63 Ni65 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 l Cu64 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05. En65 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05 , En69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83 0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 - Br84 0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 1.940E-08-0.000E+00 0.000E+00 0.000E+00 0.000E+00 r Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 , i Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 j Rb89 0.000E+00 2.860E-07 1.970E-07 0.000E+00 0.000E+00 0.000E+00 9.740E-08 Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04 Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E , Y91m 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06. ! Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 - Y93 2.430E-08 0.000E+00 G.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04 Zr95 2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 , Nb95 4.200E-08 1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05 ' Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 i Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07 . Rul03 1.480E-06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05. Rul05 1.360E-07 0.000E+00 4.580E-08 0.000E+00 1.000E-06 0.000E+00 5.410E-05 4 Rul06 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04 Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05 Tal25m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 Tol27m 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05 i Tal27 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 , Ta129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 - Tal29 2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 . Ta131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 [ 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 Ta131 Te132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05 0.000E+00 3.810E-05
l ODCM RLv. 15 Paga 115 l 12/94 Table 1-1 (Continued) Liquid' Dose Factors Frem Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant: BONE LIVER T. BODY THYROID KIDNEY LUNG. GI-LLI I130 6.000E-06 1.320E-05 5.300E-06 1.480E-03 1,450E-05 0.000E+00 2.830E-06. I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 iLI132- 1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 I133 1.250E-05 1.820E-05'5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 I134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 - I135 3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E-06 Cc134 3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04 7.420E-05 1.910E-06 + Cs136 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05 2.050E-06 Cs137 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 Cs138 4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 Bn139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 i B2140 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 Bn141 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Bn142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 Ls140 2.110E-08 8.320E-09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11 0.000E+00 0.000E+00 0.000E+00 6.860E-05 Co141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 Ca143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5.730E-05 Ca144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E-04 Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 Nd147 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 l W187 9.030E-07 6.280E-07 2.170E-07 0.000E+00 0.000E+00 0.000E+00 3.690E-05 Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 i 9 r i l
)
l
)
1
- -. . . - ~ . .. -.. . . . - .- . . _ .
-l. ODCM Rsv. 15 Paga 116:
ll 12/94 ' Table 1-2 Assumptions used in Limerick Liquid , Effluent Dose Evaluation IndSX Description Value 1 1 Fraction of produce-from local garden. 7.600E-01 - 2 Fraction ~of leafy veg from local garden 1.000E+00~ 3 Soil density'in plow layer (kg/m**2) 2.400E+02. J 2.500E ' 4 Fraction of activity retained on sprayed vegetation 5 Shielding factor for residential structures 7.000E-01 6 Pi3riod of buildup of activity in soil (hr) , 1.752E+05 i n 7'Porlod of pasture grass exposure to activity (hr) 7.200E+02 l 8-Period of crop exposure to activity (hr) .
- 1.440E+03 9 Holding time in animal drinking water pond (hr) 0.000E+00 ,
10 Delay time for ingestion of grass by animals (hr) 0.000E+00 1 11 Delay time for ingestion of stored fee by animals (hr) 2.160E+03 12 Delay time for ingestion of leaf veg by man (hr) 2.400E+01 - 4 13 Delay time for ingestion of other veg by man (hr) 1.440E+03 r 14 Transport time milk-man (hr) 4.800E+01' 15 Time betwesn slaughter and consumption of meat animal (hr) 4.800E+02 ' 16 Grass yield, wet wt'(kg/m**2) 7.000E-01 17 Other vegetation yield, wet wt (kg/m**2) 2.000E+00 18 Weathering rate constant for activity on vegetation (1/hr) 2.100E-03 19 Milk cow feed-consumption rate (kg/ day wet) 5.000E+01
)
20 Goat feed consumption rate (kg/ day wet) 6.000E+00 21 Beef Cattle feed consumption rate (kg/ day wet) 5.000E+01 22 Milk cow water consumption rate (1/ day) 6.000E+01-23 Goat water consumption rate (1/ day) 8.000E+00 . 24 Beef cattle wnLer consumption rate (1/ day) 5.000E+01
- 25 Enytl transit time for water ingestion (hr) 1.200E+01 l 26 Enytl transit time for fish ingestion (hr) 2.400E+01 27 Enytl transit time for invertebrate ingestion (hr) 2.400E+01 ,
28 Enytl transit time for shore exposure (hr) 0.000E+00 i 29 Water-ingestion (1 yr) adult 7.300E+02 , 30 Water ingestion (1 yr) teen 5.100E+02 31 Water ingestion (1 yr) child 5.100E+02 32 Water ingestion (1 yr) infant 3.300E+02
- 33 Shore exposure (hr/yr) adult 1.200E+01 34 Shore exposure (hr/yr) teen 6.700E+01 ;
35 Shore exposure (hr/yr) child 1.400E+01 36 Shore exposure (hr/yr) infant 0.000E+00 37 Fresh water sport fish ingestion (kg/yr) adult 2.100E+01 s38 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01 *
/ child 6.900E+00
'39 Freshwater 40 Fresh watersport sportfishfish ingestion ingestion (kg(kg/yr) yr) infant 0.000E+00 41 Fresh water commercial fish ingestion (kg yr) adult 2.100E+01-42 Fresh water commercial fish ingestion (kg yr) teen 1.600E+01 43 Fresh water commercial fish ingestion (kg yr) child 6.900E+00 44-Fresh water commercial fish' ingestion (k yr) infant 0.000E+00 45_ Fresh water invertebrate ingestion (kg yr) adult 5.000E+00 46 Fresh water invertebrate ingestion (kg r) teen 3.800E+00 47 Fresh water t uvertebrate ingestion (kg r) child 1.700E+00 48 Fresh water invertebrate ingestion (k yr) in* ant 0.000E+00
l; ' ODCM rov. 15 j PCga 117 j' 12/94 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation I Index Description value 49 Salt Water Sport Fish Ingestion (kg yr) Adult 2.100E+01 50 Salt Water Sport Fish Ingestion (k yr) Teen 1.600E+01 51 Salt Water Sport' Fish Ingestion (kg yr) Child 6.900E+00 52 Salt Water Sport Fish. Ingestion (kg yr) Infant 0.000E+00 53 Salt Water Commercial Fish Ingestion (kg yr) Adult 2.100E+01
'54 Salt Water Commercial Fish Ingestion (k yr) Teen 1.600E+01 55 yr) Child 6.900E+00 56 Salt Salt Water Water Commercial Commercial Fish Fish Ingestion Ingestion (kg/yr)
(kg Infant 0.000E+00 57 / 5.000E+00 58 Salt Water Invertebrate Ingestion (kg/yr) Adult 3.800E+00
.59 Salt Water Invertebrate Ingestion (kg/yr) Teen 1.700E+00 -60 Salt Water Salt Invertebrate Ingestion Water Invertebrate Ingestion (kg (kg/yr) yr) Child Infant 0.000E+00 61 Irrigated Leafy Vegetable Ingestion (kg yr) Adult 6.400E+01 62 Irrigated Leafy vegetable Ingestion.(kg yr) Teen 4.200E+01 63 2.600E+01 64 Irrigated Leafy Vegetable Ingestion (kg/yr) Child Infant 0.000E+00 65 Irrigated Leafy Vegetable Ingestion (kg/yr) Irrigated Other Vegetable Ingestion (kg yr) A 5.200E+02 '66 Irrigated Other Vegetable Ingestion (kg yr) Teen 6.300E+02 67 Irrigated Other Vegetable Ingestion (kg yr) Child 5.200E+02 68 Irrigated Other Vegetable Ingestion (k yr) Infant 0.000E+00 69 r) Adult 5.200E+02-70 Irrigated IrrigatedRoot Root Vegetable Ingestion (kg/yr)
Vegetable Ingestion (kg Teen 6.300E+02 71 Irrigated Root Vegetable Ingestion (kg/ 5.200E+02 72 -Irrigated Root Vegetable Ingestion (kg/yr) yr) Child Infant 0.000E+00 73 Irrigated Cow Milk Ingestion (1 yr) Adult 3.100E+02 74 Irrigated Cow Milk Ingestion (1 yr) Teen 4.000E+02 75 Irrigated Cow Milk Ingestion (1 yr) Child 3.300E+02 76 r) Infant 3.300E+02 77 Irrigated Cow Milk Ingestion Irrigated Goat Milk Ingestion (1 (1 y/yr) Adult 3.100E+02 78 Irrigated Goat Milk Ingestion (1 yr)' Teen 4.000E+02 79 Irrigated Goat Milk Ingestion (1 yr) Child 3.300E+02 80 Irrigated Goat Milk Ingestion (1 yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1 yr) Adult 1.100E+02 82 Irrigated Beef Ingestion (1 yr) Teen 6.500E+01 83 Irrigated Beef Ingestion (1 yr) Child 4.100E+01 84 Irrigated Beef Ingestion (1/yr) Infant 0.000E+00
-l ODCM R;v. 15-Page-118 l 12/94 Table 2-1 1 Dose Factors for Noble Gas Total Body Beta Skin Gamma Air Beta Air j Dose Factor Dose Factor Dose Factor Dose Factor i Ki (mrem /yr Li (mrem /yr Mi (mrad.yr Ni (mrad /yr ;
per per per per )
;Index Radionuclide pCi/m3 ) pCi/m3 ) pCi/m3 ) pCi/m3 ) l 3 Ar-41 8.84E-03 2.69E-03 9.30E-03 3.28E-03 4 Kr-83m 7.56E-08 -------
1.93E-05 2.88E-04 5 Kr-85m 1.17E-03 1.46E-03 1.23E-03 1.97E-03 6 Kr-85 1.61E-05 1.34E-03 1.72E-05 1.95E-03 7 Kr-87 5.92E-03 9.73E-03 6.17E-03 1.03E-02 8 Kr-88 1.47E-02 2.37E-03 1.52E-02 2.93E-03 9 Kr-89 -_ 1.66E-02 1.01E-02 1.73E-02 1.06E-02 10 Kr-90 1.56E-02 7.29E-03 1.63E-02 7.83E-03 , 11 Xe-131m 9.15E-05 4.76E-04 1.56E 1.11E-03 12 Xe-133m 2.51E-04 9.94E-04 3.27E-04 1.48E-03 13 Xe-133 2.94E-04 3.06E-04 3.53E-04 1.05E-03 14 Xe-135m 3.12E-03 7.11E-04 3.36E-03 7.39E-04 15 Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E-03 16 Xe-137 1.42E-03 1.22E-02 1.51E-03 1.27E-02 17 Xe-138 8.83E-03 4.13E-03 9.21E-03 '4.75E-03
- 1 .i
;;; 7 +
ll1
'ODCM Rdv.215
~
> Pag 3 119 12/94 el: ,
--TABLE 2-2 INGESTION INDIVIDUAL' DOSE FACTORS (DFgy) '
For Gaseous Effluents r UNITS FOR AIRBORNE PATHWAYS
-(Pathway. Numbers 1 and 7) are: .
3 mrem-m /Ci-sec UNITS FOR DEPOSITION PATHWAYS (Pathway Numbers 2-6)(are* 2 mrem-m /Ci
.i Pathway No. Pathway <
'~
1 Plume 2 Ground ., 3 Vegetable 4 Meat 5 Cow Milk - 6 Goat Milk 7 Inhalation ; e 1 l
-I I
-. __- _ _ _ . _ . . - ~,
I ODCM Rsv. 15 z P1g31120 <
-l 12/94 Table 2-2 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 - For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN - ' Adult: 0.00E+00-0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00!
Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00: Child:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00) - For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY: THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00i Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Vegetable 3 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00,
'Tcsn: 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child: 1.21E+02 1.21E+02 0.00E+00 1.21E+02 1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, For. Pathway: Meat T. BODY ~ GI-TRACT BONE LIVER KIDNEY THYROID LUNG : SKIN - Adult: 7.98E+00 7.98E+00 0.00E+00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 Tson: 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00' Child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN - Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 Tacn: 2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Child: 3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00*
Infant: 5.87E+01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 i For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00' Tecn: 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+01 4.99E+01 4.99E+01 0.00E+00,
- Child: 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infant: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1.20E+02 1.20R+02 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.01E+01 4.01E+01 0.00E+00 4.01E+01 4.01E+01 4.01E+01 4.01E+01 0.00E+00.,
Tasn: 4.03E+01 4.03E+01 0.00E+00 4.03E+01 4.03E+01 4.03E+01 4.03E+01 0.00E+00, Child: 3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.00E+001 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00
)
i l i l 1 r_ m . _ < _ _ . _ _ _ _ . _ _ <
kl ODCM Rsv. 15 Paga 121 , l 12/94 Table 2-2.(Continued) ; 'TMDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN -Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ^Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ~ Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tson: 8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00 Child: 2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 , Tasn: 1.392+03 1.39E+03 6.04E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 0.00E+00 Child: 2.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN " Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tacn: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00-Child: 8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 ' Tasn: 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00
-Tecn: 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 l Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.68E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00 i l
l l
?
( l ODCM Rsv. 15'- Page 122 i
-! 12/94 Table 2-2.(Continued) ,
INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 t
' For' Pathway: Plume .
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02-
- Tscn: 1.96E+02-1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02; Chi ld: '1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02' Infant: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02-1.96E+02 1.96E+02 1.96E+02:
For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID- LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Tasn: 0'00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' For Pathway: Vegetable ' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tasn: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' For Pathway: Meat
. SKIN.
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+003 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0~.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. -LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
~ Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 : Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00i For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00! Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l _ -__ ._-________L_-__ _ _ _ _ _ _ _ _ _ _ _ _ _.
N ,
!l ODCM Rsv.-15 Paga 123 l 12/94 3 Table 2-2 (Continued) -INDIVIDUAL DOSE FACTORS'FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 i 'For Pathway: Plume T. BODY' GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN- - Adults- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - Tacn t ' O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.
Childt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' LI nfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For' Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN Adult: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05! TSGn: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Infant: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05.1.43E+05 1.43E+05 1.69E+05 . t
-For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID ' LUNG SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00.
Tacn 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child: 3.05E+03 1.62E+05 C.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 :!
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 !
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN t Adult: 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 4 Tsan: 1.03E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71P+01 1.47E+02 0.00E+00 Child: 1.60E+02 8.50E+03 0.00E+00'O.00E+00 2.43E+01 8.90 01 1.62E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00h 00 0.00E+00 0.00E+00 For Pathway: Cow Milk : T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 ) Tacn: 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 I Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Infant: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk . T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
]
Adult: 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00
-Tosn: 1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 Child: 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E+00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 Tsan: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 , . Child: 4.89E+00 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 l Infcnt: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 ,
i W.. , , _ , , , -n- e , - ,
-)
! ODCM Rsv. 15 PIga 124 12/94 ,
Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Mn854 LFor Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Tarn : - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00; l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00! Infant: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00i For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID LUNG SKIN
-Adult: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+073 TcEn: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07-4.23E+07 4.23E+07 4.96E+07 Child: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07i Infant: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+071 'For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY TH7ROID LUNG SKIN ,
Adult: 1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00:
'Tscn: 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00J Child: 5.03E+06.1.59E+07 0.00E+00 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00!
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00! For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 3.21E+04 5.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 l Torn: 2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00'O.00E+00 l Child: 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Cow Milk T. BODY GI-TRACT ' BONE' LIVER KIDNEY -THYROID LUNG SKIN . Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00'O.00E+00 0.00E+00! Tacn: 5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+001 Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 i Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00. For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 Tasn: 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00' Child: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00s Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00, For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Tacn: 2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00! Child: 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00l Infant: 1.58E+02 2.24E+02 0.00E+00 8.03E+02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 1 L
- .. . . _ . - .-- . . . . - - . . . . ~ . . . .
l' ODCM Rsv. 15 Paga 125 l' 12/94-Table 2-2 (Continued) INDIVIDUAL DOSR FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8
'For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-
} Adults ,0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOsn t. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 LChild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
' Adult: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07-Tsan: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Infcnt: 1.16E+07 1.16E+07 1.16E+07 1.16E+07.1.16E+07 1.16E+07 1.16E+07 1.16E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 2.72E+06 1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 5.43E+06.1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
' Adult: 7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <
Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: 1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00.0.00E+00 4 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
-Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;
l Tson: 3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 7.96E+04 1.52E+05 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 Infant: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00 Tocn: 8.80E+01 3.02E+03 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00 1 _ _ - - - - - - _ _ _ _ _ - - _ _ _ - -- .-a - , - - -- .-
l ODCM RLv. 15 Prga 126 l 12/94 1 Table 2-2 (Continued) j INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Fe59 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tcen: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Infant: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.80E+06 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tc;n: 4.28E+06 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child: 8.69E+06 1.32E+07 1.08E+07 1.75E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+03 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 l Tscn: 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 l Child: 5.43E+06 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.79E+05 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 Tczn: 8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+06 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infant: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Tacn: 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child: 2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Adult: ton: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Child: 5.29E+02 2.24E+03 6.56E+02 1.06E+03 0.00E+00 0.00E+00 4.02E+04 0.00E+00 Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00
~ll .ODCM Rav. 15- ,)
Paga 127 l 12/94; Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Co60 q I For Pathway: Plume T. BODY GI-TRACT BONE ~ LIVER KIDNEY THYROID LUNG SKIN . Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOcn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground ; T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 T32n:' 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 LChilds 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08
. Infant: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
Tacn:. 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00- l Child: 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 e For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' SKIN Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0.00E+00 0.00E+00'O.00E+00 3 Tasn: 2.46E+06 1.42E+07 0.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN . . Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00- , Tsen: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ; Child: 2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Tosn: .1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.'00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN pAdult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00E+00
-Tasn: 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 child: 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 LInfant: 3.73E+02 1.01E+03 0.00E+00 2.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00 ,
l! .ODCMLROv. 15 [ Pag 3.120 l 12/94 Table 2-2 (Continued)
'1NDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: En65 JFor Pathway: Plume T. BODY GI-TRACT BONE LIVER- KIDNEY THYROID LUNG' SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00:
Tssn: 0.00E+00-0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00: Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00: LInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00! ' c For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG . SKIN Adult: 2.29E+07.2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07.2.29E+07 2.63E+07~ Tosn: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07.2.29E+07 2.63E+07: Infant: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07, , For Pathway: Vegetable
. T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 Tasn: 2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Child: 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN J- Adult: 1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E+00 0.00E+00 0.00E+00 8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Tasn: Child: 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.15E+07 5.79E+07 2.89E+07 9.20E+07 6.15E+07 0.00E+00 0.00E+00 0.'00E+00 Tacn: 7.19E+07 6.63E+07 4.44E+07 l'.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 Infant: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN [- Adult: 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00
- Tacn
- 8.63E+06 7.83E+06 5.33E+06 1.85E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00, L Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 2.22E+07 4.07E+07 1.40E+07 4.81E+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 i
l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 TsOn: 1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 I Child: 2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 i' Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00;
' l' ODCM R2v. 15 .
P Pega 129
'l 12/94 ,
Table 2-2 (Continued)
' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: KrB3m For Pathway:' Plume . .
T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID- LUNG SKIN Adults 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E TOsn: 1.68E-03 1.68E-03'1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Childs" 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02-4.75E-01 Infcnt: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03'9.39E-02 4.75E-01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Tssnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 Child:. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 ~ ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+b0 0.00E+00 0.00E+00 0.00E+00 :
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ; Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Infant: 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk . T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
_ _ _ _ . _ + - _ _ _ _ _ _ - - -
--u - ---
. , .~ . - . . . - . . .
]' ~ ODCM rov.'15-Pag 3 130. '
f 12/94 ' 1 1
. Table 2-2 (Continued)
~
- INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE Kr85 ,
.For Pathway: Plume _ _
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
- Adult 3.57E-01 3.57E-01 3.57E-01-3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01'
' Tcan: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01.9.50E-01 4.29E+01 Child: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 Infant: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 For Pathway: Ground .
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG _ SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00Eo00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00F+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00;+00 0.00E+00 0.00E+00 0.00E+00
- For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 i Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN- , Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID- LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '
. . . . r -r .- .., - . . , , , . .-- , , - - -y. ,
.- . . -. -.--g-. . .
~ - . . . - ~ ~ . .
4 lL ODCM Rsv.'15-lPaga.131
, -!. 12/94 Table 2-2 (Continued)
,!TMDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85m
< For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG ' SKIN > Adult:
2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Tasn: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01
- Childs 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01
- Infant
- 2.60E+01 2.60E+01.2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01.
For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID' LUNG SKIN
~ Adults- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
~Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' T&Sn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00,0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! For Pathway: Meat T. BODY- GI-TRACT BONE LIVER KIDNEY THYROID -LUNG SKIN-Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 E i . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
- Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
- - _ _ _ - - . _ _ _ _ , - . - - - - , , . - - - - - ,r , - - - - -
I g :) . ODCM R0v. 15 l o~ Paga'132 l-12/94 4 Table.2-2 (Continued) TunIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- POR ISOTOPEt Kr87 For Pathway:' Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02' Tacn: 1.31E+02-1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02: Child: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02.1.35E+02 4.60E+02 Infant: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT ~ BONE LIVER KIDNEY THYROID LUNG SKIN , ' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00:0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , For Pathway: Meat T. BODY GI-TRACT BONE LIVER- KIDNEY THYROID LUNG SKIN'
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+002 #
l Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 L Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk
, T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tacn: 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.' Infant: 0.00E+00 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00;
-For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00> "* ~ -- -- . . . , . , - - .
1 5
- l. ODCM Rsv. 15' Paga 133-i
- l. .12/94 Table 2-2 (Continued) l INDIVIDUAL DOSE' FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE Kr88 For Pathway: Plume
.T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: .3.26E+02 3.26E&O2 3.26E+02 3.26E+02'3.26E+02 3.26E+02 3.27E+02 4.50E+02 Tasnt 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02'4.50E+02 lChilds 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02
. Infant: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 JFor Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E- ^)- , For Pathway: Vegetable ' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00- ! Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 [ Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 , Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk ' l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tsant 0.00E+00 0.00E+00 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN -Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
. . _ , _. _ . _ _ _ _ _ _ ~_ . - . _ __ _ . _ _ _
d - .' *'k-
-l ODCM RSv, 15 Paga 134 l -12/94 !
-l
-Table 2-2.(Continued) -j
' INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Kr89' -)
l \ 'For. Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY . THYROID LUNG SKIN Adult:: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Tasn: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02
- - Child: 3.68E+02 3.68E+02 3.68E+02.3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Infant: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02~
g :For Pathway: Ground , SKIN-l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Tocn: 3 Child: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00iF00 - For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER- KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 . Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 o Tcan : - 'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00-l For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN - i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , T@cn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2 t Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00R+00 ' ! Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00; Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00J! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN Adult: 'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 > Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 : L l
b ODCH Rsv. 15
-Paga 135
_ l' 12/94 Table 2-2 (Continued) TNDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Sr89
'For' Pathway: Plume T. BODY GI-TRACT -BONE LIVER KIDNEY THYROID LUNG SKIN Adulta- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacus. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 LChild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
, Adult 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 . Taans 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 , Childs 6.62E+02 6.62E+02 6.62E+02 6.62E+02.6.62E+02 6.62E+02 6.62E+02 7.68E+02 Infant: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN , J Adult: 7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson 1.20E+07 5.00E+07 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child 2.91E+07 3.95E+0? 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 l Tacn t . 1.42E+05 5.90E+05 4.95E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , , Child: 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 < For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID- LUNG SKIN jAdult: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . l L'Tcsni 1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 J I
- _ Infant
- 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
c For Pathway: Goat Milk
- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult
- 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
, Infcnt: 1.47E+07 1.06E+07 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )
'For Pathway: Inhalation
- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
' Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 l Tecn 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Child: 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00 l
l I
l-
,ODCM Rnv.-15' l Paga 136 3 l 12/94 +
0 Table 2-2 (Continued) ]
- INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: Kr90
, ~For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN
~ Adult: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02.3.49E+02 6.33E+02 Tosn: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Child: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 , i Infant: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.462+02 3.46E+02'3.49E+02 6.33E+02 For: Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '
Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG _ SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID . LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Totn: 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+00j
- Fors Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN t
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Taan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00R+00 0.00E'+00 , Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l . I R 1
,-=
l ODCM R;v. 15 Paga 137
! 12/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr90 ,For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;cn: 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tarn: 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.51E+09 4.14E+08 1.43E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: 5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 l Adult: 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tecn: 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00Ev00 0.00E+00 0.00E+00 0.00E+00 Child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
-l ODCM Rev. 15 Paga 138 l 12/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Er95 For Pathway: Plume T.LODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;cn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Tasn: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child: '7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infant: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00.0.00E+00 0.00E+00
, Toon: 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 i Child: 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 Tcan: 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00.0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' l For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN L . Adult: 3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00, l Tacn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 Child: 1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00' For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00, Tacn: 7.66E-01 2.57E+03 3.53E+00 1.11?+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child: 1.61E+00 1.88E+03 8.20E+00 1.80E.00 2.58E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 2.52E+00 1.77E+03 1.46E+01 3.55E+u0 3.83E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00+ Tscn: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child: 1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.89E+03 0.00E+00 7.07E+04 0.00E+00 Infant: 6.44E+02 6.88E+02 3.662+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00,
- ~ -
l- ODCM Rsv. 15-Paga 139 , l 12/94 Table 2-2 (Continued)
, MVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS - FOR ISOTOPE: Sb124-For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i aAdult: 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. '
TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- For. Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .
- Adultt' O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' 4 - Tsen t - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' l
' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable '
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN -! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~ t Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 c For Pathway: Meat f T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ; Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . r For Pathway: Cow Milk . T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00
< Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
Infant: 'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ,
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00T*00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , .
For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN - Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 b _ _ _ - - - _ _ _ _ = - - . . -. . , _ - - _ _
l ODCM Rsv. 15 Paga 140 l 12/94 Table 2-2 (Continued) . INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:- I131
'For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN . Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 S For Pathway: Ground SKIN T. BODY GI-TRACT BONE LIVER KIDNEY TFYROID LUNG Adult: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05i Tacn: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05'3.19E+05 Child: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Infant: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 For Pathway: Vegetable SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- ' Adult: 4.43E+05 2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 Tasn: 4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 Child: 5.83E+05.9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39E+08 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 Tasn: 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child: 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E405 5.44E+07 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00s+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 Tecn: 3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child: 7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infant: 1.39E+07 1.13E+06 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.'00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00 Tecn: 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00' Child: 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infant: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00l For Pathway: Inhalation '
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG _ SKIN. Adult: 6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 Tosn: 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 child: 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00, . Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00
h l ODCM R2v. 15 Pag 3 141 l 12/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe131m Fcr Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01
'Tc n: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.033+00 2.03E+00 2.38E+00 1.89E+01 Child 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Infcnt: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00.2.03E+00 2.38E+00 1.89E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
l-ODCM Rsv. 15 Paga 142 l 12/94' Table 2-2-(Continued) INDIVIDUAL DOSE FACTORS'FOR CASEOUS EFFLUENTS -- FOR ISOTOPE: I133 For Pathway: Plume SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 + Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Child: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , I 1For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04
.Tasn: 3.75E+04 3.75E+04 3.75E+04 3.75E+04'3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04.3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04-For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00-Teen: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 Child: 1.06E+04_1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY- THYROID LUNG SKIN Adult: 2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00.0.00E+00 Tosn: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00; For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Tasn: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child: 8.12E+04 8.65E+04 1.74E+05 2.15E+05 3.58E+05 3.99E+07 0.00E+00 0.00E+00 Infant: 1.56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 Tssn: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child: 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00, Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 Taen: 1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E+00 0.00E+00 Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 Infant: 1.78E+02 6.83E+01 4.20E+02 6.08E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00-
.= _ - . -
l ODCM RLv. 15 Paga 143 l 12/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUUNTS -- FOR ISOTOPE: Xe133 For Pathway: Plume SKIN LIVER KIDNEY THYROID LUNG T. BODY GI-TRACT BONE Adult 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 i TOcnt 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Child 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infcnt: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 For Pcthway: Ground LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcons 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN , Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tonn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
~ _ _- ._ _ .- - . _ . .
1
' l:
ODCM Rtv. 15 ) Phg3 144 ! l 12/94 i Table 2-2 (Continued) TMDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR-ISOTOPE: Xe133m
' For Pathway: Plume SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' Adult: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 T:sn: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01
. Child: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00.3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00.3.96E+01 I 'For Pathway: Ground SKIN T. BODY GI-TRACT BONE LIVER- KIDNEY THYROID LUNG
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT' BONE LIVER KIDNEY THYROID LUNG' SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' ' - Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID ' LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00; i' Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk ! T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00l Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00) Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00l
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00(
l
ODCM Rsv.-15 l Pags 145 l 12/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For. Pathway: Plume SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: ~0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tacn: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Child:- 2.11E+08 2.11E+08 2.11E+08'2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tosn: 2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child: 1.60E+08.4.10E+06 4.63E+08 7.60E+08 2.35E+08 0.00E+00 8.46E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05 1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 ;
Teen: 1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.0SE+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 Tacn: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5.22E+07 0.00E+00 child: 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 ; Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i 1 Adult 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00'8.07E+07 0.00E+00 Toen: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 Infant:-3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00
- For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 i
Tonn: 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00 Child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 I l Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00
)
- l. ODCM rov. 15 i Paga 146 l 12/94 ,
4 Table 2-2 (Continued) INDIVIDUAL DOSE' FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135m l For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN Adult: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01l6.95E+01 1.05E+02 Tenn: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 . Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01.6.95E+01 1.05E+02 For. Pathway: Ground SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- ,
' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ~ Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E*00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00=0.00E+00 . Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00; For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN , -Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00)
Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00l Child:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00j
- , , + _ -
l .: ODCM Rsv. 15 Paga 147 l_ 12/94 - Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135 For Pathway: Plume LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 T&2n: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Childt. 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pathway: Ground LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T@2n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk { T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
ODCM R0v. 15 .= l~ Paga 148
-l 12/94 Table 2-2 ( nued)
Cm136
~IMDIVIDUAL DOSE FACTORS FOR CAEROUS EFFLUENTS -- FOR ISOTOPEr For Pathway: Plume THYROID LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tazn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground THYROID LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06' -
Tsen: 4.60E+06 4.60E+06 4.60E+06 4.00E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Child: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06.4.60E+06 4.60E+06 5.21E+06 Infant: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: _ Vegetable LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 0.00E+00 Tssn: 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child: 2.88E+06_1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat SKIN LIVER KIDNEY THYROID LUNG T. BODY GI-TRACT BONE Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05E+05 0.00E+00 6.92E+04 0.00E+00-Tcon: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84E+05 0.00E+00 6.05E+04 0.00E+00 Child: 5.50E+05 2.99E+04 3.09E+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk LUNG SKIN T. BODY GI-TRACT- BONE LIVER KIDNEY THYROID Adult: 1.43E+07 2.26E+06'5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06-0.00E+00 Tccn: 2.26E+07 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child: 3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infant: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00-9.05E+06 0.00E+00 For Pathway: Goat Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID
' Adult: 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 Tann: 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.00E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07.0.00E+00 For Pathway: Inhalation LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 Toen: 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infant: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00
l ODCM Rsv. 15 l Paga 149 R j 12/94 i
/
Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 For Pathway: Plume SKIN T. BODY GI-TRACT BONE LIVER KIDNEY- THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 -Tasn: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Infant: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tasnt 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child: 1.17E+08_4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00
-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00E+00 2.80E+06 0.00E+00 Tsen: 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 Child: 3.92E+06 1.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 l j
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Cow Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tacn: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1.26E+08 0.00E+00 4.90E+07 0.00E+00 1 Child: 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 Tasnt 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00 Child: 2.84E+08 1.21E+07 2.01E+09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infant: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tosn: 9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 Child: 4.07E+03 1.15E+02 2.87E+04 2.62E+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00
=
ODCM R0v. 15 l Paga 150 l 12/94 Table 2-2 (Continued) Xa137 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE! For Pathway: Plume THYROID LUNG SKIN T. BODY GI-TRACT BONE- LIVER KIDNEY Adult: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02
-T@sn: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Child: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.'54E+01 4.24E+02 Infant: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway: Ground THYROID LUNG- SKIN T. BODY GI-TRACT BONE LIVER KIDNEY Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' ~ -Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E,JO 0.00E+00 For Pathway: Cow Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
( Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
tu ODCM Rsv. 15 < l- Paga 151 L 12/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR CASEQUE EFFLUENTS -- FOR ISOTOPE: Xe138 For Pathway: Plume LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID , Adults 1.96E+02 1.96E+02 1.96E+02-1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 { TOcn 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02'3.58E+02 Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Infant: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02
.For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN )
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i TOsn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l 1 Child: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00EF00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Tasn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l E _____ ___
ODCM R2v. 15 ==
-l Pega 152 12/94 l
Table 2-2 (Continued) Ba140 TMDIVIDUAL DOSE' FACTORS FOR CASEOUS EFFLUENTS -- FOR ISOTOPEr
'For Pathway: Plume LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground THYROID LUNG ' SKIN.
T. BODY GI-TRACT BONE LIVER KIDNEY Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 - Tasn: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Infant: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 For Pathway: Vegetable LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 Tacn: 1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 Child: 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tasn: 2.93E+04 7.02E+05-4.55E+05 5.58E+02 1.89E+02 0.00E+00 3.75E+02 0.00E+00 Child: 4.90E+04 4.25E+05 8.40E+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 3.37E+04 1.06E+06 5.15E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 l Tcon: 5.99E+04 1.43E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Child: 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 Infant: 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 For Pathway: Goat Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID l Adult: 4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 " Tacn: 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Infant: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+02 0.00E+00 For Pathway: Inhalation LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 Tasn: 1.12E+02 7.25E+03 1.73E+03 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infant: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00, l 1
ODCM Rsv. 15 l Page 153 l 12/94 Table 2-2 (Continued) Cel41 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: For Pathway: Plume LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Toen: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Infant: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 ,For Pathway: Vegetable THYROID LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY l Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 Teen: 5.57E+02 1.39E+07 7.26E+03 4.85E+03 2.28E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.29E+02 1.08E+07 1.74E+04 8.67E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00EF00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 Teen: 1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 Teen: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 child: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN L Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+02 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Teen: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: 9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 ' Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00
l ODCM RLv. 15 - Paga 154 l 12/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cel44' For Pathway: Plume T. BODY: GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 _
Tacn:- 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Child: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 Tasn: 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child: 1.87E+05._2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY. THYROID LUNG SKIN Adult: 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00 Tacn: 1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Tasn: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID L'UNG SKIN Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00-Tecn: 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00 l ~ Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+02 0.00E+00 0.00E+00 0.00E+00 L
'For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E+04 0.00E+00 2.46E+05 0.00E+00 Tasn: 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4.24E+05 0.00E+00 Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03 4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00
m,.. Il ODCM rov. 15- l peg 2'155 l
.l. 12/94' 'lj
-TABLE 2-3 Assumptions Used.in Limerick Gaseous-Effluent Dose Evaluation- ')
l Value Index Description 1 Fraction of produce from local garden 0.76 2 Fraction of leafy vegetable from local garden 1.00 3 Soil density in plow. layer (kg/m**2) 240.0 Fraction of deposited particulates retained on vegetation 0.20 4
'S Fraction of deposited. iodines retained on vegetation .l.0 6" Shielding factor of residential structures 0.7 7 Period of buildup of activity in soil (hr) 175200.0 8 Period of pasture grass exposure to activity.(hr) 720.0 9 Period of crop exposure to activity (hr) 1440.0 10- Transport time milkman (hr) 48.0 ,
.11 Delay time for ingestion of grass by animals (hr) .
0.0 { 12' Delay time for ingestion of stored feed by animals (hr) 2160.0 13- _ Delay time for ingestion of leafy vegetable by man (hr) 24.0 14 Delay time for ingestion of other vegetable by man (hr) , 1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0-16 Grass yield, wet-wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 18 Weathering rate constant for activity on veg (1./hr) 0.0021 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.0 21 Goat feed consumption rate (kg/ day wet) 6.0 l
. 22 Plume exposure adult (hr/yr) 8760.0. ]
23 Plume exposure teen (hr/yr) 8760.0 1 24- Plume exposure child (hr/ r) 8760.0 l 25 Plume exposure infant (hr yr) 8760.0 1 Ground exposure adult (h yr) 8760.0 I 26 27 Ground exposure teen (hr r) 8760.0 f C 28' Ground exposure child (h yr) 8760.0
,. 29 Ground exposure infant (hr/yr) 8760.0 30 Inhalation exposure adult (m**3/yr) 8000.0-31 Inhalation exposure teen (m**3/yr) 8000.0 1 32 Inhalation exposure child (m**3/yr) 3700.0 33- Inhalation exposure infant (m**3/yr) 1400.0 34 Leafy veg exposure adult (k /yr) 64.0 3 35 Leafy veg exposure teen (kg r) 42.0 i 36 Leafy veg exposure child (kg yr) 26.0 37 Leafy veg exposure infant (kg/yr) 0,0 38 Non-leafy veg exposure adult (kg/yr) 520.0 39 Non-leafy veg exposure teen (kg/yr) 630.0 40 r) 520.0 41 .Non-leafy Non-leafy veg exposureinfant veg exposure child (kg/y/yr)
(kg 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate teen (kg/ r) 0.0 44 Root veg consumption rate child (kg r) 0.0
ODCM R;v. 15 = fl 'Prge 156
=l~ 12/94 L
TABLE 2-3-(Continued) Assumptions Used in Limerick Gaseous Effluent Dose Evaluation L L Ind:x: Description Value Root veg consumption rate infant-(kg/yr)- 0.0 45'
.46 Cow milk consumption rate adult (1/yr) 310.0 47 Cow milk consumption rate teen (1/yr)- 400.0 48 Cow milk consumption rate child (1/yr) ~330.0 49 Cow milk consumption rate infant (1/yr)- 330.0 L yr) l-50 Goat milk consumption rate' adult ( 310.0 51 Goat milk consumption rate teen (1 r) 400.0 52' Goat milk consumption. rate child-(1 yr) 330.0 53 Goat milk consumption rate' infant (1 330.'O 54 Meat consumption rate adult (k /yr) /yr) 110.0 55 Meat consumption rate teen (k r) 65.0 41.0 56 Meat consumption rate child (k yr) i 57 Meat consumption rate infant (kg/yr) 0.0 58 Fraction of year animals on pasture 0.75 59 Fraction of-feed from pasture when on pasture 0.88-60 Fraction of year leafy veg grown 0.42
-61 Atmosphere hydrogen concentration (gm/m**3)- 8.0 t . . .
l ODCM Rev. 15 Page 157
- l. 12/94 TABLE 2- 4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
Plume Ground Inhalation Vegetation Meat Cow Goat Direction Pathways Pathway Pathway Pathway Pathway N 805 2414 3414 7562 0 805 1609 1585 0 0 NNE 965 3218 1097 4183 0 NE 965 2414 3871 0 0 ENE E 805 1770 1890 6758 0
~ESE 965 805 4511 1770 1770 1609 3862 7241 7241 0 SE SSE 1609 1609 7224 7241 0 S 1287 1931 3018 3701 5654 SSW 1609 1609 1433 2896 0 SW 965 1287 2835 4827 0 WSW 1287 1287 2134 2255 0 W 965 2574 4084 0 0 WNW 1126 1440 0 0 0 NW 1126 2574 6660 0 7401 NNW 1448 1931 6325 0 0 I
-ll ODCM Rev. 15 P:ge 158
- j. 12/94 APPENDIX A l
I l
'l
~
'ODCM Rev..15 Pcge 159
- j. .12/94 TABLE A-1 Technical. Specification /ODCM Matrix ODCM ODCM Section I Equation
[.1 Technical . Requirement Section II DEnecification*- 3.3.7.11 3.2.1 1-1
. 1 1 1-4 I' -- 3. 3. 7 .12 3.3.1 2-1.(or 2-9) o 2-2 (or 2-9).
2-4 (or 2-10) 2-5 (or 2-10) 3.11.1.1 3.2.2 1 t
.1-2 1-3 1-4 3.11.1.2 3.2.3 1-5 6
1-7 3.11.1.3 3.2.4 1-8 1-9 3.11.2.1 3.3.2 2-22 2-23 3.11.2.3 3.3.4 2-26~ 2-27 2-28
.3.11.2.2 3.3.3. 2-24 2-25 3.11.2'.4 3.3.5 2-33 3.11.2.7 3.3.6 2-4 2-5 l
- Transferred to ODCM'.via T.S. amendment #'48 for Unit 1 and 11 for Unit 2.
l
l ODCM Rev. 15 ?
.Page-160 l
12/94~ TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM Technical- Section I Equation-Specification *. . Requirement. Section II 1-5
~6.9.1.8 3.6 1-6 1-7 2-24 2-25 -_
2-26 2-27 2-28 3.11.4 3.3.7 3-1 3.12.1 3.4.1 Section.II App. B 6.9.1.7 3.5 .1-5'- 3.12.3 3.4.3 1-6 1 1-7 2-29 2-30 2-31 2-32 3-2
- Transferred to ODCM via T.S. amendment i 48 for Unit 1 and 11 for Unit 7.
, y
'l-t i
,g
.g-ODCM R;v.'.15 P ge 161' s ..
12/94. t APPENDIX B-
~
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM - S. AMPLE TYPE, LOCATION, AND ANALYSIS ao
?
a
-.ODCM Riv. 15; _
s m, - Prge 162' , 2
-12/94-I TABLE B-1 Page 1 of-4; ODCM - Limerick Generating Station Radiological Environmental Monitoring Program-Pathway Station Code Location Collection Method Analyses ,
e I. Direct Gamma dose quarterly
Site Boundary 36S2 3,183 feet N of site 1 set of-four (4) TLDs
! 3S1 2,301 feet NNE of site from each location at SS1 2,350 feet NE of site least quarterly
' 7S1 3,09? feet ENE.of site
-g 2,648 feet E of site' 10S3 11SI- 2,017 feet ESE'of site 13S2 2,149 feet-SE of site I 14S1 3,319-feet SSE of site I 18S2 1,390 feet S of site 21S2 977 feet SSW'of site 23S2 2,793 feet SW of site g 2,445 feet WSW of site 25S2 ~
g 2,088 feet W of site 26S3 g 2,886 feet WNW'of site
, 29S1 31S1 1,395 feet NW of' site 34S2 3,071 feet NNW'of site-i 8
Intermediate L36D1 18,527 feet:N-of site Distance 2El' 25,112-feet NNE of site 4E1 25,221~ feet NE.of site 7El 122,489- feet ENE of site 10E1 20,826 feet"E of site-10F3 29,442; feet ESE of site 13E1 22,772 feet SE of site 16F1 26,608' feet SSE of site l 19D1. 18,439 feet S of. site' ~ I -20Fl? '27,648' feet SSW of' site '
!' 24D1~. 20,972 feet SW of' site
! 25D1 '21,044 feet'WSW of. site: '
.! 28D2. -20,231'.. feet W of site f- 29El 26,110Lfeet-WNW.of site '
3102 20,446 feet NW of site - _ _ . . - - - . . . - - - _ - - - - - _ _ - . . - - - - - - - - - - . - - - - - - _ m _ r % -
3, ODCM R;v. 15 8
' P;ge 163l 12/94~
TABLE B-1 4 ODCM - Limerick Generating Station Radiological Environmental Monitoring Program Location Collection Method Analyses-Pathway Station Code 34E1 24,243 feet NNW of site l 1 Distant SH1 C 130,742 feet NE of site I and 6C1 11,305 feet NE of site Special 9C1 11,377 feet E of site Interest 13C1 14,980 feet SE of site 15D1 16,877 feet SE of site-17Bl. 8,462 feet S of site g 16,157 feet SSW of site l 20D1 31D1 15,853 feet WNW of site i ! II. Airborne 2,648 feet E of site Approximately 1 cfm Gross beta analysis Particulates 10S3 on each weekly. 11S1 2,017 feet ESE of' site continuous flow through 14S1 3,319 feet SSE of' site glass fiber filter. sample.- Gamma I 13C1 14,980 feet SE of site 'which is collected spectrometry shall be 93,619 feet SW of site weekly. done when gross beta f 22G1 C exceeds ten times the yearly mean of control station"
'value..
Gross beta analysis done 224-hr after-
. sampling to allow for--
. Radon and Thoron daughter. decay.
Gamma Spec-on quarterly. composite. j 1
~ ~ '
--i -- '
l }l
~ "., , , _
" ~
^
, ~ ODCM Rnv.- 15 (
'l -
' Peg 2-164- - 4t y ' -
~ 12/94' w: . _- .#. i - TAB LE ' B 3' Pagef3 of?4 ODCM - Limerick Generating Station
. ~
Radiological ~ Environmental Monitoring Program m
- Collection Method ; Analyses.
Pathway Station Code Location 2,648. feet E of site A TEDA impregnated Iodine 131-
' - Iodine. 10S3 flow-through cartridge; a, i
I -11S1 2,017' feet ESE of site 1 is connected to air
! 14S1 3,319 feet SSE of site sampler and is 14,980 feet SE ofTsite.
! 13C1 cellected weekly at 22Gl~C 93,619 feet SW of site site filter change.
III. Water
- Sample collected from a Gamma. isotopic-8 Surface 24S1 C 1,058 feet SSW of site analysis-monthly;_
13B1 9,225 feet ESE of site continuous water l . sampler, monthly. . In . event sampler is H-3 on quarterly. inoperable, weekly grab. composite samples will be collected'until sampler-returned to service.. A' sediment-sample is Gammaiisotopic Sediment 16C4 11,510 feet ESE of Site '. analysis leach sample-8 taken down streavi of' l discharge. semi-
- annually.
IV..Incestion 10B1 5,725 feet ESE of site Sample of. fresh milk'is ' GammaLisotopic and: 8 Milk' .I-1311 analyses on' 1981 10,317" feet SSW of= site -collected from each'
~21Bl~ 9,263 feet SSW of' site . farm' biweekly when cows- each sample' are' on ' pasture -' ( April'
' .22F1-C 50,569efeet SW of site' Lthrough October),
, monthly at other times.
I i r f
=ww y -- 3 ,ye v- w.r d g-. evmw e-,,.=<m'-w~79'+ 4 * * *- 9 w+T-*-*'e'e-ver'f=- 1N+ rte *-'**** M't+**"w'-r*--*-wwNe"--"-'W'P v *te-a' ***4-evt' W w-w-
- v uw= ' " 'd * * * ' - ' --*r" am.ee."sm.-.. 4** em
['4[ , l.v I l' ODCM R;v. 15 - O P2ge 165-j , 12/94 TABLE B-1
-ODCM - Limerick Generating Station "9"
- Radiological Environmental Monitoring Program
~
Pathway Station Code Location . Collection Method Analyses
' Drinking 15F7 33,400 feet SSE of site Sample collected from a Gross beta'and gamma-I 15F4 45,514 feet SE of site continuous water isotopic _ monthly, 16C2 14,034 feet SSE of site sampler monthly.- In ! 28F3 C 30,811-feet WNW of site event sampler in H-3 on quarterly inoperable, weekly grab composite-samples will be collected until sampler returned to service. ' Fish 16CS 9,251 feet SSE of site Two species of Gamma isotopic ! 29C1 C 13,725 feet WNW of site recreationally analyses on edible important fish portions.
(Predator and bottom feeder). sampled in season or semiannually if not seasonal. Food Two offsite locations of. highest Samples of three (3) Gamma isotopic Products predicted annual average ground different kinds of anaysis level D/Q and one location (15-30 km distance) in the least broad leaf vegetation. monthly when available. prevalent wind direction as- if milk samplingis not determined- using the results of performed the most recent annual Landuse. Survey. l C = Control Location
,y,n, . . . . . . -. . . - , .a w. -.. ,
i
, q ., .
FIGURES I M e t r W e n t 4 f I J s i 4
m j
. tifflT 2 IIennlur !! ict, linst liitlineist Illneh til 4 I18 .
7tilitl clan
~
! l'stillettlntn/lentillist litttilnllnti Multilnt ,
- ~ ~ y A s ,
j
', } . . ... ..
V , L_Q .gg_ . - ...g-Qy 4.- tancuni..nien
\ ( l Inng 1:lltur (typical) V 4
. l'hlintintphin tilecific Cornp.
s
, . l.hnsstick tintietaling Utnlluti 1)!i!!!_1_&_;
Gonotal liepnir Aren : unanuun IIlltiinnt l'inw l>lngenin ll'J1 Mtiliiteltelia? Ulini'_ .
. liXilAll!Ill 1 AN - f 1:11.1till l 'lN I.INI$NN I[.bb ODCM, Rev.15 Page 166-
! ...... . ___._ 12/94 e -d T W' et .'-vw( p ' tg is -
- w guy,T', 3 y- ;; ~ v e-
y Ep South Vant- South Vent - Particulate Unit 1 ' Unit 2 Particulate , lodine end El. 411' todine end
, ' El. 4 1 .
Noble Oes Continuous Continuous Noble Gee ' Monitor (2) Monitor (2) i (2)[ _ g,, - 234.000 234.000 b
- CFM' CFM M a n. M a n, nefueling Floor nefueling Floo, 4]
i 2 Enheuet T Enhaust (s) is
>G .
neector Enclosure Exhaust [ ist s4,000 gay 54.000 CFM CFM Min. Min. Equipment p ca * m 'a ' I 4 \ Equipment
,,g,, Vfj .{y **P*"*"'
,, o (21 Phliedelphie Elecirlo Comp.
Limerick Generating $letion Unite t & 2 Geseous Effluent - Flow Diagram South Stack-l ODCM, Rev.15-Page 167' l 12/94
~ 4 _.
~
I - Osa Monites Neath Vong Wide ' onne I a n x
" *"' / D ~l ui, , ,,,,, hnge p.,,,,,,,,,,, nenne Accident.
/\ - onel le itne L*" U*"U* ). Monitor Pas 9eutete, lodine &
Caatta"eee b Fiffer
"*'**** __l liebte Gee Hosenet 7
-M Sernple nonge Monitore One Montsee p
~~
(3) lenttine Estelosuse Ent.ai..t ese.cco CFM
- i. .e E e. e Y Equip. Cosupe.l Eshouel lushine Enetoause Enheuel
~
(2) I'I [+> + W l(2) Meeharleel Vee. Pump - Tinbtne Enetosure Esgulp. Comport Enheueg II. III + ' l'I Datteer noon Eshouel N'*I' Y" I""'P Stacen Peching Enhauster Steam Peck, Enhauster ' A nedonote Encl. Enheuet
- 4 '
- p..e e nndweste Encl. Equip.
(2) [ ' Y - Compostment Enhovetet Stamiby Gee Treet. Sye. I r-{2)- eats Geesous nedweste leselmont l , 4 Unit I Condenset Offges (2) + a Y ** """*C'"d*" N"' rume H d E=houet
+[/4l (*3h -
Pittladelphla Electric Comp. Centeel Area Enheuet 5,
+ Limesick Generating' Station Y gl (2) V V!'!!8.. t_& 2 , , , , ,
Gnseous Elltuosits Flow Diagenm Notth Stack .
.ODCM, Rev.15
! . unti t Chere.w sv ei.m Page 168 Filter " u. l g Exhaust Fan V[f2 >Ch ..els.iem r 12/94
+ .m i -
- r ,-r* - _ _ , a
'^~
f - , 4; ' ; , - s . l^ , 19 l . i I - a. - i
-> L.D. TANK - 'G FE nE' i Laundry -g '\
Denin (LD) L*D* ( Subsystem l U-L_y
> h SAMPLE -
FILT ED TANK To Cooling
- Tower
' Blowdown Line
-> L.D. TANK t) to GPM (Nom.) (Release Polag FD -
from Cliem. , Weste Tank SAMPLE 7,Q
TANK #1 FD FD FD FD
__g
- 'g g[,,n (FD) c ttE tmw 1 g FILTEli > DEMIN SAMPLE -
1 ANK #2 _p I^"" '"'"I suheystem ,
- In comtunent.
FD lo W aste tu W aste 2tm GPM Stosagte lamk _p ' Storfoe Tank Studge lank . (Nom) Sun 0E -l-TANK JL ED -
-> SAMPLE y
'" TANK A nr ED __p EU ED Equipment coti totuwe FILTER b DEMIN
~ ~ ~
TANK G D#ain (ED) ED Bubsystem ,, _ _) SAMPLE -
-p s b~ > To Weste -> To Weste TANK B -
y sludge Tanic sludge Tank To FDCT Phltaileiphim Electilo Camp.
- FE-83-053 thneilck Genierating Station CW p p u gusag.e3412 OR604 Ms l' & 2 -
Chem Waele h (CW) TANK I Liquid Effluent
*I* Flow DinDrani e ODCM, Rev.15 i
Page 169 8 12/94
* +^_____ - - _ _ _ _ _ - _+ . _ _ _
g - ,-w , , , m
pc y
' [!] - '
ODCM Riv.15'.
- Page'170
* ; [.. ' 12/94-l, u ,
1
- 4 y 'l mw _ we 3d12 9
& .c egi
\ ,,,,
3'S . nt Q "'*
,,,,. ,.,. IE.
.. J. ,s :
wsw ESE i?si .. sw ! se 4e g# # saw -" see
\
~
;I ,
\.
9 Figure B-1 Environmental Sampling Locations on Site or Near The Limerick Generating Station 0
. - . ~ -
r;
'}
ODCM Rev.15 Page 171 ,
..li 12/94 soo A.
4 NNW NNE 340 20 NW i NE
' 3' '
2 4it 3f1 WNW 29E ,7g ENE' 3got I 2eo2 N sc1 E '
.30 0
, ' 5s 17B% ESE WSW 2 I01 3301 2401
- _ 33{3.
20ot ng & 7' SSW g SSE ( O l d Figure B-2 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station
I ODCM lt.v.15 Page 172 7!
- ' 12/94 N
*N 4 ,
NNW , , NNE NW NE ENE WNW /
\ /
I N 28F3
\
29Ci W $
'l ie .
E 1Bp/ C2 WSW *'"' , l ESE 15F7 g 22F1 , l W SW j s Isr4 [ f f
\
SSW lv- e . m$ \ ssp = 1 Figure B-3 Aquatic and Milk Environmental Sampling Locations at Intermediate-Distances from the Limerick Generating Station i 1 i
J
- a Wa< Ht 1 O J _
f ee-w4W _. , Hw%9k s .
~
3 I s e c n a t s
,#c i Dn o
) ei tt oa
- w, ,f mt p eS
~# R g
tn ai t sa 4 nr
- - Bin oe E
N E
- E N" =,
rc te
'eaG uok e
e
~ -
i gLc F gr i
~,
3 + ne
- im
# li pL
- ' ss m ae 6 'e Sh
+
o, t
'l N
s am
., to 1
nr y n o 2 ef m n
- ~j I o
. r' .
i v
/*s n
=
=
w E' w
' )
w c W ** 2 2 e f x wD ' A
Paga 174 b l' REFERENCES 12/94:
) 1. Regulatory Guide 1.109, " Calculation of Annual . Doses to .' Man from
" ~ Routine Releases of Reactor Effluents for the' Purpose of Evaluating , Compliance with 10 CFR Part 50,-Appendix I," Revision 1, U.S. Nuclear !
' Regulatory Commission, Washington, D.C. 20555, October 1977.
l r . I L 2.- Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport ! and Dispersion of Gaseous Effluents in Routine Releases from Light-
. Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory 3
Commission, Washington, D.C. 20555, July 1977. L3. . Regulatory Guide 1.112, " Calculation of Releases of -Radioactive q Materials in Gaseous and Liquid Effluents from Light-Water-Cooled' Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1976. 4.. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and ~ Routine . ' Reactor Releases for the Purpose - of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977. I
- 5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of .J Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR-GALE Code)," USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976.
- 6. U.S. Nuclear Regulatory Commission, ' "X0QD0Q, Program for the 'l Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C. 20555, September, 1977. I
- 7. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 20, Appendix B, U.S. Government Printing Office, Washington, D.C. 20402, 4 January 1, 1977. l
- 8. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 100, j Government Printing Office, Washington, D.C. 20404, January 1, U.S.
1977.
- 9. Title '40, " Protection of Environment," Chapter I, Code of Federal
Reculations, Part 141, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.
- 10. Regulatory Guide- 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, June 1974.
I i l
~
=
'O: ODCM R0v.15 PEge 175 Ll) 12/94
*11.- Title 40, " Protection of Environment," Chapter 'I, Code of Faderal Regulations, Part 190, Federal Register, Vol. 42, No. 9, Washington,.
D.C. 20402, January 13, 1977. 12 . ' U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates," Section 2.3.4, Standard Review Plan'for the Review of Safety analysis Renorts for Nuclear Power Plants - LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975.
- 13. U.S. Nuclear Regulatory ' Commission, _" Preparation of Radiological-Effluent Technical Specifications for Nuclear . Power _ Plants," USNRC Report NUREG-0133, Washington, D.C. 20555, October 1978.
- 14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director _
Operations, Nuclear. Management and Resources Council, 6/30/93.
- 15. ANSI N42.14-1991'(Revision of ANSI N42.14-1978) " Calibration and Use of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2
- 16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors,
~
U.S. Dept. Of Energy (Revised Annually)
- 17. L.A. Currie, " Limits For Qualitative Detection and Quantitative Determination - Application to Radiochemistry", Analytical Chemistry, Vol. 40, pp. 586-593 (TABLE II), 1968
- 18. NUREG/CR-4007, " Lower Limit of Detection: Definition and: Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie (Chapter II,-Sect. D.2; 4 Chapter III, Sect. C.1), September 1984
- 19. Tech. Spec. Section 1.24 (Definitions)
- 20. USNRC Generic Letter, 89-01 I
-}}